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2 Zusammenfassung 
Kalziumionen sind eines der wichtigsten intrazellulären Botenstoffe der Zelle. Kleinste Veränderungen 
ihrer zytosolischen Konzentration triggern eine Vielzahl von zellbiologischen Prozessen, u.a. 
Exozytose, Kontraktion und Veränderungen von Enzymaktivität. Eine genaue und enge Kontrolle ihrer 
Konzentration durch Regulation ihres Einstroms, z.B. durch Ionenkanäle, aber auch ihrer Speicherung 
und des Transports aus der Zelle heraus ist deshalb essentiell. TRPV5 und TRPV6 sind die einzigen 
Mitglieder der TRP Kationenkanal Familie die eine hohen Selektvität für Kalzium aufweisen und sind 
an der Aufrecherhaltung der Kalziumhomeöstase im Körper beteiligt. Eine weitere Familie von 
Ionenkanälen mit hoher Selektivität für Kalziumionen wird von den Orai Genen kodiert. Hierbei gibt 
es drei homologe menschliche Gene, von denen das ORAI1 Protein der wesentliche ionenleitende 
Bestandteil des Speicherentleerungs-aktivierten Kalzium Einstroms (CRAC) in Lymphozyten ist. Das 
Ziel dieser Arbeit war es, Regulationsmechanismen der Ca2+ selektive Ionenkanäle TRPV6 und ORAI1 
zu untersuchen. 
Um die intrazelluläre Kalziumkonzentration konstant zu halten, müssen Zellen dynamisch auf 
Änderungen ihres metabolischen Zustandes, z.B. durch Änderungen der zellulären ATP Konzentration, 
reagieren. Ein erstes Ziel dieser Arbeit war es zu untersuchen, ob und wie der von TRPV6 getragenen 
Kalziumstroms durch ATP reguliert werden kann. Hierzu wurden zunächst elektrophysiologische 
Messungen in der sog. „whole-cell patch-clamp“ Konfiguration durchgeführt. ATP bewirkte eine 
signifikante Veränderung sowohl im Zeitverlauf der Entwicklung als auch in dem „rundown“ 
Verhalten der TRPV6 getragenen Ströme. Diese Effekte zeigten eine Spezifität für das verwendete 
Nukleotid und waren nicht abhängig von der Hydrolyse von ATP. Da bereits eine Regulation der 
kalziumabhängigen Inaktivierung von TRPV6 durch PIP2 in der Literature beschrieben war (Rohacs et 
al., 2005), wurde die Unabhängigkeit des ATP Effektes vom PIP2 Effekt mittels Mutagenese einer 
putativen PIP2 Bindungsstelle (R606Q) und durch die fehlende Wirkung eines wasserlöslichen PIP2 
Derivats bestätigt.  
Die Konzentrationsabhängigkeit des ATP-Efffektes ergab eine halbmaximale ATP konzentration 
(EC50) von ~380 µM mit einem apparenten Hill-Koeffizient von 4.8. Der EC50 Wert des ATP Effektes 
liegt nahe am Bereich der freien intrazellulären ATP Konzentration (Gajewski et al., 2003) und 
ermöglicht den Kanälen sensitiv auf geringe Schwankungen der ATP Konzentration zu reagieren. Um 
zu untersuchen ob ATP direkt an den Kanal bindet, wurden zunächst Versuche mit in-vitro 
translatierten TRPV6 an ATP-Agarose durchgeführt. Zur weiteren Eingrenzung von Bindungstellen 
wurden mehrere Fusionproteine der intrazellulären Proteindomänen hergestellt und in Bakterien 
exprimiert. Aufgrund eines integrierten Histidin-tags konnten die Fusionsproteine unter verschiedenen 
Bedingungen (nativ oder denaturiert) aufgereinigt werden und anschliessend im ATP-Agarose „pull-
down“ auf Bindung untersucht werden. Da die Aktivierung von Proteinkinase C (PKC) durch PMA die 
Effekte von ATP auf den Kalziumeinstrom von TRPV6 zu einem grossen Teil verhindern kann, 
wurden zunächst potentielle ATP Bindungsstelle in unmittelbarer Nähe der putativen 
Phosphorylierungsstellen von TRPV6 untersucht. Durch Mutagenese eines doppelten Arginin Motifs 
innerhalb der N-terminalen Ankyrin-repeat Domäne (R153Q/R154P) konnte der funktionellen ATP 
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Effekt aufgehoben werden und so eine spezifische Bindungstelle charakterisiert werden. Um die 
Spezifität des PMA Effektes weiter zu untersuchen wurde das inaktive Analogon von PMA (PDD) 
und verschiedene PKC Inhibitoren getestet. Hierbei konnte eine Spezifität des Effektes auf einen 
Subtypus der klassischen PKC’s, PKCßII, eingegrenzt werden. Diese Isoform war auch in in-vitro 
Phosphorylierungsversuchen in der Lage rekombinantes TRPV6 Protein schwach zu phosphorylieren. 
Eine zusätzliche Analyse durch Mutagenese der putativen Phosphorylierungsstellen innerhalb des 
TRPV6 Proteins ergab dass sowohl eine N-terminale PKC Erkennungsstelle, S144, als auch eine C-
terminale Stelle, T688, an der Vermittllung des PMA Effektes beteiligt ist. 
Zusammenfassend postulieren wir ein Model, indem ATP durch Bindung sowohl an den N- als auch an 
den C-terminus von TRPV6 den Kalziumeinstrom limitiert und dadurch den sog. „rundown“ 
verhindert. Aktivierung von PKCßII kann diesen Effekt durch Phosphorylierung spezifischer 
Aminosäuren verhindern und stellt somit einen Gegenregulationsmechanismus dar. 
Ein weiterer Aspekt dieser Arbeit beschäftigte sich mit der Regulation der ORAI1 Kanäle durch 
Änderungen des extrazellulären Redoxzustandes. In entzündetem Gewebe sind differenzierte 
Immunzellen (Effektor Th-Zellen) einer relativ hohen Konzentration von reaktiven Sauerstoffspezies 
(ROS) ausgesetzt. Da die Lymphozytenfunktion von der Aktivität der ORAI Kanäle gesteuert wird, 
wurde der Einfluss von reaktiven Sauerstoffspezien, in diesem Fall H2O2, auf ORAI1 untersucht. 
Messungen der intrazellulären Kalziumkonzentration und des Speicheraktivierten Einstroms zeigten, 
dass H2O2 den ORAI1 vermittelten Einstrom mit einem IC50 Wert von ~ 40 µM blockiert. 
Interessanterweise wurde der homologe ORAI3 Kanal nicht durch H2O2 inhibiert. Gerichtete 
Mutagenese einzelner reaktiver Cysteine mit anschliessender biochemischer und funktioneller Analyse 
ergab, dass Cystein 195 der wesentliche Redoxsensor von ORAI1 ist. Da die homologe Stelle in 
ORAI3 ein Glycin ist, haben wir durch Mutagenese dieses Glycins in ein Cystein H2O2 sensitive 
ORAI3 Kanäle generiert, also eine sogenannte „gain-of-function“ Mutation hergestellt. Um zu 
untersuchen, wieso menschliche Effektor-T-Zellen weniger sensitiv auf H2O2 reagieren als naïve T-
Zellen haben wir RT-PCR Versuche durchgeführt um die relativen Mengen an ORAI1 bzw. ORAI3 
Transkripten zu erfassen. In der Tat wurde in Effektor Zellen mehr ORAI3 exprimiert. Eine heterologe 
Ko-transfektion von ORAI1 mit ORAI3 zeigte eine Reduktion der H2O2 Sensitivität. Diese Ergebnisse 
könnten also eine mögliche Erklärung für reduzierte ROS Sensitivität der Effektor Th-Zellen darstellen 
und es wäre möglich durch eine Regulation der ORAI1/3 Expression die Aktivität der Th-Zellen in 
entzündetem Gewebe zu steuern. 
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3 Summary 
Since recognition of Ca2+ as a second messenger, considerable research has been directed towards 
understanding the tight Ca2+ homeostatic mechanisms that keep the intracellular free calcium 
concentration in a very tight range. Controlling the activity of Ca2+ selective ion channels is one critical 
component of these homeostatic mechanisms. TRPV6 and TRPV5, as members of the non-voltage 
gated family of TRP ion channels, have an exceptional Ca2+ selectivity and are considered gate keepers 
for Ca2+ homeostasis. An additional Ca2+ selective family of ion channels is the ORAI family that 
includes three homologous channels in humans with ORAI1 being the main component mediating 
Ca2+-release activated calcium (CRAC) current in lymphocytes. The present work aimed at 
understanding regulation of the Ca2+ selective ion channels TRPV6 and ORAI1.  
To understand how cells adapt their Ca2+ uptake to changes in cellular metabolic state, regulation of 
Ca2+ influx by ATP was characterized. ATP dramatically alters both the kinetics of current 
development and completely prevents rundown of TRPV6-mediated currents. These effects are 
nucleotide specific and do not require hydrolysis of ATP. Furthermore, the ATP effect is  independent 
of regulation by PIP2, which has previously been shown to regulate TRPV6 (Rohacs et al., 2005).  
Using a range of ATP concentrations a dose response curve was constructed and the EC50 of the ATP 
effect was calculated to be ~380 µM with a Hill coefficient of 4.8. This value corresponds well to 
cellular free ATP concentrations (Gajewski et al., 2003) and renders the channels sensitive to small 
fluctuations within cellular ATP. To identify whether ATP directly binds to the channel protein, the 
binding of in vitro translated TRPV6 protein to ATP-agarose was investigated. To narrow down 
specific binding site(s), different histidine tagged fusion proteins covering different intracellular 
domains were generated. Fusion proteins were purified under two different experimental conditions 
(denaturing and native). Subsequent ATP-agarose pull-down experiments identified several potential 
binding domains. Because activation of protein kinase C (PKC) by PMA prevented the effects of ATP 
both on kinetics and run-down of TRPV6 currents, potential ATP complexing residues in vicinity of 
phosphorylation sites were analyzed. Mutational analyses (R153Q/R154P) identified specific residues 
within the ankyrin repeat domain critical for conferring the functional ATP effect. To address the 
specificity of the PMA effect, an inactive analogue of PMA (4PDD) and a range of PKC inhibitors 
were applied. Analyses of PKC modification indicates that the effects of PMA are mediated by a 
specific PKC isoform PKCßII. This specific isoform can weakly phosphorylate TRPV6 as shown by in 
vitro phosphorylation experiments. Moreover, mutational analyses of potential phosphorylation sites 
identified two sites (S144, T688) as being of particular importance in mediating the effects of PMA. 
Altogether, the results suggest a model in which ATP binds to both C- and N-termini of TRPV6 
limiting Ca2+ influx and preventing rundown, an effect that can be prevented if the channel is 
phosphorylated at PKC consensus sites within the N- or a C-terminus (S144, T688). 
Regulation of ORAI1 by changes in the extracellular environment was also subject of the present work. 
Because differentiated lymphocytes (effector Th-cells) are exposed to substantial concentrations of 
reactive oxygen species (ROS) within inflamed tissues, regulation of ORAI1 channels by ROS was 
investigated. Measurements of Ca2+ signals and whole cell currents show that H2O2 inhibits ORAI1-
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mediated Ca2+ influx with an IC50 ~ 40 µM. In contrast, ORAI3 channels are not inhibited by H2O2. 
Site directed mutagenesis followed by functional and biochemical investigation identifies C195 to be 
the redox sensor of ORAI1. This finding is confirmed by introducing a potential “gain-of-function” 
mutation that renders ORAI3 sensitive to H2O2 regulation. RT-PCR performed using RNA purified 
from naïve and effector Th cells showed that the relative expression of ORAI1/ORAI3 is shifted to a 
higher ORAI3 ratio in effector compared to naïve Th cells. Cells co-transfected with ORAI1/ORAI3 in 
a ratio similar to upregulated ORAI3 showed less H2O2 inhibition than ORAI1 alone. These results 
provide a possible explanation of the observation that effector T Th cells are more tolerant to H2O2 than 
naïve Th cells. In addition, the data suggests that ROS regulation of ORAI channels fine tunes the 
activity of Th cells. 
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4 Glossary 
Units and measurements  
% (v/v) Percent volume/volume 
% (w/v) Percent weight/volume 
g Multiples of force of gravity 
µg microgram 
µl Microlitre 
bp Base pairs  
cfu Colony forming unit 
Ci Curi 
cm Centimeter 
Da Dalton 
g Gram 
h Hour 
kb Kilo base 
kD Kilo Dalton 
kV Kilo volt 
l Litre 
M Molar 
mA Milliampere 
min Minute 
ml Millilitre 
mM Millimolar 
mV Milli Volt 
ng Nanogram 
pA Pico Ampere 
pF Pico Farad 
PKC Protein kinase C 
pS Pico Siemens 
rpm Revolution per minute 
RT Room temperature 
s Second 
U Unit (of enzymatic activity) 
V Volt 
Miscellaneous abbreviations 
 Delta, deletion 
Ab Antibody 
ADP Adenosine-5’-diphosphate 
AEBSF 4-(2-Aminoethyl)-benzenesulfonylfluorid 
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AMP Adenosine-5’-monophosphate 
ANK Ankyrin repeat domain 
APS Ammonium persulfate 
ATP Adenosine-5’-triphosphate 
BCA Bicinchoninic acid 
BSA Bovine serum albumin 
cAMP Cyclic adenosine monophosphate 
cDNA Copy DNA 
CIP Calf intestine phosphatase (alkaline phosphatase) 
Co-IP Co-immunoprecipitation 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
dNTP Desoxynucleotide-5’-triphosphate 
DTT Dithiothreitol 
E.coli Escherichia coli 
EDTA Ethylendiamin-N, N, N`,N`-tetraacetic acid 
EGFP Enhanced green fluorescent protein 
EGTA Ethylene glycol tetraacetic acid 
FCS Fetal calf serum 
G-418 Geneticin 
GPCR G-protein coupled receptor 
GTP Guanoosine-5’-triphosphate 
HEK293 Human embryonic kidney cells 
IMP Inosine monophosphate 
IPTG Isopropyl--D-thiogalaktosid 
IRES Internal ribosome entry site 
LB Luria Bertani Nutritive medium 
NMDA N-methyl-D-aspartic acid 
OD600 Optical density at wave length 600 nm 
PBS Phosphate buffered saline 
PEG Poly ethylene glycol 
PKC Protein kinase C 
PMSF Phenylmethylsulfonylfluoride 
Primer Oligodesoxynukleotide 
PS Phosphatidylserine 
SDS Sodiumdodecylsulfate 
TBE Tris-Borat-EDTA-Buffer 
TBS Tris buffered saline 
TBST Tris buffered saline with 0.1% tween 20 
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TCA Trichloroacetic acid 
TEMED N,N,N`,N`-Tetramethylethylendiamin 
Tm Melting temperature 
Tris Tris-(hydroxymethyl)-aminomethan-hydrochlorid 
TRP Transient receptor potential 
Tween Polyoxyethylensorbitanmonolaureate 
UTP Uridine-5'-triphosphate 
UV Ultraviolet 
WB Western blot 
WT wildtype 
X-Gal 5-Brom-4-Chlor-3-indolyl--D-galactoside 
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5 Introduction 
For a cell to preserve its integrity and perform its functions it has to fulfil its needs from the available 
surrounding resources, respond to the perceived stimuli and adapt to changes. Communication between 
different intracellular components, signalling, is therefore a crucial requirement for cellular survival 
and efficiency. Calcium ions (Ca2+) are ubiquitous second messengers that trigger a plethora of 
biological processes. An array of Ca2+ “on” and “off” switches act in concert to tightly regulate 
intracellular Ca2+ levels. While different calcium permeable ion channels in the plasma membrane 
allow Ca2+ influx and endoplasmic and sarcoplasmic reticula allow Ca2+ release form internal stores 
both sources leading to subsequent increase in cytoplasmic levels ([Ca2+]i), a diversity of intracellular 
Ca2+ distribution systems, Ca2+ ATPases and ion exchangers work on extrusion of Ca2+ whenever in 
excess.  
The scope of our work are regulatory mechanisms governing the activity of two plasma membrane 
Ca2+-selective channels. On the basis of their activation mechanisms, Ca2+ channels are classified into 
four main groups. First the voltage operated Ca2+ channels (VOCC) that mediate heart action potential 
and fusion of vesicles of many excitable cells. VOCCs are activated by depolarization of the plasma 
membrane. Second, the ligand-gated calcium channels which comprise a range of structurally and 
functionally diverse channels that are particularly prevalent in secretory cells and at nerve terminals. 
They are activated by the binding of an agonist (e.g ATP, serotonin, glutamate and acetylcholine) to 
the extracellular domain of the channel. Depletion of Ca2+ stores is the mechanism activating the third 
subset of channels, store operated calcium channels (SOCC). This depletion can be induced by a Ca2+–
mobilizing messenger or a pharmacological agent. Less prevalent are the mechanically activated Ca2+ 
channels which respond to deformation and thereby convey information concerning stress and shape 
changes that a cell is experiencing such as those occurring with stretched tracheal or heart cells or in 
auditory hair cells. In addition to these well established mechanisms of activation, there is growing 
evidence that some Ca2+ channels are activated by lipid second messengers though these are not 
classified as an independent group.  
5.1 TRP Ion Channels 
The transient receptor potential superfamily entails a diverse family of cation channels. This 
superfamily is distinct in displaying a remarkable diversity of ion selectivities, modes of activation and 
physiological functions. A prevalent property of TRP members is being of particular importance in 
sensory physiology ranging from vision to gustation, olfaction, audition, mechanosensation and 
thermosensation. TRP channels also allow individual cells to sense changes in the local environment 
such as alteration in fluid flow, pH, temperature and mechanical stress. Trp gene was first identified as 
a Drosophila melanogaster phototransduction defective mutant. While calcium stores in wildtype 
photoreceptors resond to a prolonged light stimulation with an initial and an adaptive phase response, 
the trp-carrying photoreceptors show a transient response that decays to a basal line (Cosens and 
Manning, 1969). Montell and Rubin (Montell and Rubin, 1989) first cloned the gene underlying the trp 
phenotype, although the physiological role of the protein was unknown. The firm role of calcium as a 
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second messenger involved in adaptation and excitation led Minke and Selinger (Minke and Selinger, 
1992) to suggest that trp gene may code for a plasma membrane calcium transporter essential for 
replenishment of stores and Hardie and Minke demonstrated in the same year that the TRP protein 
indeed functions as a calcium permeable ion channel (Hardie and Minke, 1992). Also in 1992, a 
closely related channel was identified from photoreceptors and termed TRPL (Phillips et al., 1992). 
The photoreceptor response in Drosphila requires both channels as mutants lacking both TRP and 
TRPL are completely unresponsive to light (Niemeyer et al., 1996).  
Since then, TRP channels have been identified in various multicellular organisms from worms to 
humans. According to their sequence and topological similarities, the TRP channels are divided into 
two main groups that together include the seven TRP subfamilies. Group 1 includes the five 
subfamilies that bear the strongest sequence homology to the founding member Drosophila TRP. These 
subfamilies are the ankyrin (TRPA), canonical (TRPC), melastatin (TRPM), and vanilloid (TRPV) in 
addition to TRPN (no mechanopotential, NOMPC) which is not found in mammals although expressed 
in some vertebrates such as zebrafish. The subfamilies acquire their names from the initially described 
member, which in most cases is named after the channel activator. Mucolipin (TRPML) and polycystin 
(TRPP) channels constitute group 2 because they are distantly related to group one. The founding 
TRPP ant TRPML proteins were discovered as gene products mutated in autosomal dominant 
polycystic kidney disease (ADPKD) and mucolipidosis type IV (MLIV), respectively. TRPY is a 
group of ancient proteins expressed in fungi (founding member is the yeast vacuolar protein, Yvc1). 
These proteins are weakly related to TRP proteins and thus not classified along either Group 1 or 2 
TRPs (Montell, 2005). An overview on the classification of TRP channels subfamilies is depicted in 
figure 1 
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Figure 1: Phylogenetic tree showing the relatedness of TRP proteins. The dendrogram of vertebrate TRPs 
includes mostly human TRPs, except for mouse TRPC2 and zebrafish TRPN1. White text and cartoons highlight 
the TRP proteins from worms and flies. One C.elegans and one Drosophila member of each subfamily are 
included (Venkatachalam and Montell, 2007) 
The core of a TRP channel structure has N- and a C- termini located intracellularly and 6 domains 
spanning the plasma membrane with a pore region flanked between the fifth and sixth. Hydropathy 
analyses predict a seventh N-terminal hydrophobic domain in many TRPC, V, M, P and ML family 
members. TRPP and TRPML have an extended extracellular loop between S1and S2. TRP proteins 
Generated by Foxit PDF Creator © Foxit Software
http://www.foxitsoftware.com   For evaluation only.
                                                                                                                                      Introduction 
14 
 
like many other 6 transmembrane domain channels form a tetrameric quaternary structure where each 
subunit contributes to a shared selectivity filter and ion-conducting pore (Venkatachalam and Montell, 
2007).  
The N-terminus of TRPC, V, A and N contain a number of ANK repeat domains. While the canonical 
and the vanilloid subfamilies have few repeats (up to 4 and 6, respectively), the ankyrin (TRPA) and 
no mechanopotential (TRPN) subfamilies have many conserved repeats (up to 18 and 29, respectively). 
By definition, an ANK repeat domain is a ~ 33 residue motif found in tandem arrays ranging from 3 to 
more than 30 repeats (Mosavi et al., 2004). However, an ANK repeat is not a tightly conserved 
sequence but rather a conserved secondary and tertiary structure: helix-turn-helix or a hairpin of two 
short –helices, followed by a hairpin loop that projects perpendicular to the helical axes (Gaudet, 
2008). Poor conservation of the ANK sequence hampers an accurate definition of the number of ANK 
repeats in a given protein. TRPM channels are different from other group 1 TRP. They are longer 
proteins and lack ANK repeats. Instead they contain TRPM homology domains (MHD) of unkown 
function. For ANK repeats several functional aspects have been proposed that include self-interacting 
motifs, necessary for tetramerization of TRPV6, TRPV5 and TRPV4 (Arniges et al., 2006; Chang et 
al., 2004; Erler et al., 2004), the formation of a gating spring of the putative mechanosensory channels 
TRPN and TRPA1 (Corey et al., 2004; Howard and Bechstedt, 2004) as well as binding to regulatory 
molecules like calmodulin and ATP (Lishko et al., 2007). However, although necessary for overall 
function of the channels containing them, the detailed function ANK repeats remain elusive.  
C-terminal to the sixth transmembrane domain a loosely conserved homologous block of ~25 residues 
appears in all TRP channels, and is termed the TRP domain. The TRP domain encompasses two TRP 
boxes; the first is a highly conserved 6-amino acid sequence (e.g EWKFAR in TRPC channels) that is 
separated from the second proline-rich TRP box by ~12 residues. TRP domains are shown to be 
required for PIP2 binding and regulation of channel gating in TRPM8 and TRPV5 (Voets and Nilius, 
2007). TRP channels also contain partial pleckstrin homology (PH) domain that forms functional PH 
holodomain only when associated with cognate sequences in other proteins (Lee et al., 2003).  
Several subgroups and some single members also contain a very well described structural domain 
known as coiled coil domain. These heptad repeat (abcdefg)n structures are some of the best defined 
protein-protein interaction domains with a conserved alpha-helical structure where hydrophobic amino 
acids at the (a) and (d) positions form the core of the domain. Coiled coils are suggested to play a role 
in TRP channel subunit-subunit interactions to mediating heteromultimerization [TRP and TRPL, (Xu 
et al., 2000)] and homomultimerization of TRPM channels (Tsuruda et al., 2006). An interesting 
property of some TRP members, namely TRPM channels is the possession of an unusual C-terminal 
domain with atypical protein kinase enzyme activity. These channels are thus termed chanzymes 
(Venkatachalam and Montell, 2007). Main structural domains of TRP channels are shown in figure 2 
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Figure 2: Structural features of TRP superfamily. A schematic representative of each subfamily belonging to 
group 1 (upper panel) or group 2 (lower panel). Domains indicated depicted in the index panel. Reproduced from 
(Venkatachalam and Montell, 2007) and (Pedersen et al., 2005) 
TRP channels mediate transmembrane flux of cations down their electrochemical gradients. With the 
exception of TRPM4 and TRPM5, all TRP channels are permeable to Ca2+. TRPV5 and TRPV6 are 
highly Ca2+ selective unlike other TRP channels. There are several established modes for activation of 
TRP channels. While some TRP channels are indirectly modulated via a GPCR-mediated pathway, 
others are activate by ligand binding. Ligands can be exogenous molecules like capsaicin or icilin, 
endogenous lipids or lipid metabolites, purine nucleotides or inorganic ions. Direct physical activation 
can also evoke a TRP response. Putative direct activators include acute temperature changes, 
mechanical stimuli, cell swelling, conformational coupling to IP3 and channel phosphorylation 
[activation mechanisms reviewed in (Ramsey et al., 2006)]. 
5.2 TRPV subfamily and TRPV6 
The founding members of TRPV subfamily are OSM-9 in C.elegans and TRPV1 in mammals. OSM-9 
was identified during genetic screening for defects in osmotic avoidance (Colbert et al., 1997) while an 
elegant expression cloning strategy was able to identify TRPV1 among channels activated by vanilloid 
compounds (Caterina et al., 1997). The TRPV channels can be subgrouped into four branches by 
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sequence homology (Fig.3) Two branches constitute the mammalian TRPVs: the thermosensitive 
TRPV1-4 and the Ca2+ selective TRPV5-6. The other two branches are invertebrate branches including 
the C.elegans OSM-9 and the Drosophila Inactive (Iav) and Nanchung (Nan) proteins. Osmo-9 
functions in osmotic avoidance, olfaction, mechanosensation and social feeding (de Bono, 2003), while 
Drosophila Iav and Nan participate in auditory response (Kim et al., 2003); (Gong et al., 2004). 
In addition to the vanilloid compound capsaicin, TRPV1 is shown to be activated by other substances 
including resiniferatoxin, endocannabinoid lipids such as anandamide, eicosanoids, and 2-APB. Heat  
43°C activates TRPV1 and this threshold is shifted to room temperature by injury-induced tissue 
acidosis and inflammatory cytokines (Zhang et al., 2005) which underlie the nociceptive function of 
TRPV1. TRPV2, as well, is activated by noxious heat ( 52°C) and is, together with TRPV1, 
expressed in small to medium-diameter dorsal root ganglia (DRG) neurons maintaining the fidelity of 
signalling in response to painful heating (Caterina et al., 1999). Warmer temperature are, on the other 
hand, enough to activate TRPV3 (33-39°C) and TRPV4 (27-34°C) (Montell, 2005). Besides heat, 
thermosensitive TRPVs can integrate several other stimuli [reviewed in (Vennekens et al., 2008)]. 
While TRPV1-4 are Ca2+ permeable with little selectivity to divalent over monovalent cations (PCa/PNa 
between 1 and 10), TRPV5 and TRPV6 are explicitly classified in the second subset of TRPV channels 
because they show strikingly high Ca2+ selectivity (PCa/PNa >100) that makes them virtually 
impermeable to monovalent ions except in absence of divalent cations (Vennekens et al., 2000; Yue et 
al., 2001). 
 
Figure 3: Phylogenetic tree showing the four branches of TRPV family. The mammalian TRPVs: subgroups into 
TRPV1-4 and TRPV5, 6; Drosophila TRPVs: Nanchung and Inactive; C. elegans TRPVs:OSM-9 and OCR1-3. 
Distance scale is expressed as the number of substitutions per amino acid (Liedtke and Kim, 2005) 
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TRPV6 was first identified as the calcium transport protein responsible for calcium uptake and thus 
named (CaT1) (Peng et al., 1999). The completion of the genome sequencing project declared CaT1 
and CaT-L, identified by Wissenbach and co-workers in 2001(Wissenbach et al., 2001), to be 
orthologous proteins that were, together with ECaC2 (Hoenderop et al., 2001), named as TRPV6. 
TRPV5 and 6 are only 22-24% identical to thermosensitive TRPVs but they share 74% amino acid 
identity (Ramsey et al., 2006) and are located in close proximity on the human genome where TRPV6 
is located on chromosome 7q33-q34 and TRPV5 on 7q35. The fact that these human chromosomal 
locations correspond to murine chromosome 6 and to chromosome 4 in rat suggest that TRPV5 and 
TPRV6 have arisen by gene duplication from an ancestral gene, the pufferfish Takifugu rubripes, for 
example, has only one gene which is slightly more similar to TRPV6 than to TRPV5 (Qiu and 
Hogstrand, 2004). The chromosomal organization of TRPV6 is conserved among several species. 
Depending on the species, the deduced amino acid sequence results in 719, 725, and 727 amino acid-
proteins in pufferfish, humans and rodents, respectively. The calculated molecular weight of human 
TRPV6 is 83.21 kDa, with a pI of 7.56. Due to posttranslational glycosylation, heterologously 
expressed TRPV6 protein can be detected at molecular weights ranging between 75-100 in a 
denaturing SDS-PAGE gel (Wissenbach and Niemeyer, 2007).  
TRPV6 was initially cloned from rat duodenum and Northern blot analysis showed that it is expressed 
chiefly in the small intestine and rat colon (Peng et al., 1999). Trials to detect TRPV6 in murine and 
human intestinal tissues were divergent. In two independent studies, TRPV6 could not be detected in 
human (Wissenbach et al., 2001); or mouse (Hirnet et al., 2003) intestinal tissue while two other 
groups were able to detect TRPV6 transcripts in human patients’ duodena (Barley et al., 2001; Peng et 
al., 2000). Expression of TRPV6 is, however, prevalent in placenta, pancreas (human and murine), 
testis, epithelial cells of salivary glands (Hirnet et al., 2003; Hoenderop et al., 2001; Muller et al., 2000; 
Peng et al., 2000; Wissenbach et al., 2001; Xu et al., 2009). In addition, it has been shown that Ca2+-
transporting epithelia can coexpress TRPV5 and TRPV6 generating in theory a pleiotropic set of 
functional heterotetrameric channels with different Ca2+ transport kinetics (Hoenderop et al., 2003). 
Expression of TRPV6 associates with prostate cancer progression (Fixemer et al., 2003) and is shown 
to underlie Ca2+-mediated cell proliferation believed to be essential for tumour progression (Schwarz et 
al., 2006).  
TRPV5/6 display a selectivity for monovalent cations corresponding to Eisenman sequence X or XI 
(Na+~Li+>K+>Cs+) and for divalent cations Ca2+>Ba2+>Sr2+>Mn2+. In absence of divalent cations, 
TRPV6 has single channel monovalent cation conductance of 27-73 pS measured over a range of -10 
to -80 mV (Semenova et al., 2009; Vassilev et al., 2001). A positively charged aspartate residue in the 
pore region of TRPV6 (D541) and TRPV5 (D542) are shown to play a pivotal role commanding the 
conductive properties of the two channels (Nilius et al., 2001; Voets et al., 2004). Mutating the 
aspartate to alanine abolishes Ca2+ permeation, and to lysine renders the channel non functional. By 
binding to this aspartate Mg2+ blocks TRPV6 pore, as Voets and colleagues have shown (Voets et al., 
2004; Voets and Nilius, 2003; Voets et al., 2001).  
Structurally, TRPV6 is a typical TRPV channel. The N-terminal end encompasses six ANK repeat 
domains with the third domain being of prevalent importance for homotetramerization of TRPV6 as 
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well as for the dominant negative effect of a pore mutant on native channel subunits (Erler et al., 
2004). A potential PIP2 binding residue is located within the TRP box at the C-terminal end of TRPV6 
protein. Depletion of PIP2 is shown to mediate Ca
2+-dependent inactivation (Rohacs et al., 2008). In 
heterologous expression systems, TRPV6 shows constitutive activity at low intracellular Ca2+ 
concentrations and negative voltage. Hyperpolarizing cells expressing TRPV6 increases the electrical 
driving force and thus lets more Ca2+ through the channel. TRPV6 shows distinct inward rectification 
with minimal outward currents with highly buffered pipette solutions. Calcium selectivity is also 
manifested by the channel’s impermeability to monovalent cations except in absence of divalent 
cations (Wissenbach et al., 2001; Hoenderop et al., 2001).  
TRPV6 regulatory mechanisms: Because TRPV6 channels could be constitutively active in native 
systems, regulating the number of channels at the plasma membrane is critical. The auxiliary protein 
S11A10 associates with the conserved VATTV motif in the C-terminal end of TRPV6 and is found to 
be crucial for TRPV6 targeting to the plasma membrane (van de Graaf et al., 2003). Furthermore, 
surface expression is driven by interaction with the calcium binding protein 80K-H to the MLERK 
motif downstream of the S11A10 binding site (Gkika et al., 2004). The same motif has been shown to 
bind preferentially to the GDP-bound form of Rab11a prior to routing of TRPV5/6 to the plasma 
membrane (van de Graaf et al., 2006). This regulatory mechanism was later confirmed for TRPV5 
which was shown to be internalized in a clathrin-dependent manner into vesicular structures then 
localizes to perinuclear structures positive for Rab11a (van de Graaf et al., 2008). TRPV5/6 have a 
conserved glycosylation site at the extracellular loop between transmembrane domains 1 and 2 (Hirnet 
et al., 2003). Hydrolysis of the complex carbohydrate residues at this site by klotho, a ß-glucuronidase 
with sialidase activity (Kuro, 2009), keeps the channels anchored at the plasma membrane enhancing 
their currents (Chang et al., 2005). 
Besides the control of surface expression, TRPV6 is a subject of Ca2+ dependent and independent 
regulation. When TRPV6-expressinng cells are subjected to a prolonged hyperpolarizing pulse they 
show a multiphasic inactivation pattern. The first phase is rapid witnessed only in presence of 
extracellular Ca2+ but not Ba2+. The subsequent complex slower phase is partially mediated by binding 
of Ca2+ activated calmodulin (Derler et al., 2006; Niemeyer et al., 2001). Calmodulin binding is 
prevented by in vitro PKC phosphorylation at threonine 702 (Niemeyer et al., 2001). As a Ca2+ sensor, 
calmodulin was also shown to regulate activity of mouse TRPV6 where consensus motifs were 
identified within the N-terminal end, the transmembrane domain and at the C-terminal end (Lambers et 
al., 2004). However, N-terminal binding could not be confirmed for murine TRPV6 by two 
independent groups (Derler et al., 2006; Phelps et al., 2008).  
A distinguished property of the human TRPV6 gene is that it exhibits non-synonymous substitutions at 
three loci, namely amino acid 157, 378 and 681, resulting in two different alleles with a coupled 
polymorphism: the ancestral allele (TRPV6a: RVT) and the derived allele (TRPV6b: CMM). A unique 
attribute of the two alleles is the confinement of the ancestral allele to a distinct geographical 
distribution as it is predominant in African populations and the derived allele in other tested 
populations thus also termed new world allele (Akey et al., 2006). The geographical confinement 
suggests that the ancestral allele of TRPV6 must have been subjected to selection of a pre-existing 
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mutation in the ancestral African population which subsequently became advantageous in a new 
environment and rose to high frequency represented by the derived allele in the new world (Hughes et 
al., 2008). However, if and how selection conferred functional advantage remain elusive. Trying to 
reveal potential functional differences between the two alleles, Huges et al compared the 
electrophysiological properties of both alleles in patch clamp experiments but could not spot 
significant differences (Hughes et al., 2008). Clinically, a higher occurrence of renal stones was 
observed in individuals heterozygous for the ancestral allele (Suzuki et al., 2008a), however, only one 
patient homozygous for the ancestral allele was part of the study. Because the expression of TRPV6 is 
shown to correlate with developmental stage and invasiveness of some cancers like prostate cancer 
(Fixemer et al., 2003), it is interesting to find out whether TRPV6 polymorphism is involved in the 
higher occurrence of prostate cancer among African Americans (Abdalla et al., 1998). Our study 
attempts to contribute to uncovering possible differences between the two alleles in heterologous 
systems. 
 
 
5.3 Regulation of ion channels by ATP 
ATP is a multifunctional nucleotide representing the molecular unit of intracellular energy. ATP tunes 
the electrical activity of excitable and nonexcitable cells through direct or indirect modulation of 
several ion transporters and channels. The already identified mechanisms underlying this modulation 
are variable: while some require ATP hydrolysis and involve protein kinases, others are mainly carried 
out by intermediary regulatory proteins that are not for all cases well identified. The structural motifs 
regulating ATP binding and hydrolysis have been elucidated by the resolution of numerous crystal 
structures, both of isolated domains and of complete proteins (Hollenstein et al., 2007)  
ATP-mediated regulation of many ion exchangers is well described. For example, ATP increases the 
activity of Na+/Ca2+-exchanger (NCX) by direct PKA- and PKC-mediated phosphorylation (Caroni and 
Carafoli, 1983), increasing PIP2 production (Hilgemann and Ball, 1996) and via a GPCR-mediated 
stimulation (DiPolo and Beauge, 1998). Other exchangers regulated by ATP include Ca2+- , H+-, 
Na+/K+ -ATPases and Na+/H+ exchanger [reviewed in: (Annunziato et al., 2004)]. 
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Figure 4: Mechanisms by which ATP modulates ion transporter and channel function (Hilgemann, 1997) 
Figure 4 summerizes the ATP-dependent mechanisms regulating ion transporters. By activation of 
lipid kinases, ATP increases the production of PIP2 that modulates activity of several ion channels 
(Huang, 2007). ATP also stimulates the outward chloride current by chelating Ca2+. A drop in 
intracellular ATP level induces pronounced changes of cytoskeletal organization, often appearing as 
depolymerisation of F-actin (Golenhofen et al., 1995). This effect conceivably disturbs interaction of 
ATP with the actin filaments and anchoring of ion transporters to the plasma membrane. 
Compartmentalized ATP i.e. ATP bound to the plasma membrane is another way of modulation 
channels. Availability of membrane-bound ATP determines how well the different pumps are fuelled. 
While the molecular evidence for the aforementioned mechanisms is still in most cases unclear, 
mechanisms regulating the ATP-sensitive K+ (KATP) channels are extensively described. Single-
channel studies showed that direct binding of ATP to Kir6.2 decreases channel activity by decreasing 
the mean open time, reducing the mean burst duration and increasing the frequency and duration of the 
interburst closed states (Craig et al., 2008). Besides direct binding to a classical or unique motif, ATP-
dependent modulation of channel activity could be mediated by changing intrinsic channel properties, 
for example increasing the open channel probability of InsP3R TypeI (Betzenhauser et al., 2009). 
Contrary to the inhibitory effect of ATP on KATP channels, ATP was shown to reduce rundown of L-
type Ca2+ channels with a dual mechanism with only one mechanism involving phosphorylation and 
not requiring ATP hydrolysis (Yazawa et al., 1997). 
Many TRP channels are regulated by ATP. In rat cardiac myocytes ATP is shown to activate TRPC3/7 
(Alvarez et al., 2008) and TRPM4 (Scamps and Vassort, 1990). ATP is also shown to be essential for 
activation of TRPC6 in a calmodulin kinaseII (CamKinaseII)-dependent manner (Shi et al., 2004). 
TRPM7 is activated by reducing intracellular level of magnesium ATP (Penner and Fleig, 2007). By 
replenishment of PIP2, ATP is able to prevent desensitization of TRPA1 (Karashima et al., 2008). On 
the contrary, Dattilo and coworkers reported that intracellular ATP inhibits TRPC5 currents in a 
phosphorylation independent effect that does not require hydrolysis of ATP (Dattilo et al., 2008). 
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Compared to other TRP channels, interaction of ATP with TRPV1 is probably the most intensively 
investigated. The crystal structure of the ankyrin repeat domain of TRPV1 revealed an ATP binding 
site that overlaps with a calmodulin binding domain. Competitive interaction of both ligands at this site 
regulates TRPV1 activity in a Ca2+-dependent manner. Sufficient intracellular ATP prevents capsaicin-
induced tachyphylaxis that would otherwise be induced by calmodulin binding (Lishko et al., 2007). 
Interestingly Phelps et al reported that TRPV6-ARD, though containing a similar number and a related 
structure of ankyrin repeats as TRPV1, neither binds calmodulin within its ankyrin repeat sequence nor 
is the ATP binding pocket of TRPV1 conserved (Lishko et al., 2007; Phelps et al., 2008). For TRPV6 
and TRPV5, however, ATP was shown to prevent run-down in divalent-free conditions (Hoenderop et 
al., 2001). To unravel the underlying mechanism was one goal of the current work. 
5.4 Regulation of ion channels by phosphorylation 
Protein phosphorylation and dephosphorylation are common reversible posttranslational modifications 
resulting in changes in conformation, cellular location or association with other proteins with an 
ultimate regulatory effect on the function of ion channels. Protein kinases constitute a family of 
divergent enzymes responsible for addition of phosphate groups on definite consensus sites within 
proteins. This family of enzymes classically comprises tyrosine kinases and serine/threonine kinases. 
The next section presents few examples of regulatory effects of different kinases on ion channels. 
Tyrosine kinase (TK)-mediated regulation is described for several ion channels. TK phosphorylates the 
alpha-subunit of large conductance Ca2+-dependent K+ channels (BKCa) shifting the Ca2+ sensitivity of 
the channel and producing hyperpolarisation (Fukao et al., 1999). In addition, tyrosine kinase enhances 
single-channel gating of NMDA receptors and consequently increases the NMDA receptor-mediated 
synaptic currents in neurons (Salter and Kalia, 2004). Tyrosine kinase was also shown to enhance 
activities of TRPC3 (Vazquez et al., 2004) and TRPM7 channels (Gwanyanya et al., 2006) 
Similarly, the diverse subfamily of serine/threonine kinases is shown to modulate the activity of an 
array of ion channels including several TRP channels. PKC stimulation by PMA is shown to potentiate 
TRPM4 (Guinamard et al., 2004), TRPV1 when phosphorylated at S-502 and S-800 (Bhave et al., 
2003; Numazaki et al., 2002; Premkumar and Ahern, 2000; Vellani et al., 2001) and TRPV4 (Xu et al., 
2003). Furthermore, activation of PKC was shown to inhibit caveolai-mediated endocytosis thereby 
increasing current density and surface abundance of TRPV5 (Cha et al., 2008). Likewise, a recent 
study using mutational analysis of the putative phosphorylation sites S-299 and S-654 in TRPV5 shows 
that activation of the Ca2+ receptor CaR stimulates TRPV5-mediated Ca2+ influx via a PMA-insensitive 
PKC isoform pathway (Topala et al., 2009). On the other hand, inhibition of PKC-mediated 
phosphorylation favours cytosolic over plasma membrane distribution of TRPM7 (Yogi et al., 2009). 
Moreover, stimulation of PKC down regulates activities of TRPC6 (Zhang and Saffen, 2001) as well as 
TRPC3,4 and 5 (Venkatachalam et al., 2003). CaM-kinase is shown to enhance activities of TRPC6 
(Hisatsune et al., 2004) and TRPV1 (Jung et al., 2004). Casein kinase (CK2)-phosphorylated forms of 
TRPP2 (Kottgen et al., 2005) and TRPP1 (Roitbak et al., 2004) are more susceptible to retrieval into 
the cytoplasmic compartment. PKA phosphorylation of TRPV1 at S502 leads to both heat and 
capsaicin-sensitization (Lopshire and Nicol, 1998; Rathee et al., 2002). On the other hand, when PKA 
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phosphorylates T-370 and S-116 of TRPV1, the result is a desensitized channel and modulated pain 
perception (Bhave et al., 2002; Mohapatra and Nau, 2003; Mohapatra and Nau, 2005). For TRPV2, 
channel activity is increased by PKA phosphorylation (Stokes et al., 2004).  
Within TRPV6 protein putative phosphorylation sites for different kinases were identified. S142 and 
S144 were identified by sequence analysis as putative targets for CaM-dependent kinaseII and PKC, 
respectively (den Dekker et al., 2003). In vitro phosphorylation of TRPV6 at S702 by PKC prevents 
calmodulin binding at the C-terminus thus hindering Ca2+-dependent calmodulin inactivation 
(Niemeyer et al., 2001). Interestingly, the derived TRPV6b allele lacks a putative PKC consensus site 
compared to the ancestral TPRV6a allele due to the R158C polymorphic substitution. The current work 
addresses how TRPV6 is regulated by PKC-mediated phosphorylation focusing on possible differential 
regulation of the two alleles  
 
Because the general scope of the present work is to understand how Ca2+ signalling is regulated, we 
also investigated regulation of another family of ion channels, the ORAI family, that is not related to 
TRP channels but exhibits as well exquisite Ca2+ selectivity and will be introduced in the following 
chapter. 
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5.5 ORAI Ion Channels 
In 1986, James Putney proposed the “capacitative Ca2+ entry hypothesis” that suggests the presence of 
Ca2+ permeable channels at the plasma membrane that are activated when IP3 binds its receptors on ER 
and mediates store depletion in order to replenish these stores (Putney, 1986). Yet, he did not neither 
characterize the current nor the channels. The calcium release activated calcium current (ICRAC) was 
first measured and characterized in patch-clamp recordings from mast and Jurkat T-cells and the 
channels were named CRAC channels (Hoth and Penner, 1992; Lewis and Cahalan, 1989; Zweifach 
and Lewis, 1993). ICRAC measurement and the observation that thapsigargin-induced store depletion 
was also accompanied by Ca2+ influx, as seen from Ca2+ imaging data (Putney and Bird, 1993) strongly 
supported the theory. Basic biophysical features of ICRAC are high selectivity for Ca
2+, pronounced 
inward rectification and an estimated single channel conductance of less than 1 pS (Hoth and Penner, 
1993). Specific CRAC blockers are not yet identified. On the other hand, it is now well established that 
the stromal interaction protein STIM1 is a Ca2+ sensor that is required for CRAC activation, as 
revealed by RNAi screens (Liou et al., 2005; Roos et al., 2005; Soboloff et al., 2006). STIM1 was 
primarily identified in a library screen by its ability to confer binding of pre-B lymphocytes to stromal 
cells (Oritani and Kincade, 1996). Drosophila and Caenorhabditis elegans have a single STIM protein 
while birds and mammals have two homologues. The human STIM2 gene shares 61% sequence 
identity with STIM1. Soon after identification of STIM1, the molecular identity of CRAC channels 
was disclosed using an unbiased genome-wide RNA interference (RNAi) screen in Drosophila S2 cells 
(Vig et al., 2006b; Zhang et al., 2006). Feske and coworkers identified three human homologs of 
CRAC channels and named them ORAI1-3. Furthermore they conducted a mutation linkage analysis 
using T cells isolated from patients suffering from severe combined immunodeficiency syndrome 
(SCID) and were able to identify a naturally occurring single point mutation (R91W) as the underlying 
cause of the disease(Feske et al., 2006). 
Structurally (Fig. 5), STIM1 is a single transmembrane phosphoprotein with an N-terminus extending 
in the lumen of the ER and containing an EF-hand that binds and senses luminal [Ca2+] as well as a 
sterile-alpha motif (SAM) including two N-linked glycosylation sites. The C-terminus protrudes into 
the cytosol and contains two lengthy coiled-coil domains overlapping with an ezrin-radixin-moesin 
(ERM)-Like domain. This end of the molecule diverges substantially: the Drosophila protein lacks the 
proline-rich region and the lysine-rich tail (Liou et al., 2005). 
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Figure 5: Domains of STIM proteins. Drosophila and human STIM proteins are situated in the ER membrane. 
Modules of STIM1, STIM2 and Stim include: the signal peptide, the predicted EF hand and SAM domains, the 
transmembrane region and two regions predicted to form coiled coil structures comprising the ERM domain. 
Proline-rich domains (P) and the lysine-rich C-terminal regions are unique to the mammalian STIM family 
members. Drosophila Stim contains an N-terminal sequence in the ER that is not present in either STIM1 or 
STIM2. The N-linked glycosylation sites at the SAM domain, experimentally verified for STIM1 are indicated. 
Background colours represent basal Ca2+ concentrations of ~50 nM in the cytosol and > 400 µM in the ER 
lumen. Ca2+ ions are shown as red dotst including Ca2+ bound to the EF hand domain. (Cahalan, 2009) 
Unlike STIM1, both N- and C- termini of ORAI proteins are cytosolic and bracket four membrane 
spanning domains as predicted by hydropathy analysis (Fig. 6). As for many Ca2+ channels, a putative 
interaction and regulatory coiled-coil domain is found in the C-terminus of ORAI. An N-glycosylation 
site was identified in the extracellular loop between transmembrane domains three and four. Mutants  
of this site showed comparable channel activity to wildtype (Zhang et al., 2008). A part from that, 
ORAI channels share no other structural properties with other ion channels. The selectivity filter of 
ORAI pores are formed by acidic residues in transmembrane domain one and three and the first loop 
domain (Vig et al., 2006a). 
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Figure 6: ORAI channel at basal state present as dimers. An ORAI channel is formed of four transmembrane 
domains and intracellular N- and C- termini. A coiled coil domain is indicated on the C-terminus (modified from 
(Cahalan, 2009)) 
5.5.1 Store activated operation of STIM1/ORAI  
Owing to its large surface area the ER serves as an ideal intracellular Ca2+ capacitator, charged by 
SERCA pump and discharged via Ca2+-permeant channels. Among the latter, are the IP3 receptors 
(IP3R) that are activated by ligand (IP3) binding leading to release of Ca
2+ content and subsequent rise 
of cytosolic Ca2+ with a concurrent drop in ER Ca2+ content below resting level [300-500 µM, (Brini et 
al., 1999; Montero et al., 2001; Yu and Hinkle, 2000)]. At the resting state STIM exists as dimers 
stabilized at the ER membrane by C-terminal coiled-coil interactions and binds Ca2+ with low affinity. 
When a drop in [Ca2+]ER <300µM is sensed the EF hand of STIM dissociates Ca
2+ and a SAM-domain 
interaction is initiated leading to further Oligomerization of STIM. The formed oligomers are then 
redistributed from the tubular structures, where STIM dimers bind the microtubule-plus-end-tracking 
protein EB1 at resting state, to a punctuate cluster (puncta) close to the plasma membrane (Liou et al., 
2007). At the plasma membrane STIM directly interacts with and opens ORAI channels, the effector 
domain being within the C-terminal end as shown by co-immunoprecipitation and FRET studies 
[reviewed in (Cahalan, 2009)]. Expressing the C-terminal domain of STIM was adequate for 
constitutive activation of ORAI circumventing store depletion (Park et al., 2009). Recently, the 
minimal sequence essential for ORAI activation (CRAC Activating Domain, CAD) was mapped to a 
stretch of ~100 residues within the coiled coil region (Park et al., 2009; Yuan et al., 2009). In 
summary, the molecular components of CRAC current are tetramers of ORAI subunits activated by 
oligomers of STIM, the aggregation of which is store depletion-evoked.  
5.5.2 ORAI channels and the immune response 
In an immune response, variable types of immune cells are recruited to the site of immunogen contact. 
Professional antigen-presenting cells (APCs e.g. dendritic cells, macrophages and B-cells) process the 
antigen and convey the perceived immunological information, in the form of peptides bound to Class 
II-MHC receptors, to CD4+-Th1 cells. Together the APCs and Th1 cells form the so called 
immunological synapse (IS). Activated T h1 cells will subsequently migrate into the infected tissues and 
in turn stimulate the locally infiltrated macrophages provoking a multiple effector pathway immune 
response. To eradicate an immunogen, the activated macrophages initiate an “oxidative burst” 
generating superoxide (O2-) and hydrogen peroxide (H2O2) (Babior, 1984; Forman and Torres, 2001). 
Despite exposure to the elevated concentration of oxidants in inflamed versus normal tissues, 
differentiated Th-cells are still able to perform their defensive function. 
The formation of an immunological synapse is accompanied by a rapid increase in the free [Ca2+]i, 
which is a prerequisite for activation, differentiation and proliferation of T-cells (Feske, 2007; Lewis, 
2001; Negulescu et al., 1994; Quintana et al., 2005). The [Ca2+]i rise is mediated by Ca
2+ release from 
the endoplasmic reticulum (ER) through IP3R and subsequent Ca
2+ influx through calcium-release 
activated Ca2+ (CRAC) channels. CRAC channels in T-lymphocytes are mainly formed by homomers 
of ORAI1, however, heteromeric channels can also be formed with ORAI2 or ORAI3 proteins. The 
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ORAI-mediated Ca2+ influx is indispensable for an efficient immune response as indicated by the 
compromised immunity of SCID patients (mentioned above). 
5.6 Regulation of ion channels by hydrogen peroxide 
Reactive oxygen species (ROS) are typically defined as molecules or ions formed by the incomplete 
one-electron reduction of oxygen. Classically, ROS include free radicals such as superoxide, hydroxyl 
radical, and singlet oxygen as well as non-radical species such as hydrogen peroxide (H2O2). ROS 
contribute to physiological processes including microbicidal activity of phagocytes, signal transduction 
and gene expression and conversely they can cause oxidative damage to nucleic acids, proteins and 
lipids (Pan et al., 2009). In addition, many cellular processes are modulated by the redox state of 
proteins. Changes in structure caused by oxidation of reactive cysteine residues can change the activity 
of enzymes and ion transporters (Feissner et al., 2009).  
In the context of ion transport, regulation of several ion transport systems and channels by ROS is well 
established though the mechanisms are not always understood. For example, ROS are shown to 
stimulate ryanodine receptors (RyR) either directly by oxidizing the redox-sensing thiols (Zima et al., 
2004) or indirectly by oxidizing nitric oxide (NO) to nitrosium (NO+) that in turn reacts with free RyR 
thiols and forms the RyR-stimulator, S-nitrosothiol (Stoyanovsky et al., 1997; Xu et al., 1998). The 
Na+/ Ca2+ exchanger (NCX), SERCA and PMCA are also modulated by H2O2 [reviewed in (Feissner et 
al., 2009)]. Redox modification of sulfhydrals is thought to be responsible for a thimerosal-dependent 
IP3 receptors sensitization to IP3 (Bootman et al., 1992). Reduced glutathione/glutathione disulfide 
(GSH/GSSG) couple is the main cellular redox buffer and is maintained at high ratio of GSH:GSSG 
(Schafer and Buettner, 2001). GSSG has been shown to stimulate IP3R channel activity by increasing 
the binding affinity to hepatocyte IP3R (Missiaen et al., 1991; Renard-Rooney et al., 1995). In addition, 
ROS have been shown to directly stimulate IP3R-mediated Ca
2+ release from ER (Rooney and Thomas, 
1991). Among the ion channels regulated by ROS are several K+, Na+ and Cl- channels [reviewed in 
(Kourie, 1998)]. Likewise, many TRP channels are redox sensitive. In a PLC-dependent pathway, 
TRPC3 and TRPC4 are shown to form redox-sensitive cation channels that participate in Na+ loading 
and membrane depolarization (Miller, 2006). Furthermore, hydrogen peroxide is shown to evoke Ca2+ 
influx through TRPM2 (Hara et al., 2002; Yamamoto et al., 2008), and cation conductance of TRPM7 
(Aarts et al., 2003) and TRPM8 (Yoshida et al., 2006). 
A major target of ROS-induced modification of proteins are the reactive cysteine residues. A reactive 
cysteine contains a thiolate group (S-) which reacts with H2O2 with rates ranging from 10-10
5 M-1s-1, 
depending on their local environment, while the thiol groups (SH) do not react physiologically with 
H2O2 unless the reaction is catalyzed (Forman et al., 2004). The thiolate undergoes reversible (sulfenic) 
or irreversible (sulfinic and sulfonic acid) covalent modifications upon oxidation. Additionally, mild 
oxidation can induce reversible cysteine disulfide bond formation and thus prevent further irreversible 
cysteine modifications (Droge, 2002). The thiolate oxidation produces intermolecular cross-links that 
underlie ROS-induced protein oligomers (Huang et al., 1992; Jamme et al., 1995; Kako et al., 1988). 
The physical changes in the structure of the channel and pump proteins, like intermolecular cross 
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linking resulting from oxidation, modify the function of the transporting proteins and /or the 
availability of regulatory sites on these proteins (Kourie, 1998).  
While it is clearly established that Ca2+-signals in T-cells are necessary for regulation of the immune 
response, the role of redox status for Ca2+-dependent T-cell activation is less well understood. The goal 
of the work presented in chapter (7.2) was to identify whether and how the main component of Ca2+ 
signal in immune response, ORAI channels, are influenced by redox status and how that affects T-cells 
functions at different stages of the immune response. 
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6 Materials 
6.1 Resources 
AmershamPharmacia Biotec (Freiburg, GER) 
AppliChem (Darmstadt, GER) 
Applied Biosystems (Foster City, USA) 
BD Biosciences (Bedford, USA) 
Beckman (München, GER) 
Becton Dickinson Labware (Franklin Lakes, NJ, USA) 
Bio-Rad Laboratories (München, GER) 
Biotrend (GentaurBVBA-Bioxys) (Brussels, BEL) 
Biozym (Hessisch Oldendorf, GER) 
Cell signaling (Frankfurt, GER) 
Dagan (Minnesota, USA) 
Eppendorf (Hamburg, GER) 
Fermentas (St. Leon-Rot, GER) 
Fuji (Düsseldorf, GER) 
Hermle (St. Leon-Rot, GER) 
Hettich (Tuttlingen, GER) 
Holten (Allerod, DK) 
IKA (Staufen, GER) 
Infors-HT (Bottmingen, Switzerland) 
Integra Bioscience (Fernwald, GER) 
Invitrogen (San Diego, USA) 
Memmert (Schwabach, GER) 
Merck (Darmstadt, GER) 
Millipore (Schwalbach/Ts, D) 
MWG Biotech (Ebersberg, GER) 
New England Biolabs (NEB) (Frankfurt, GER) 
New Brunswick Scientific (Edison NJ, USA) 
Operon (Köln, GER) 
Pierce (Rockford, USA) 
Peqlab (Erlangen, GER) 
Promega (Mannheim, GER) 
Qiagen (Hilden, GER) 
Roche (Basel, CH) 
Roth (Karlsruhe, GER) 
Sarstedt (Nürnbrecht, GER) 
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Sigma (Deisenhofen, GER) 
Stratagene (Heidelberg, GER) 
ThermoScientific (Gert-Jan Bakkenes, GER) 
Uniequip (Martinsried, GER) 
Wescor (Langenfeld, GER) 
Whatman (Brentford, UK) 
Wolf Laboratories Limited (Pocklington, UK) 
Zeiss (Oberkochen, GER) 
6.2 Supplies 
Nitrocellulose-Membrane Hybond N (Amersham Pharmacia) 
Sterile containers for laboratory and cell culture Falcon (BD Biosciences) 
Sterile disposable pipettes  Falcon (Becton Dickinson Labware) 
Filter Tip FT 20, 200 und 1000 Peqlab 
Biozyme 
Sephadex TM G-50 Amersham Pharmacia 
Petri dishes Sarstedt 
PVDF membrane ImmobilonTM-P (Millipore) 
Needles Microlance 0.7, 0.55, 0.4 (BD Biosciences) 
6.3 Equipment 
Centrifuges L8-60M-Ultracentrifuge (Beckman) 
OptimaTM MAX-E Ultracentrifuge (Beckman) 
Table centrifuge 5415 C (Eppendorf) 
J2-HS centrifuge (Beckman) 
96-well plate centrifuge 4-15C (Sigma) 
Universal 32R (Hettich) 
Mikro 220R (Hettich) 
Mini spin 5452 (Eppendorf) 
Horizontal Gel electrophoresis apparatus Sub-cell GT Agarose Gel Electrophoresis Systems 
(Bio-Rad) 
Photometer Gene quant II (Pharmacia Biotech) 
Biophotometer (Eppendorf) 
Shaking water bath WB 14 (Memmert) 
Shaker Vibrax-VXA (IKA) 
Thermomixer Vortem 56 EVC (Uniequip) 
Thriller (Peqlab) 
Biological safety cabinet HERAsafe Class II (KS12) 
Electroporation machine Nucleofector II (Amaxa bioscience) 
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Thermocycler Gene Amp PCR System 9700 (Applied 
Biosystems) 
Master cycler, Persoanl 5332 (Eppendorf) 
DNA sequencing equipment Abi Prism 310 Genetic Analyzer (Applied 
Biosystems) 
Fermenter Scientific Series 25 Incubator Shaker (New 
Brunswick Scientific) 
Heidolph Unimax 1010 (Wolf Laboratories 
Limited) 
Minitron (Infors-HT) 
Pipetting Pipetboy acu (Integra Biosciences) 
Vertical electrophoresis systems Mini VE (Amersham Biosciences) 
Mini-Protean Tetra cell (Bio-Rad) 
Electrophoresis power supply Power Pac HC (Bio-Rad) 
Molecular imager (gels and WB) ChemiDocTM XRS 
Rocking platform shaker Heidolph duomax 1030 
Cell culture incubator Heraeus Function Line Incubator (Thermo 
Scientific)  
Water bath Lauda A100 
Incubation shaker Minitron CH-4103 (Infors HT ) 
Gel dryer Gel dryer 583 (Bio-Rad) 
Amplifier EPC9 and EPC10 USB (HEK electronics) 
Micromanipulater LN Pivot Manipulator (Luigs & Neumann) 
Microscope Axio Observer A1 (Zeiss) 
Puller DMZ-Universal Puller (Dagan) 
Osmometer VAPRO ® Vapor Pressure Osmometer (Wescor) 
6.4 Chemicals 
Unless otherwise indicated, chemicals used for this work were purchased from one of the following 
suppliers Amersham Pharmacia, Boehringer Ingelheim, Invitrogen, Merck, Roth or Sigma 
6.5 Reagent systems (Kits) 
ABI Prism Big Dye TM FS Terminator Cycle Sequencing Ready Reaction Kit V 1.1 (Applied 
Biosystems) 
BCATM Protein Assay Kit (Thermo Scientific) 
Hi Speed Plasmid Maxi Kit (Qiagen)  
Phusion polymerase High-Fidelity PCR kit 
Qiaprep spin Mini Kit (Qiagen) (27106) 
QiaQuick gel extraction kit (28706) 
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Quik Change XL Kit (Stratagene) 
Western LightningTM Plus ECL (Perkin Elmer) 
TNT(R) Quick Coupled Translation System (Promega) 
6.6 Size standards 
DNA Size standard marker: 1 kb DNA Ladder (Invitrogen) 
2-Log DNA Ladder, 0.1-10 kb (NEB) 
M9-Marker (Self made, Dr. U. Wissenbach) 
Prestained Proteinmarker (Peqlab) 
Dual Color Proteinmarker (Bio-Rad) 
Kaleidoscope Proteinmarker (Bio-Rad) 
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6.7 Constructs 
6.7.1 TRPV6 Constructs 
Construct Primer 
Name 
Primer sequence 5’3’ Tm 
°C 
Restriction 
site(s) 
ARD- 
(C) 6His  
(43-266) 
BAN429 
BAN432 
GTGGCGGCCGCGGTGTGCTTCCGCTTCTG 
GATATACATATGAAGAGGATCTGGGAGTCTCC  
58 
62 
NdeI 
NotI 
ARD 
(N) 10His 
(43-266) 
BAN375 
BAN376 
CGGGATCCGAAGAGGATCTGGGAGTCTCC 
CGGGATCCTTAGGTGTGCTTCCGCTTCTG 
62 
58 
BamHI 
BamHI 
CT2 
(C) 6His  
(633-725) 
BAN431 
BAN432 
GATATACATATGGTGGAAGACAGGCAAGATC 
GTGGCGGCCGCGATCTGATATTCCCAGCTCTC 
58 
62 
NdeI 
NotI 
CT2 
(N) 10His 
(633-725) 
BAN382 
BAN117 
CCGCTCGAGGTGGAAGACAGGCAAGATC 
CCGCTCGAGTTAGATCTGATATTCCCAGCTC 
58 
56 
XhoI 
XhoI 
CT3 
(N) 10His 
(647-725) 
BAN 83 
BAN 17 
CCGCTCGAGTACGCACAGGCCTTCCAC 
CCGCTCGAGTTAGATCTGATATTCCCAGCTC 
58 
56 
XhoI 
XhoI 
NP 
(267-330) 
BAN377 
ISE 06 
CGGGATCCGCAGTGGACGTATGGACCAC 
CGGGATCCTTAGAAGTACGGCCGCCCG 
60 
52 
BamHI 
BamHI 
R153Q/ 
R154P/ 
EGFP/ 
pcDNA3 
BAN190 
  
BAN191 
CAGGCACTGCCTTCCAGCCTAGTCCCTGCAACCTC 
 
GAGGTTGCAGGGACTAGGCTGGAAGGCAGTGCCTG 
114
114 
- 
- 
R606Q BAN371 
BAN371 
CACGGTGATGCTGGAGCAGAAGCTGCCTCGCTGCC 
GGCAGCGAGGCAGCTTCTGCTCCAGCATCACCGTG 
116 
116 
- 
- 
R686A BAN380 
BAN381 
CCTATGCCCTCAGTGTCTGCAAGTACCTCCCGCAGCAG 
CTGCTGCGGGAGGTACTTGCAGACACTGAGGGCATAGG 
122 
122 
- 
- 
S144A BAN351 
BAN352 
CCGCAGGGCCAGTGTCGCTGCCAGAGCCACAGGCAC 
GTGCCTGTGGCTCTGGCAGCGACACTGGCCCTGCGG 
124 
124 
- 
- 
S144D BAN361 
BAN362 
CCGCAGGGCCAGTGTCGATGCCAGAGCCACAGGCAC 
GTGCCTGTGGCTCTGGCATCGACACTGGCCCTGCGG 
122 
122 
- 
- 
S155A BAN369 
BAN370 
GCACTGCCTTCCGCCGTGCTCCCCGCAACCTCATCTAC 
GTAGATGAGGTTGCGGGGAGCACGGCGGAAGGCAGTGC 
126 
126 
- 
- 
S155D  BAN367 
BAN368 
GCACTGCCTTCCGCCGTGACCCCCGCAACCTCATCTAC 
GTAGATGAGGTTGCGGGGGTCACGGCGGAAGGCAGTGC 
126 
126 
- 
- 
S318A BAN357 
BAN358 
CGGTGAAGGAGCTGGTGGCCCTCAAGTGGAAGCGGTAC 
GTACCGCTTCCACTTGAGGGCCACCAGCTCCTTCACCG 
124 
124 
- 
- 
T150A BAN353 
BAN354 
CTGCCAGAGCCACAGGCGCTGCCTTCCGCCGTAGTC 
GACTACGGCGGAAGGCAGCGCCTGTGGCTCTGGCAG 
122 
122 
- 
- 
T298/299A BAN355 
BAN356 
CCCTGCTGGAACTTATCATCGCCGCCAAGAAGCGGGAGGCTC 
GAGCCTCCCGCTTCTTGGCGGCGATGATAAGTTCCAGCAGGG 
136 
136 
- 
- 
T298/299D BAN388 
BAN389 
CCCTGCTGGAACTTATCATCGACGACAAGAAGCGGGAGGCTC 
GAGCCTCCCGCTTCTTGTCGTCGATGATAAGTTCCAGCAGGG 
132 
132 
- 
- 
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T688A BAN359 
BAN360 
GCCCTCAGTGTCTCGAAGTGCCTCCCGCAGCAGTGCC 
GGCACTGCTGCGGGAGGCACTTCGAGACACTGAGGGC 
124 
124 
- 
- 
T688D BAN365 
BAN366 
GCCCTCAGTGTCTCGAAGTGACTCCCGCAGCAGTGCC 
GGCACTGCTGCGGGAGTCACTTCGAGACACTGAGGGC 
122 
122 
- 
- 
6.7.2 ORAI Constructs 
Construct Primer 
Name 
Primer sequence 5’3’ Tm 
°C 
Restrictio
n site(s) 
ORAI1 WT 
pCAGGS 
BAN416 
BAN392 
GGCGATATCCTAGGCATAGTGGCTGCCGG 
5'PHO-CGCCACCATGCATCCGGAGCCCGC 
58 
58 
EcoRV 
ORAI2 WT 
pCAGGS 
BAN394 
BAN402 
5'PHO-CGCCACCATGAGTGCTGAGCTTAACGTG 
5'PHO-TCACAAGACCTGCAGGCTGCG 
64 
60 
- 
- 
ORAI3 WT 
pCAGGS 
BAN397 
BAN403 
5'PHO-CGCCACCATGAAGGGCGGCGAGGG 
5'PHO-TCACACAGCCTGCAGCTCCC 
58 
58 
- 
- 
ORAI1  
C126S 
BAN406 
BAN407 
GCTCATCGCCTTCAGTGCCAGCACCACAGTGCTGGTGG 
CCACCAGCACTGTGGTGCTGGCACTGAAGGCGATGAGC 
124 
124 
- 
- 
ORAI1  
C143S 
BAN408 
BAN409 
CGCTCATGATCAGCACCAGCATCCTGCCCAACATCG 
CGATGTTGGGCAGGATGCTGGTGCTGATCATGAGCG 
124 
124 
- 
- 
ORAI1  
C195S 
BAN410 
BAN411 
GCTGAGGTGGTGCTGCTCAGCTGGGTCAAGTTCTTGCC 
GGCAAGAACTTGACCCAGCTGAGCAGCACCACCTCAGC 
122 
122 
- 
- 
ORAI3 
G170C 
BAN447 
BAN448 
CTTGCTGAAGTTGTCCTGGTTTGTTGGGTCAAGTTTGTGCCC 
GGGCACAAACTTGACCCAACAAACCAGGACAACTTCAGCAAG 
126 
126 
- 
- 
ORAI1- (N)- 
mEGFP- 
pMAX 
BAN412 
BAN401 
5'PHO-ATCATGCATCCGGAGCCCGC 
5'PHO-TCAGGCATAGTGGCTGCCGG 
58 
58 
- 
- 
ORAI2 WT 
-(N)- 
mEGFP 
pMAX 
BAN413 
BAN402 
5'PHO-TCATGAGTGCTGAGCTTAACGTG 
5'PHO-TCACAAGACCTGCAGGCTGCG 
 
60 
60 
- 
- 
ORAI3 WT 
-(N)-mEGFP 
pMAX 
BAN414 
BAN403 
5'PHO-ATCATGAAGGGCGGCGAGGG 
5'PHO-TCACACAGCCTGCAGCTCCC 
58 
58 
- 
- 
ORAI1 WT -
(C)-mEGFP 
pMAX 
BAN392 
BAN425 
5'PHO-CGCCACCATGCATCCGGAGCCCGC 
5'PHO-GGCATAGTGGCTGCCGG 
58 
58 
- 
- 
ORAI3 WT 
-(C)-mEGFP 
pMAX 
BAN397 
BAN426 
5'PHO-CGCCACCATGAAGGGCGGCGAGGG  
5'PHO-CACAGCCTGCAGCTCCC-3' 
58 
58 
- 
- 
6.7.3 Miscellaneous Constructs 
Construct Primer 
Name 
Primer sequence 5’3’ Tm 
°C 
Restriction 
site(s) 
PKCßII BAN 386 
BAN 387 
TGTGGGCGAAATGCTGAAAAC 
CTACTTAGCTCTTGACTTCGG 
62 
62 
- 
r TRPV1 
ARD 
BAN 390 
BAN 391 
CGGGATCCGTCCGTCTCCGCTGGTGAG 
CGGGATCCTTAGTGTCGGCACTCGGGTTC 
60 
60 
BamHI 
BamHI 
 
6.7.4 Primers for sequencing vector plasmids 
Vector plasmid OligonucleotideName Oligonucleotide sequence 5‘  3‘ Tm °C 
pCAGGS pCAGGS for AACGTGCTGGTTATTGTGC 56 
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pCAGGS pCAGGS rev ACCTTCTGATAGGCAGCC 56 
pcDNA3 pRC for CTAGAGAACCCACTGCTT 54 
pcDNA3 pRC rev GCACAGTCGAGGCTGATC 58 
EBFP/ECFP 
/EGFP/EYFP 
EGFP-N-Primer  CGTCGCCGTCCAGCTCGACCA 72 
EBFP/ECFP 
/EGFP/EYFP 
EGFP-C-Primer 
 
CATGGTCCTGCTGGAGTTCGTG 68 
6.8 Plasmids 
pBlueScriptII (Stratagene) 
pCAGGS (J. Miyazaki) 
pcDNA3 (Invitrogen) 
pET21a (Novagen) 
pET19b (Novagen) 
pMAX (Addgene) 
6.9 Restriction endonucleases and modifying enzymes 
Restriction endonucleases 
All restriction endonucleases were purchased from New England Biolabs (NEB). 
Modifying Enzymes 
Antarctic Phosphatase (Roche) 
DNAse I (Calbiochem) 
Pfu Turbo (Proofreading Polymerase) (Stratagene) 
Phusion polymerase (Finnzymes, NEB) 
RNAse A (Sigma) 
T4-DNA-Polymerase (New England Biolabs) 
T4-DNA-Ligase (New England Biolabs) 
T4-Polynucleotide kinase (New England Biolabs) 
Taq-Polymerase (Peqlab) 
6.10 Antibodies 
Antibodies made by Prof. Flockerzi's group: 
429 Rabbit polyclonal antibody against hTRPV6, affinity purified. 
26B3 Mouse monoclonal antibody against hTRPV6, affinity purified. 
737 Rabbit polyclonal antibody against Histidine tag, affinity purified. 
Commercial antibodies 
Anti-GFP Monoclonal 0,4 mg/ml; mixture of clones 7.1 and 13.1 (Roche) 
27E8 Monoclonal anti His-tag antibody (Cell signalling) 
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Conjugate antibodies 
Anti-Mouse IgG Horseradish peroxidase-linked , detects mouse immunoglobulins  
Anti-rabbit IgG Horseradish peroxidase-linked, detects rabbit immunoglobulins 
6.11 Antibiotics 
Antibiotics were supplied by Applichem 
Stock solution concentration End concentration 
50 mg/ml Ampicillin in H2O 100 g/ml 
25 mg/ml Chloramphenicol in Ethanol 34 g/ml 
50 mg/ml Kanamycin in H2O 50 g/ml 
6.12  Cells 
XL1-Blue subcloning grade competent cells (Stratagene) were used for amplificationof plasmids. 
BL21 competent cells (Novagen) were used for protein expression. 
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7 Methods 
7.1 Recombinant DNA Technolgies 
7.1.1 Polymerase Chain Reaction (PCR) 
During a PCR a thermostable DNA polymerase, directed by a pair of specific primers and in presence 
of sufficient nucleotides, amplifies a desired fragment of DNA in vitro. After the initial round of 
amplification from the original template, both the starting DNA as well as the amplified fragment are 
used as templates in the next cycles. This sets in motion a chain reaction in which the template DNA is 
exponentially amplified where the amount of DNA depends on the number of cycles. 
PCR is initiated by denaturing template DNA that enters then a reaction cycle repeated as often as 15-
40 times. In each cycle the primers anneal to the specific recognition sequence, then, in the extension 
stage, the polymerase synthesizes the new strand of DNA utilizing the available nucleotides and guided 
by the template.  
The specificity of the PCR is largely controlled by annealing temperature but also by buffer conditions. 
The annealing temperature should never be greater but can be 3-5 °C lower than the calculated melting 
temperature (Tm) of the oligonucleotides. Tm can be calculated from the empirical equation: 
Tm (in °C)  2  count (A, T)  4  count (G, C) 
The general PCR reaction for the Phusion polymerase was as follows: 
1µl Template DNA (30-50 ng/µl) 
2.5 µl Oligonucleotide 1 (10 pmol/ µl) 
2.5 µl Oligonucleotide 2 (10 pmol/ µl) 
10 µl 5 High Fidelity Buffer 
1µl dNTPs (10mM of dATP, dCTP, dGTP, dTTP) 
0.5µl Phusion DNA polymerase 
32.5 µl H2O 
The standard program of an amplification PCR was as follows: 
95°C 30 sec 1 cycle 
95 °C 10 sec 
Tm (56-58°C) 30 sec 
72°C 20 sec/Kb 
20-40 cycles 
72°C 10 min 1 cycle  
4°C ∞  
Primers can be designed to add a restriction endonuclease recognition site to the amplified DNA 
fragment facilitating cloning into the desired vector. In this case the specificity of the PCR can be 
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improved by using the two-step PCR benefiting from the increased annealing temperature due to the 
added bases. 
The two-step PCR program was usually as follows: 
95°C 30 sec 1 cycle 
95 °C 10 sec 
Tm1 (56-58°C) 30 sec 
72°C 20 sec/Kb 
6 cycles 
95 °C 10 sec 
Tm1 + 6-8°C 30 sec 
72°C 20 sec/Kb 
22-24 cycles 
72°C 10 min  
4°C ∞  
7.1.2 Site directed mutagenesis 
Introduction of point mutations, exchange or deletion of amino acids was done according to the Quick 
change Site-Directed Mutagenesis Kit (Stratagene). The method in principle utilizes a double-stranded 
DNA circular plasmid vector containing the insert of interest and two complementary synthetic 
oligonucleotide primers designed to contain the desired mutation flanked between ~15 bases of 
complementary sequence. The oligonucleotide primers were extended during temperature cycling by 
Turbo or alternatively Phusion DNA polymerase. The final PCR product contained the mutated insert 
within the vector plasmid and also contained staggered nicks within the DNA backbone. Following 
temperature cycling, the product was treated with DpnI. The DpnI endonuclease recognizes methylated 
and hemimethylated DNA and is used to digest the parental DNA template and to select for mutation-
containing amplified DNA. The DNA isolated from bacteria is dam-methylated and therefore 
susceptible to DpnI digestion. After DpnI digestion, the nicked vector DNA containing the desired 
mutations was transformed into XL1-Blue competent cells which contain DNA repair mechanisms and 
will ligate the nicks in the backbone. DNA isolated from clones grown on selection media were 
sequenced. 
The standard site directed mutagenesis PCR was as follows: 
1 µl Template DNA (30-50 ng/µl) 
1.1 µl Oligonucleotide 1 (10 pmol/ µl) 
1.1 µl Oligonucleotide 2 (10 pmol/ µl) 
10 µl 5 High Fidelity Buffer 
1µl dNTPs (10mM of dATP, dCTP, dGTP, dTTP) 
0.5µl Phusion DNA polymerase 
35.3 µl H2O 
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The general site directed mutagenesis cycle parameters were: 
95°C 30 sec 1 cycle 
95°C 10 sec 
55°C 30 sec 
68°C 20 sec /Kb 
12-18 cycles 
4°C ∞  
7.1.3 Colony PCR 
To check that an insert of interest is ligated into a cut vector in the correct orientation, screening of a 
large number of colonies can be done in a time saving method namely the colony PCR. In colony PCR, 
a forward oligonucleotide primer recognizing 5 insert sequence and a reverse oligonucleotide primer 
recognizing an antisense vector sequence 3, or vice versa, are selected so that a PCR product can only 
be detected if the insert is correctly ligated. Using a yellow pipette tip, tiny swabs of prenumbered 
colonies growing on the selective plate were placed directly into numbered tubes containing the PCR 
reaction mixture. After the PCR reaction, the product was separated with agarose-gel-electrophoresis 
and, if DNA of the correct size was amplified, the remainder of this colony were grown in 5 ml LB 
medium overnight at 37°C. 
The general colony PCR reaction was as follows: 
1.5 µl Oligonucleotide 1 (10 pmol/ µl) 
1.5 µl Oligonucleotide 2 (10 pmol/ µl) 
3 µl 10 PCR buffer 
0.6µl dNTPs (10mM of dATP, dCTP, dGTP, dTTP) 
0.6µl Taq polymerase 
22.8 µl H2O 
 + Half of a colony picked from the agarose plate 
The general site directed mutagenesis cycle parameters were: 
98°C 5 min 1 cycle 
98°C 30 sec 
58°C 30 sec 
72°C 1 min/Kb 
24-27 cycles 
72°C 10 min 1 cycle  
  4°C ∞  
7.1.4 Alcohol precipitation of DNA 
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DNA is precipitated out of aqueous solution either for concentrating or purifying it. This was done by 
addition of 0.2 volume of 5M NaCl, mixing and then addition of 2.5 volumes absolute ethanol, 
followed by a 30 min centrifugation at high speed (14000 rpm). The DNA pellet was washed with 70% 
ethanol to remove excess salt, centrifuged for 10 min, air dried. DNA and finally resuspended in water 
or suitable DNA elution buffer. 
7.1.5 DNA cleavage by restriction endonucleases 
Most type II restriction endonucleases are able to recognize a 4, 6 or 8 nucleotide palindromic 
sequences where they cut double stranded DNA to create either overhanging or blunt ends. Restriction 
endonucleases are found in bacteria and are believed to play defensive role against invading DNA. 
Restriction enzymes are used as a tool to insert desired fragments into particular vectors that are cut 
and prepared so that ends match for ligation. They are also utilized to monitor the cloning process. 
In general, a solution containing 0.5-4 µg of DNA was prepared in a total volume of 30 µl with 1 µl of 
the enzyme in an appropriate buffer (according to the recommendations of the manufacturer). Time 
and temperature of incubation also depend on the enzyme used. 
7.1.6 Alkaline phosphatase dephosphorylation: 
To reduce the possibility that a blunt-end cut vector religates into circular DNA resulting in colonies 
lacking the desired insert, the vector ends should be dephosphorylated to prevent religation. This was 
done by the enzyme alkaline dephosphatase directly after cutting the vector fragment.  
The dephosphorylation reaction mixture contained: 
30 µl Vector cut fragment 
4 µl 10Antarctic phosphatase buffer 
2 µl Antarctic phosphatase 
4 µl H2O 
Reaction mixture was incubated at 37°C for 1 h then the enzyme was inactivated at 65°C for 5 min 
followed by vector fragment purification either by GTG-gel electrophoresis or by alcohol precipitation. 
 
 
7.1.7 DNA phosphorylation (Kinase reaction) 
The presence of a phosphate at the 5`-end of a DNA fragment is a prerequisite for a ligase reaction. 
PCR products that are used for ligation directly without being cleaved at their end with a restriction 
endonuclease, should therefore either be amplified with a phosphorylated pair of primers or 
phosphorylated after amplification. To phosphorylate DNA at its 5`-ends, DNA was incubated with T4 
Polynucleotide kinase in presence of a buffer containing ATP. 
The kinase reaction mixture contained: 
Generated by Foxit PDF Creator © Foxit Software
http://www.foxitsoftware.com   For evaluation only.
                                                                                                                                                        Methods 
40 
 
 
26 µl PCR product precipitated then resuspended in bidistilled H2O 
3 µl 10Ligase buffer 
1 µl T4 Polynucleotide kinase 
Reaction mixture is incubated at 37°C for 1 hour then the enzyme is inactivated at 75°C for 10 min 
followed by DNA purification either by GTG-gel electrophoresis or by alcohol precipitation. 
7.1.8 Fill-in Reaction 
To ligate DNA fragments with incompatible ends, a mixture of DNA polymerase with 3to 5or 5to 3 
proofreading ability and a kinase was used to create blunt ends and simultaneously phosphorylate the 
ends 
The fill-in reaction mixture contained: 
22.75 µl DNA fragment precipitated then resuspended in bidistilled H2O 
3 µl 10Ligase buffer 
2 µl T4 Polynucleotide kinase 
1 µl T4 DNA polymerase 
1.25 µl 1.25mM dNTPs mix 
Reaction mixture was incubated at 37°C for 1 h followed by enzyme inactivation at 65°C for 10 min 
and DNA purification either by GTG-gel electrophoresis or by alcohol precipitation. 
7.1.9 DNA analysis and purification by gel electrophoresis. 
Agarose or PAGE gels provide the matrix for identification, separation or purification of DNA 
fragments based on charge migration. DNA molecules, being negatively charged, move through an 
applied electric field from the negative to the positive pole with a speed inversely proportional to their 
size (non linear). Ethidium bromide (EtBr) was used to visualize the DNA fragments. EtBr intercalated 
into DNA molecules becomes fluorescent when excited with 254 nm UV light. Gels were prepared 
with TBE buffer. Before loading into the gel pockets, DNA probes were mixed with loading buffer 
containing glycerol to make DNA sink into gel pockets and a dye to visualize the front. A standard 
DNA ladder was loaded for identification of fragment size. 
The 10TBE-buffer pH 8.0 is prepared as follows: 
0.89 M Tris-HCl 
0.89 M Boric acid 
0.02 M EDTA 
The 10 Loading-buffer is prepared as follows: 
40% (w/v) Urea 
Generated by Foxit PDF Creator © Foxit Software
http://www.foxitsoftware.com   For evaluation only.
                                                                                                                                                        Methods 
41 
 
 
40% (w/v) Absolute glycerol 
50 mM EDTA, pH 8.0 
10 mM Tris-HCl pH 7.0 
0.25%(w/v) Bromophenolblue 
0.25%(w/v) Xylencyanol FF 
7.1.10 Agarose gels: 
The strength of agarose gel used depends on the size range of the fragments to be isolated. Regularly, 
0.5 to 2% gels were used to resolve DNA fragments ranging in size from 0.05 to 10 Kb. Multipurpose 
agarose (Roth) was used for analytical gel electrophoresis while the low melting seakem GTG-agarose 
(Cambrex) was used for preparative purposes. To prepare the gel a slurry of the appropriate amount of 
agarose was mixed with 1 TBE, heated up in a microwave to dissolve the agarose and then stirred to 
cool down to a temperature of 55-60C. Ethidium bromide solution was added to a final concentration 
of 0.001 mg/ml. The gel was poured into a chamber of a proper size with suitable combs and solidified 
at room temperature. Upon use, the gel was placed in the gel electrophoresis chamber and submerged 
in running buffer (1 TBE). 
7.1.11 PAGE gels 
Fragments of DNA smaller than 0.05 Kb were optimally isolated using 5-7% polyacrylamide gels. To 
prepare this gel, a (1:29) mixture of acrylamide and bisacrylamide was diluted with water to 40% (w/v) 
then used to prepare the gel with the desired concentration using 1 TBE buffer and adding 0.08% 
APS (w/v) and 0.12% (v/v) TEMED to initiate polymerization of the acrylamide solution. The mixture 
was poured between two glass plates and a comb was inserted. After running the DNA probes through 
the gel with 1 TBE in a vertical chamber, the fragments were visualized by staining the gel with 
ethidium bromide solution (0.5 µg/ml) for 10 min  
7% PAGE gel 
5 ml 40% Acrylamide:bisacrylamide (1:29)  
3 ml 10 x TBE 
35 µl TEMED 
80 µl APS (30%) 
Ad 30 ml H2O 
7.1.12 Isolation of DNA by electroelution: 
Small DNA fragments that were isolated by PAGE gel were thereafter purified by electroelution. The 
gel fragment was placed in an autoclaved semipermeable flexible tube (Dialysis Tubing MWCO 
12000, Sigma) together with 300µl 1 TBE buffer and ends were tightly closed with clamps. The 
flexible tube was placed in 1 TBE buffer in an electrophoresis chamber and a 135 mA current was 
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applied for about 45 min at 4°C until the DNA was eluted into the buffer enclosed in the flexible tube. 
DNA solution was then carefully collected, and remains of DNA washed out of the flexible tube with 
100 µl 1 TBE. DNA was precipitated with alcohol and salt as above. 
7.1.13 Ligating DNA fragments: 
The ligation reaction aims at joining together the compatible ends of a DNA fragment and a linearized 
vector. In presence of ATP and Mg2+ T4-DNA ligase catalyzes, the formation of a phosphodiester bond 
between juxtaposed 5 phosphate and 3 hydroxyl termini of both fragments.  
A standard ligation reaction consists of the following: 
x µl Insert fragment 
y µl Vector fragment  
1.5 µl 10 x T4 DNA ligase buffer 
1 µl T4 DNA ligase 
Ad. 15 µl H2O 
The reaction mixture was incubated at 16°C over night or alternatively at room temperature for 4 h. 
The total amount of DNA used (x + y) was about 200 ng and the ratio was set to be 1:1 in case of 
ligating DNA fragments with cohesive (sticky) ends and to 6:1 in case of blunt ends  
7.1.14 Preparation of chemically competent E. coli cells 
Bacteria can be made competent for uptake of foreign DNA when treated with calcium or magnesium 
chloride in the mid-log phase of growth. From a stock solution of XL-1 Blue subcloning grade 
competent bacterial cells (Stratagene), single colonies were obtained by fractionation on an antibiotic-
free agar plate. A single colony was used to inoculate 5 ml LB media over night from which one ml 
was diluted into 100 ml LB medium the next day. This culture was grown at 37°C to an OD600 of ~0.5. 
Cell pellets were obtained by centrifugation at 4°C, 6000g for 10 min. The pellet was resuspended in 
5-10 ml cold TSS buffer (calcium-rich buffer that facilitates plasmid uptake by cells) and aliquots of 
100, 200 or 300 µl were immediately shock-frozen in liquid nitrogen and stored at -80°C (Chung et al. 
1989). 
To estimate transformation efficiencies (competency), defined as the number of colonies per µg 
transformed DNA, a test transformation was done with a test plasmid of known concentration.  
From three different dilutions (1:10, 1:100, 1:1000) of cells in LB-medium, 100 µl was plated on agar 
plate containing the selection antibiotic corresponding to the test plasmid. After 24 h incubation at 
37°C the competency of the cells was calculated from the following formula: 
µginPlasmidvolumePlated
volumeTotal
factorDilutioncoloniesofNumberCompetency
1
  
Cells were considered competent for cloning if their transformation efficiency was in the range 106:107 
cfu/µg of DNA. 
Generated by Foxit PDF Creator © Foxit Software
http://www.foxitsoftware.com   For evaluation only.
                                                                                                                                                        Methods 
43 
 
 
The composition of TSS buffer was as follows: 
10% PEG 3350 
50 mM MgCl2 
5% DMSO 
Ad. 50 ml LB-medium 
7.1.15 Transformation of plasmids into bacterial cells 
An aliquot of competent cells was slowly thawed on ice. The DNA (ligation mixture) was gently 
mixed with the cells incubated on ice for 20-30 min. To induce DNA uptake by the cells, cells were 
heat shocked at 42°C for 90 seconds then placed on ice for 2 min. To recover, 1 ml of LB medium was 
added and cells were incubated at 37°C with 200 rpm shaking for 1 h. On an agar plate containing the 
corresponding selection antibiotic, 100 µl of the recovered bacterial suspension was plated with a 
Drigalsky spatula while the rest was concentrated by centrifugation at 5000 rpm for 5 min. The pellet 
was resuspended in about 100 µl LB medium and plated on the selective agar plate. Plates were 
incubated at 37°C overnight. 
7.1.16 Small scale plasmid preparation (Miniprep) 
For preparation of recombinant DNA plasmid DNA was amplified in bacteria. DNA was prepared on a 
small scale using the commercial kit (Qiaprep Spin Mini Kit, Qiagen). According to the provided 
“alkaline lysis” protocol, the desired number of colonies were picked with a sterile toothpick and 
grown overnight in 5 ml LB medium containing the corresponding selective antibiotic. A cell pellet 
was obtained by centrifuging a 1.5 ml of the preculture at 5000 rpm for 5 min. This step was repeated 
for low copy plasmids. Cells were resuspended in 250 µl resuspension buffer containing RNAse and 
mixed with 250 µl detergent-rich lysis buffer. To precipitate RNA, proteins and low-molecular weight 
impurities 350 µl neutralizing buffer was added. Contents were mixed immediately by inverting the 
tube. The mixture was spun at full speed for 10 min. The resulting clear lysate was added to an anion-
exchange resin packed in a spin column, spun for 1 min at 13000 rpm to bind DNA under low salt 
conditions. The bound DNA was washed with 750 µl buffer with medium salt content, dried by further 
spinning after removal of the flow-through and finally eluted with 50 µl elution buffer. Using a 
spectrophotometer absorbance of UV light at 260 nm and the ratio of absorbance at 260/280 nm were 
measured to check the quantity and purity of DNA, respectively. The prepared DNA was used for 
further restriction mapping or sequence analyses. 
7.1.17 Large scale plasmid preparation (Maxiprep) 
When a recombinant DNA was proven to be of the correct sequence, DNA plasmid was amplified to a 
larger scale to yield enough DNA for further applications. Overnight cultures (200-400 µl) were 
diluted into 400 ml LB medium and grown at 37°C for 12-15 hours with the corresponding selective 
antibiotic. Plasmid purification follows the modified alkaline lysis protocol as above using buffer 
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volumes and column sizes suitable for the larger scale preparation and according to instructions of the 
manufacturer. DNA was eluted with high-salt containing buffer. Salts were removed by isopropanol-
precipitation followed by a 70% ethanol washing step. 
7.1.18 Sequencing DNA 
Sequence of prepared recombinant DNA was analyzed using the “Cycle Sequencing Method” (Sanger 
et al., 1977). In this method, a polymerase synthesizes a complementary DNA strand, using a mixture 
of dNTPs and dideoxyribonucleotides tagged with fluorophors (ddNTPs). The latter nucleotides are 
reaction terminators because they lack the terminal hydroxyl group essential for extension. This way a 
number of DNA strands of different lengths are synthesized which contain one terminator ddNTP that 
can be recognized by detectors as they emit light of definite wave length when excited by a laser beam. 
Strands are sorted according to their size and aligned by the accompanying software “Sequence 
Analysis” that creates the full sequence of aligned bases. Sequencing was either done in Prof. 
Flockerzi’s laboratory using the sequencer “Genetic Analyzer 310” (Applied Biosystems) controlled 
by “Data Collection” software and using “Big Dye TM FS Terminator Cycle Sequencing Ready 
Reaction Kit V 1.1” (Applied Biosystems) to prepare the DNA copies in a modified PCR reaction or 
sent for sequencing to the commercially available sequencing services of MWG/Operon or SeqLab. 
The modified PCR reaction for sequencing: 
1 µl Primer 
1.5 µl BigDye Terminator Ready Reaction Mix  
x µl Template DNA = 500 ng 
Ad.12 µl  HPLC water to 12 µl 
The cycle parameters were: 
95°C  1 min  
95°C 30 sec 
58°C 2 min 30 sec 
 35 cycles 
4°C ∞  
A 96-well plate was used for purification of the modified PCR products. In each well a filtration entity 
(Whatman Microplate Devices Unifilter) covered with sepharose (SephadexTM G-50, Amersham 
Pharmacia) was swelled with 300 µl HPLC-grade water for 3 h. The plate was centrifuged at 2930  g 
and sepharose was washed with 150 µ HPLC-grade water. Finally probes are loaded in individual 
wells and the plate was centrifuged so that the purified probe was collected into PCR tubes containing 
8 l HiDi-Formamide (Highly deionized Formamide). The probes were stored at 4°C until they were 
assembled into the sequencer. 
7.2 Biochemical Technologies 
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7.2.1 Cell culture 
Cells were cultivated in humified incubators kept at 37°C and supplied with 5% CO2. Handling the 
cells for passage, transfection or splitting was done aseptically in a laminar flow hood (Biological 
safety cabinet, HERAsafe) using sterile equipment and containers sprayed with 70% ethanol before 
placing into the cabinet. Cell passage was done with trypsin (0.5 mg/ml trypsin + 0.2 mg/ml EDTA). 
Harvested cells were collected by centrifugation at room temperature, 1000 rpm for 5 min.  
7.2.1.1 HEK293 cells 
HEK293-cells (CRL-1573, ATCC, Manassas, VA USA) were cultured in Minimal Essential Medium 
(MEM, Invitrogen), supplemented with 200 unit/ml penicillin-G-sodium, 100 µg/ml streptomycin, 4 
mM L-glutamine and 10 % fetal calf serum (FCS, Invitrogen). 
7.2.1.2 Stable transfected cell lines 
Stable cell lines were created (Dr. Ulrich Wissenbach) from TRPV6a or b expressing vector 
(hTRPV6a/b_pcDNA5-Plasmid) transfected into Flp-In™-293 cells (In-vitrogen) using Superfect 
Transfection-Reagent (Qiagen). Cells were cultivated in HEK293 medium with 500µg/ml Geneticin 
(G-418, Invitrogen) for selection. For ICRAC measurements, a cell line stably expressing STIM1 was 
kindly provided by Dr. Soboloff. This cell line was cultured in the same medium as HEK293 cells.  
7.2.2 Transient transfection 
For transiently expressed TRPV6 wild-type or mutants, constructs were cloned into the bicistronic 
pCAGGS_IRES_EGFP vector. Two µg of the DNA to be transfected was mixed with 100 µl of 
Optimem-I Medium/Glutamax-I (Glibco) and 5 µl of the transfection reagent Fugene 6 (Roche). After 
15-45 min incubation at room temperature, the transfection mixture was directly added to 60-70% 
confluent HEK293 cells in penicillin/streptomycin-free medium. After 24h cells were trypsinated and 
seeded at low density for electrophysiological recordings or at higher density for Ca2+ imaging. 
Experiments were performed 48h after transfection. 
For ORAI expression, constructs were cloned into pCAGGS_IRES_EGFP (unless otherwise indicated) 
and 1 µg of the DNA was transfected into HEK-STIM1 cells using NucleofectorTMII electroporator 
(Amaxa Biosystems) and Cell Line V Nucleofector kit (Lonza). Cells were transfected according to 
instructions of the manufacturer and seeded at suitable density in 50µM ß-mercaptoethanol-containing 
medium. Experiments were done 24h after transfection 
7.2.3 Co-Immunoprecipitation (Co-IP) 
Co-immunoprecipitation is a widely applied method for investigating protein-protein interaction. In 
this method, an antibody is used to precipitate a target protein out of solution (mostly cell lysate) in 
which it is believed to exist in complex with other interacting partners that will be precipitated along. 
Therefore, it is a prerequisite that the epitope of the target protein remains accessible to the antibody. 
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The protein complexes are analyzed by SDS-PAGE and presence of a candidate interaction partner is 
tested for by probing with a specific antibody against the potential interacting protein. 
Cells were grown in 75 cm2 cell culture flasks to 70% confluence and transfected with the plasmid 
encoding the target protein cDNA. Forty eight hours later cells were checked for transfection 
efficiency (GFP fluorescence) and harvested with trypsin with intermittent shaking for 1 min. Reaction 
was stopped by adding 7 ml of culture medium. Cells were resuspended and transferred to 15 ml falcon 
tube, centrifuged at 1000 rpm for 5 min at 4°C. Steps following cell harvest were done at 4°C (on ice). 
Cell pellets were washed with 10 ml PBS and resuspended in RIPA buffer containing a mixture of 
proteinase inhibitors and shaken vigorously, 700 rpm, at 4°C for 15 min. To solubilise cellular 
proteins, cell lysates were sheared through 0.7, 0.55 and 0.4 mm cannulae, shaken again vigorously at 
4°C for 15 min. Clear lysate was obtained by centrifugation at 13000 rpm for 15 min at 4°C. 
To complex the protein of interest together with its potential interacting partners, if associated, 2-6 µg 
of the polyclonal antibody was added to the cell lysate. Interaction was allowed overnight at 4°C with 
overhead rotation. To purify the protein complex, 90 µl of RIPA buffer-prewashed protein A beads 
were added to the Co-IP mixture then rotated again for 3 hours at 4°C. 
To exclude non-specific binding to the beads, an equal fraction of the cell lysate is incubated with the 
same amount of beads for 3 hours without the antibody. To purify the protein complexes the beads 
were centrifuged at 500g for 2 min, a control probe was taken from the supernatant and mixed with 
equal volume of 2 Laemmli, beads were washed with 41 ml RIPA buffer and finally resuspended in 
45 µl of 2 Laemmli. All controls, prebeads and test probes were denatured (5 min at 95°C or 30 min 
at 37°C). Proteins were separated by SDS-PAGE analysis followed by blotting to nitrocellulose 
membranes that is subsequently probed with an antibody against the investigated interacting partner. 
RIPA buffer 
150 mM NaCl 
5 mM Tris.HCL, pH 8 
0.5 % Sodium deoxycholate 
1 % Nonident P40 
0.1 % SDS 
5 mM EDTA, pH 8 
2  Laemmli (Protein loading buffer, pH 6.8) 
8 % SDS 
120 mMM Tris-HCl 
20 % (v/v) Glycerol 
10 % (v/v) ß-Mercaptoethanol 
0.01 % (w/v) Bromophenol blue 
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Proteinase inhibitors mix 
1 µg/ml Leupeptin 
0.1 mM PMSF 
1 mM Pepstatin A 
0.3 µM Aprotinin 
1 mM Benzamidin 
7.2.4 SDS-PAGE 
When a mixture of proteins was analyzed by SDS-PAGE, proteins were separated according to their 
size prior to visualization and analysis. Secondary structures of proteins were denatured and molecules 
became negatively charged by hydrophobic interactions with the anionic detergent SDS. A 
polyacrylamide matrix loaded with proteins to be separated was immersed in 1 SDS running buffer in 
a vertical chamber within an electrical field. Proteins migrated to the positive pole with a speed relative 
to their charge-to-mass ratio. The loaded protein samples were first run through a stacking gel, a large-
pore polyacrylamide gel of about 2 pH units lower than the buffer of the separating gel. At the border 
between the gels, proteins were condensed. Protein molecules were resolved in the separating gel 
according to their molecular mass. The percentage of polyacrylamide can be modified to the size range 
of proteins to be separated. Lower percentage gels were used for large proteins and higher percentage 
gels were used to separate small proteins. The stacking gel should be at least 3% less than the 
separating gel.  
Stacking gel buffer, pH 6.8 
0.5 M Tris-HCl 
0.4 % SDS 
Separating gel buffer, pH 8.8 
1.5 M Tris-HCl 
0.4 % SDS 
10  SDS-electrophoresis buffer, pH 8.8 
1 % (w/v) SDS 
250 mM Tris-HCl 
1,92 % M Glycin 
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7.2.5 Coomassie staining of protein gels 
As little as 200 ng protein can be visualized with the Coomassie protein-stain. To stain the gels they 
were placed in the Coomassie solution for 30-60 min. Excess staining solution was removed and 
destaining solution was added to remove unbound stain. Protein bands as well as marker bands were 
visualized in a clear back ground of the gel. 
Coomassie stain solution 
0.125 % (w/v) Coomassie Brilliant Blue R-250 
45 % Ethanol 
10% Acetic acid 
Destain solution 
6 % (w/v) Ethanol 
9 % Acetic acid 
7.2.6 Western blot analysis 
This method aims at transferring the SDS-PAGE separated proteins onto a membrane where they can 
be detected using the proper mono- or polyclonal antibody. In electroblotting, a PAGE gel was brought 
in contact with the nitrocellulose membrane (8 Hybond-C extra, Amersham Pharmacia) or PVDF 
membrane (for smaller proteins) and together they were placed between 2 pairs of filter paper and a 
pair of pads to assemble the so called “blotting sandwich”. In the blotting apparatus (Mini Trans-Blot, 
Bio-Rad), the blotting sandwich was immersed in a blotting chamber filled with blotting buffer. A 350 
mA current was applied and the negatively charged proteins migrated out of the gel onto the positively 
charged membrane. Blotting time depends on protein size and type of membrane. Transfer efficiency 
can be checked either by staining the remaining gel with Coomassie or by transiently staining the 
nitrocellulose/PVDF membrane with Ponaceau-S stain. Nitrocellulose membranes have high affinity to 
proteins and bind them by hydrophobic as well as charge interaction. PVDF membranes offer better 
protein retention, physical strength and broad chemical compatibility (Lauritzen and Pluskal, 1988). 
Areas on the membrane unoccupied by target protein were blocked by a 5% solution of non-fat dry 
milk in TBST for one hour to prevent unspecific antibody effects. The membrane was usually 
incubated over night with the primary antibody at 4°C with gentle rocking. 
Blotting buffer, pH 8.3 
1 % SDS 
250 mM Tris-HCl 
1.92 M Glycin 
20 % Methanol 
7.2.6 Enhanced chemiluminescence development (ECL-Reaction): 
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Commonly, a horseradish peroxidase-linked secondary antibody is used to bind the immune complex 
“protein-primary antibody”. Adding the substrate of the antibody-bound enzyme results in a 
chemiluminescent product that can be visualized and the signal can be quantified. The nitrocellulose 
membrane containing the immune complex was washed 310 min with TBST (TBS buffer + 0.1 % 
Tween 20), incubated for 1h at room temperature with secondary antibody in 5% solution of non-fat 
dry milk in TBST buffer. Excess antibody was washed 210 min with TBST and finally 110 min with 
TBS. The ECL reagents were mixed in 1:1 ratio and added to the blot for 1 min. Luminescence was 
captured by a charge-coupled device (CCD) camera. The intensity of the digitized luminescence signal 
was analyzed in relation to an input control signal from known amounts of loaded protein.  
 
10  TBS-Buffer pH 7.5 
5 mM Tris-HCl 
9 %1.5 mM NaCl 
7.2.7 Redetection (Stripping) 
Using ß-mercaptoethanol and a detergent, the primary antibody bound to target protein can be cleaved 
allowing the usage of a different antibody for redetection of the same protein or another protein on the 
same blot. This was usually done to confirm the identity of test protein with a different antibody or to 
control for the expression of a house keeping gene. To strip a blot it was washed 4 5 min with TBST 
incubated at 55°C with the stripping buffer and washed 6  5 min with TBST before blocking and 
incubating with the new primary antibody. 
Stripping Buffer 
62.5 mM Tris-HCl pH 6.8 
2 % SDS 
7.2.8 Protein determination (Bicinchoninic acid reaction) 
A common method for quantification of protein content is based on the Biuret reaction. In an alkaline 
medium containing sodium potassium tartrate, proteins reduce cupric (Cu2+) to cuprous (Cu1+) and the 
latter chelates bicinchoninic acid forming a light blue complex which can be detected with a 
spectrophotometer. From a test protein solution, 1:100, 1:200 and 1:300 dilutions were made and in 
parallel, a standard BSA stock solution was diluted to yield 0.01, 0.02, 0.04, 0.06, 0.08, 0.1 mg/ml 
probes to establish a standard calibration curve. In a 96-well plate, 200 µl of the reagent mix (Pierce 
ECL Western Blotting Substrate, Thermo Scientific) were mixed with 25 µl of either the test or 
standard protein probes to obtain triplicates for each concentration. The plate was incubated at 65°C for 
30 min with shaking, absorbance was measured at λ=540 nm in a plate spectrophotometer. The 
concentration of test protein was calculated using the standard calibration curve. 
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Figure 7: Bicinchoninic acid method for determination of protein concentration. In an alkaline medium proteins 
reduce cupric (Cu2+) to cuprous (Cu1+) which chelates bicinchoninic acid forming a light blue complex detected 
with a spectrophotometer. 
7.2.9 Detection of surface proteins by biotinylation 
Biotin (Vitamin H) is a small molecule with a versatile valeric acid side chain that can bind proteins. 
Polar derivatives of biotin made with sulfonated linkers e.g N-Hydroxysulfosuccinimide (Sulfo-NHS) 
esters are charged and readily water soluble and thus are cell membrane impermeable. As long as the 
cell remains intact, only primary amines exposed on the surface can be biotinylated. Biotinylated 
proteins bind avidin (a glycoprotein of four subunits each binds one molecule of protein) with 
extraordinary affinity via noncovalent interaction with Ka=10
15M-1. The protein-biotin complex can 
therefore be isolated using avidin cross-linked to agarose beads. This way Sulfo-NHS-Biotin/Avidin 
reagents facilitate differential detection of plasma membrane proteins and give an estimate of the 
fraction of protein inserted at the plasma membrane relative to the total protein synthesized. 
Cells expressing the protein of interest were cultured in 75 cm2 culture flasks (BD), culture medium 
was removed and cells were washed 2× 10 ml PBSB (PBS containing 1 mM MgCl2 and 0.5 mM 
CaCl2, pH 8). To label membrane proteins cells were incubated with 9 ml NHS-Biotin; (0.5 mg/ml) for 
30 min at 4°C. Unbound biotin was removed and cells were washed 2× 10 ml PBSB pH 8 containing 
0.1% BSA. 10 ml of 2 mM EDTA in PBS pH 7.4 were added to cells for ~1 min with intermittent 
shaking to detach the cells. Cells were harvested by resuspension and transferred to a 15 ml Falcon, 
centrifuged for 5 min at 1000 rpm at 4°C, washed with 10 ml PBS. Pellets were resuspended in lysis 
buffer (PBS containing 1% Triton and 1 mM EDTA, pH 7.4) containing freshly added protease 
inhibitors and shaken for 15 min at 4°C then sheared through cannulae of decreasing sizes (0.7, 0.55 
and 0.4 mm). Finally, lysates were incubated for 15 min at 4°C with agitation. Cleared cell lysates 
were obtained by centrifugation at 13000 rpm for 15 min at 4°C. Protein content of cell lysate was 
determined by BCA method. An aliquot equivalent to 50 µg was kept as an input control. A volume of 
the cell lysate equivalent to 1 mg was incubated with 90 µl slurry of avidin beads (Pierce) on a rotating 
wheel at 4°C for 3 hours. Beads with bound complexes were collected by centrifugation at 5000g for 2 
min, washed with lysis buffer containing 0.25M NaCl to remove any unbound protein, resuspended in 
2 Laemmli, denatured at 95°C for 5 min and analyzed with SDS-PAGE. 
7.2.10 Detection of reactive thiol groups 
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A chemically modified form of biotin (MTSEA biotin-XX, Biotrend) selectively labels thiol (-SH) 
groups under mild condition with XX-linker optimizing biotin-avidin interaction. MTSEA-biotin can, 
therefore, be used to detect reactive cysteine residues either at the cell surface when applied to intact 
cells or within the cytosol when applied to permeabilized cells. Cells were permeabilized by 5 min 
incubation in PBSB containing 0.001% digitonin. Cells were washed afterwards 2× 10 ml PBSB and 
incubated for 40 min at room temperature with 0.5 mg/ml MTSEA in PBSB (MTSEA-biotin was 
predissolved in the minimal possible volume of DMSO then diluted to the aforementioned final 
concentration). The protocol proceeds as mentioned above for regular biotinylation. 
7.2.11 In vitro phosphorylation 
To test whether TRPV6 channel protein is directly phosphorylated, microsomal fractions prepared 
from TRPV6-expressing cells were incubated for 30 min at 30°C with recombinant PKCßII and 
32P 
labelled ATP together with either a PKCßII activator or inhibitor mix. Alternatively, lysates of TRPV6-
expressing cells that were transfected with GFP-PKCßII or untransfected control cells were used for the 
phosphorylation reaction. In a total volume of 25 µl kinase assay buffer cell lysates were mixed with 
2.5 µl of either activator or inhibitor mix and 5 µl of [32P]-ATP Assay cocktail 
Kinase assay buffer 
2.5 mM MOPS pH 7.2 
0.5 mM EGTA 
0.2 mM EDTA 
2.5 mM MgCl2 
0.25 mM DTT freshly added 
[32P]-ATP Assay cocktail 
15 µl cold ATP (10 mM stock) 
10 µl hot ATP (1 mCi/100 µl  total 100 µCi) 
575 µl Kinase assay buffer 
Activator mix 
1 µl PS (10 mg/ml) 
2 µl 100 µM PMA (1:10 predilution of 1mM stock in MOPS CaCl2 buffer) 
17 µl Buffer containing 20 mM MOPS, 1 mM CaCl2 
Inhibitor mix 
1 µl PS (10 mg/ml) 
2 µl 100 µM Ro (1:50 predilution of 5mM stock in MOPS CaCl2 buffer) 
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17 µl Buffer containing 20 mM MOPS, 1 mM CaCl2 
Proteins were analyzed by SDS-PAGE, blotted to nitrocellulose membrane and phosphorylated 
proteins were detected by exposure to phosphoimager plates or x-ray film, scanned later using Fuji 
scanner. Identity of phosphorylated bands was confirmed by incubating the membrane with specific 
anti-TRPV6 antibody and subsequent detection with ECL reagent as above. 
7.2.12 Cloning and Expression of His-tagged proteins 
The cDNA coding for different fragments of the human TRPV6 N- and C-termini were amplified with 
PCR from hTRPV6b cDNA and subcloned into the BamHI or XhoI sites, respectively, of the pET19b 
vector. This vector contains a N-terminal located 10HIS tag in frame with the cloned fragments. The 
fusion protein covering aa 1-117 was made from mouse TRPV6 (Marcel Meissner). Plasmids were 
expressed in Escherichia coli BL21 strains. Overnight cultures were diluted 1:20, grown to an OD600 of 
0.5 and protein production was induced with 100 µM IPTG for 4 hours at 30°C. Cells were collected 
by centrifugation at 6000g, 4°C for 15 min. Pellets are initially resuspended in 5 mM imidazole, 500 
mM NaCl, 20 mM Tris pH 7.9 (BB). Lysates were sonicated 330 sec, centrifuged at 13.000 rpm for 
20 min. Pellets were resuspended in BB with a repeat of sonication and centrifugation. The final 
resuspension buffer also contains 6M urea (BBU). Lysates were then shaken for an hour at 4°C for 1h 
and pottered with a Dounce homogenizer. Finally, lysates were ultracentrifuged at 24000g for 25 min 
at 4°C and supernatants were incubated overnight with Ni-NTA beads (Qiagen). Columns were washed 
once with BBU then with BBU containing 15 mM imidazole. Proteins were eluted with BBU 
containing 1M imidazole. The integrity and size of the purified proteins were checked by Coomassie 
stained PAGE gels and protein concentration was determined by BCA (Pierce).  
Alternatively, fusion proteins were purified under non-denaturing conditions. Fragments encoding for 
ARD (42-266) and CT (633-725) were cloned into a modified pET21b vector (Jin et al., 2006), 
bacteria were induced at an OD600 of 0.5 with 75µM IPTG for 16h at 25°C. Pellets were resuspended in 
20 mM Tris-HCl (pH 8.0), 300 mM NaCl, 20 mM Imidazole, 1mM PMSF, 0.1% Triton-X-100, 0.2 
mg/ml lysozyme, 50 µg/ml RNAse and 25 µg/ml DNAse and treated as above. The cleared lysates 
were incubated with Ni-NTA beads for 2h at 4°C, washed with 20 mM Tris-HCl (pH 8), 300 mM NaCl 
and 20 mM imidazole. For elution, imidazole was increased to 200 mM.  
7.2.13 ATP-Agarose binding (Pulldown) 
To test whether a His-tagged protein is retained by ATP-agarose, pull-down experiments were 
performed. The fusion protein (40 µg) is diluted in 900 µl binding buffer with or without 6 (15) mM 
ATP or adenosine and incubated at 4°C for 20 min. Seventy five µl prewashed ATP-agarose beads 
(bound by a C6-spacer to C-8 of ATP, Sigma) were added for 2 hours with gentle rotation. 
For native proteins, DTT was excluded from the binding buffer. After incubation, beads were 
centrifuged, washed 4 1 ml binding buffer and resuspended in 2 Laemmli or Tricine loading buffer, 
depending on the type of gel used. Probes were denatured at 37°C for 30 min and separated by 15% 
SDS-PAGE or 10-20% TRIS/Tricine PAGE (Biorad). Probes can be split where 80% of bound fraction 
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is loaded on gels to be Coomassie-stained and 20% on gels to be blotted to nitrocellulose or PVDF 
membranes and probed with antibody against the His-tag. Binding experiments were repeated at least 
three times also with different batches of expressed protein. 
ATP-agarose binding buffer contains: 
10 mM Tris,  
50 mM NaCl 
1 mM DTT 
0.15% dodecyl-ß-D-maltopyranoside 
Buffered to pH 7.5 with NaOH 
 
Figure 8: Schematic representation of expression, purification and pull down of His-tagged fusion proteins. 
DNA encoding for desired fragment is cloned into pET vector expressed in E.Coli BL-21 and purified either 
under denaturing or native conditions. Fusion protein is bound to ATP-agarose and bound fraction is analyzed by 
SDS-PAGE 
7.2.14 In vitro translation of TRPV6 and ATP-agarose pull down 
The TNT-Quick Coupled Translation System (Promega) was used to translate full length TRPV6 
protein in vitro. This system utilizes lysate of reticulocytes (rich in ER membranes) that are able to 
transcribe and then translate protein from circular plasmids, e.g. TRPV6 in pCDNA3. The plasmid 
must contain a T7 RNA polymerase promoter, polymerase, nucleotides, salts and recombinant RNAsin 
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Ribonuclease Inhibitor were supplied as a reaction master mix. Radioactive methionine (35S-
Methionine) was added to be incorporated into the translated protein.  
One in vitro translation reaction contains: 
25 µl TNT-reaction master mix 
1 µl 35S-Methionine 
2 µl Plasmid (1 µg/µl) 
2 µl Nuclease free water 
Figure 9: Schematic representation of invitro translation, purification and pull down of 35S-Methionine-labelled 
TRPV6. Reticulocytes in vitro translate TRPV6-pCDNA3 in presence 35S-Methionine. Labelled protein purified 
on G-50 columns and incubated with ATP-agarose for 2 hours at 4. Bound fractions analyzed by SDS-PAGE and 
detected with phosphoimager. Identity of detected bands was confirmed by incubating the membrane with anti-
TRPV6 antibody. 
The reaction components were mixed gently and incubated at 30°C for 90 min. The mixture was 
transferred to pre-equilibrated Probe Quant™ G-50 Micro Columns (GE-Healthcare) to purify labelled 
proteins, and fractions were eluted with 1 ml of the same buffer used afterwards for ATP-agarose 
binding (see below). The first fraction, containing the void volume was rejected, and the subsequent 
fractions containing the radioactive proteins were collected sequentially. Probes of the eluted fractions 
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(1 µl) were measured in a scintillation counter. A volume of the eluted protein corresponding to 
710000 cpm was mixed with 30 µl pre-washed ATP-agarose beads and volume completed to 300 µl 
with binding buffer. Binding buffer contained (in mM): 140 caesium aspartate, 10 NaCl, 10 HEPES, 
10 glucose, 10 EGTA and 0.016 MgCl2 with or without 6 mM ATP containing 0.1% Triton. Binding 
was allowed for 2 hours then beads were washed 4500 µl with the corresponding binding buffer, 
resuspended in 2  Laemmli, probes denatured at 65°C for 15 min and bound fraction analyzed by 
SDS-PAGE blotted to nitrocellulose membrane. Phosphorylated proteins can be detected by exposure 
to phosphoimager plates or x-ray film. Identity of phosphorylated bands can be confirmed by 
incubation with anti-TRPV6 antibody and overlaying both images afterwards. 
7.2.15 Fluorescence-based Ca2+ imaging (Ivan Bogeski)  
Imaging of free intracellular Ca2+ concentration ([Ca2+]i) was performed using an Olympus IX 70 
inverted microscope (Olympus Deutschland GmbH, Hamburg, Germany) equipped with a 20x (UApo/ 
340, N.A. 0.75) objective, a Polychrome V Monochromator, and a CCD camera (T.I.L.L. Imago, 
T.I.L.L. Photonics GmbH, Germany). HEK cells were loaded with 1 µM Fura 2/AM in DMEM growth 
medium, at 37°C for 15 min in a dark chamber. Images were analyzed using TILL Vision software.  
Bath solution contained the following (in mM): 
150 NaCl 
2.8 KCl 
1 MgCl2 
1 CaCl2 
20 Glucose 
10 HEPES 
pH 7.4 with NaOH 
Calcium signals were monitored over time with bath solution containing either 1mM or 10 mM CaCl2 
and 135 NaCl. The switch to the 10 mM CaCl2 containing bath was repeated twice with an interval of 
~ 50 min. For ATP-depletion, cells were incubated with deletion medium after the first switch. 
ATP depletion medium contained the following (in mM): 
140 NaCl 
2.8 KCl 
1 MgCl2 
1/10 CaCl2 
20 Deoxyglucose 
10 HEPES 
10 Na azide 
pH 7.4 with NaOH 
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The absolute intracellular Ca2+-concentration is calculated as previously described (Grynkiewicz et al., 
1985). 
7.2.16 DCF ROS measurements (Ivan Bogeski) 
As an indicator of oxidative stress (redox status), H2O2 concentration was measured in stable as well as 
transiently TRPV6-expressing cells using the fluorescent dye CM-H2DCFDA (5-(and-6)-chloromethyl-
2',7'-dichloro-dihydrofluorescein diacetate, acetyl ester, DCF), (Invitrogen, Molecular Probes). A 
standard calibration curve was constructed that relates the fluorescence of the dye to different 
concentrations of H2O2. TRPV6 stable cells or HEK cells transiently transfected with TRPV6b are 
incubated for 30 min at room temperature with 1 µM CM-H2DCFDA. Cells were washed twice with 
PBS and loaded into the wells (200 µl buffer A/well). The measurements were performed in 96-well 
plates (353948, black/transparent bottom, BD Biosciences) using a GeniosPro universal microplate 
reader (Tecan) at 485 nm excitation and 535 nm emission. Absorbance was measured from bottom 
with 30 s initial shaking, 30 s shake settle time, 10 flashes, 40 µs integration time and a gain of 60. 
7.3 Electrophysiology 
TRPV6a or TRPV6b stable HEK293 (D11, C3) cells or transiently transfected wildtype or mutant 
constructs in pCAGGS-IRES-GFP were used for patch-clamp recordings. Recordings were performed 
at room temperature in the tight-seal whole-cell configuration using electrodes of 2-4 M resistance. 
Cell capacitance and access resistance were monitored before each voltage ramp and measurements 
were discarded when a change in access resistance exceeded 5 M. Series resistance was compensated 
to 80 %. Membrane currents were filtered at 1.5 kHz and digitized at a sampling rate of 5-10 kHz. 
Currents were recorded with an EPC-9 patch clamp amplifier controlled by Pulse 8.3 software (HEKA 
Electronics). Immediately after establishing whole-cell configuration, linear voltage ramps from -100 
to +100 mV within 100 ms were applied every 10 seconds from a holding potential of +70 mV for 10 
or 20 min as indicated. For analysis, currents at -80 mV ramp potential were divided by cell 
capacitance, normalized (CD/CDmax) and plotted against time.  
The EGTA-pipette solution contained the following (mM): 
140  Cesium aspartate 
10  EGTA 
10  NaCl 
10 HEPES 
0.016   MgCl2 
pH 7.2 with CsOH 
The BAPTA-pipette solution contained the following (mM): 
140 Cesium aspartate 
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20 EGTA 
22  NaCl 
10 HEPES 
0.020  MgCl2 
pH 7.2 with CsOH 
Using CaBuf software (ftp://ftp.cc.kuleuven.ac.be/pub/droogmans/cabuf.zip), we calculated that 1 mM 
MgCl2 had to be added to keep the free Mg
2+ at 11 µM in presence of 6 mM ATP in both EGTA- and 
BAPTA- containing solutions. In BAPTA and ATP-containing solution, Cs aspartate was reduced to 
135 mM.  
TRPV6 bath solution contained the following (in mM): 
115 Tetraethylammonium chloride 
10 Cesium chloride 
2.8 KCl 
2 MgCl2 
30 CaCl2 
10 Glucose 
10 HEPES 
pH 7.4 with NaOH 
Similarly for ICRAC measurements, we made use of a STIM1-stable cell line that was transiently 
transfected with the wildtype or mutant Orai constructs. Human Orai1, 2 and 3 contructs were 
amplified from the HA-tagged constructs provided kindly by Annette Lis and Reinhold Penner then 
cloned into the bicistronic vector pCAGGS_IRES_GFP. Recordings of ICRAC were performed under 
same conditions as above except for using EPC-10 as the patch clamp amplifier and Patch Master as 
the controlling software (HEKA Electronics). When whole-cell configuration was established, linear 
voltage ramps from -150 to +150 mV within 50 ms were applied every 2 seconds from a holding 
potential of 0 mV over a 5-minute recording period. Currents at -80 mV ramp potential were divided 
by cell capacitance, and plotted against time. Cells that showed an initial inward current of > 10 pA/pF 
were considered preactivated and were therefore excluded from the analysis also were the cells 
identified as outliers by the online available GrafPad software applying Grubb’s test. 
ICRAC pipette solution contained the following (mM): 
120  Cesium glutamate 
20  Tetracesium BAPTA 
10 HEPES 
3  MgCl2 
0.05 IP3 
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pH 7.2 with CsOH 
The ICRAC bath solution contained the following (mM): 
120 NaCl 
10 Tetraethylammonium chloride 
10 CaCl2 
2 MgCl2 
30 Glucose 
10 HEPES 
pH 7.2 with NaOH 
7.4 Statistical Analysis: 
Data obtained are presented as mean ±S.E.M. Statistical significance was tested by performing 
unpaired, two-tailed Student t-test. Asterisks indicate significant differences. * p<0.05, ** p<0.01, *** 
p< 0.001. 
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8 Results 
8.1 Regulation of TRPV6 activity 
8.1.1 Regulation of TRPV6 activity by ATP 
8.1.1.1 ATP prevents rundown of TRPV6 calcium currents 
Heterologous expression of TRPV6 results in a constitutively active channel showing large inward 
rectifying currents that dramatically increase in value when cells are held at positive holding potential 
in whole-cell mode (Wissenbach et al., 2001). We recorded currents exhibiting typical TRPV6 
characteristics from stable cell lines expressing either human TRPV6a or b alleles, thus profiting from 
the targeted insertion that minimizes transcriptional differences in locus. Currents were recorded in 
whole-cell mode placing the cells in high calcium containing bath solution. The internal solution was 
EGTA buffered and contained 11µM free Mg2+ keeping it at a concentration lower than the observed 
IC50 (Voets et al., 2003). We extended the recording time to 20 min to observe regulatory processes 
and thereby seeking a potential difference between the two alleles that might emerge under conditions 
of longer observation. In our protocol cells were kept at holding potential of +70 mV and a linear 
voltage ramp from -100 to +100 mV was applied. Analyzing the current at -80 mV we observed fast 
development of current (Fig. 10a). The maximum current density (in pA/pF  SEM) recorded for 
TRPV6a was -10515, n=17 which was not significantly different from that recorded for TRPV6b 
(15527, n=11). Similar kinetics of current development were observed for both alleles which reached 
maximum value within the first 2 min of recording time (Fig. 10f). An interesting observation was the 
phenomenon of rundown where current values decreased over time to 31 and 35% of their 
corresponding maxima (Fig. 10a). For a quantitative description of this phenomenon, we termed the 
percent of maximum after 20 min “remaining current-densities (% REM)” (Fig. 10e). We also 
analyzed t½ which is the time required for development of half maximal current density (Fig. 10f). 
Because our aim was to investigate regulatory mechanisms over longer recording time, we wanted to 
impede rundown. We included 6 mM Na2ATP in our internal solution, keeping the free Mg
2+ at 11 µM 
to bar its potential interference. A significant alteration of current development was observed. The 
initial currents after break-in were small and showed small increments with each ramp in a continuous 
run up mode throughout the recoding time that ended with minimal or no rundown (Fig. 10c). 
Maximum current densities after 20 min [-98±16 (V6a); -153±11 (V6b)] were not different from the 
corresponding values observed without ATP in the recording solution. To exclude the development of 
other conductances in our recording conditions, we plotted I-V relationship that actually retained the 
typical features of TRPV6 (Fig. 10b, d). Both alleles had comparable characteristics in both control and 
+ATP conditions with no significant differences detected in %REM or t½. 
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Figure 10: Whole-cell inward current densities (CD) measured at –80 mV ramp potential normalized to CDmax 
and plotted over 20 min recording time. On top of the figure is the performed ramp protocol: from holding 
potential of +70 a voltage ramp was performed from -100 to +100 mV over 100 ms and ramp repeated after 10 s 
pause for 120 times over total recording time of 20 min. Black trace is an average of TRPV6a expressing cells, 
red trace of TRPV6b expressing cells. Error bars represent mean + SEM. a. Pipette solution without ATP 
contains 11 µM free Mg2+. b. Sample I/V relationships immediately after break-in (1), at 1 min (2) and after 20 
min (3), showing the typical inwardly rectifying TRPV6 currents. c. Normalized current densities over time in the 
presence of 6 mM Na2ATP for TRPV6a and TRPV6b expressing cells. d. Sample I/V relationships as described 
in (b) but in the presence of ATP. e. Bar graph showing the % remaining current (REM) after 20 min for TRPV6a 
and TRPV6b in the absence and presence of ATP. Numbers on bars represent number of cells. f. Quantification 
of the time to half-maximal activation for V6a and V6b in the absence and presence of ATP. 
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8.1.1.2 ATP effect on transiently expressed TRPV6 
Because we wanted to further investigate the mechanism underlying the ATP effect by introducing 
point mutations and/or making deletions in TRPV6 subsequent recording from cells transiently 
expressing TRPV6 constructs was necessary. Therefore, we had to verify that the phenotype observed 
in the stable cell lines in presence or absence of ATP is similar for transiently expressed TRPV6. 
Recordings from HEK cells transiently expressing TRPV6a or b in pCAGGS expression vector 
showed comparable rundown in absence (Fig. 11a) and in presence (Fig.11b) of ATP to those of the 
stable cell lines. Since transient cells could often not be held for 20 min, currents were analyzed after 
10 min recording time. After 10 min of recording, the rundown observed in absence of ATP in the 
transient cells was quite similar to that of the stable (45±9; 59±9%, respectively). Though slow-down 
of current development was still evident for transiently expressed TRPV6 (Fig. 11d), stably expressed 
TRPV6 was significantly more slowed down (t½117±22 vs. 57±10). The difference in the kinetic 
component of the effect of ATP was complicated to interpret especially with the similar current 
densities (-160 pA/pF stable vs. -168 pA/pF transient). Therefore, we directed further analyses to 
effects on rundown. The difference in kinetics of current development in presence of ATP is addressed 
under regulation by ROS (chapter 7.1.4). 
 
Figure 11: Whole-cell inward current densities (CD) measured at –80 mV ramp potential normalized to CDmax 
and plotted over 10 min recording time. Traces are averages of HEK cells transfected with TRPV6a (black) or 
TRPV6b (red) in pCAGGS-IRES-GFP. Error bars represent mean + SEM. Shown are the normalized current 
densities in absence (a) or presence of 6 mM ATP (b). c. Bar graph showing the % remaining current (REM) 
after 10 min for TRPV6a and TRPV6b in the absence and presence of ATP. Numbers on bars represent number 
of cells. d. Quantification of the time to half-maximal activation for V6a and V6b in the absence and presence of 
ATP.  
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8.1.1.3 Influence of ATP on Ca2+-dependent inactivation 
A well-documented regulatory mechanism for TRPV6 is Ca2+-dependent inactivation. When cells 
expressing TRPV6 are subjected to a hyperpolarizing voltage step they show strong time-dependent 
multiphasic inactivation in presence of Ca2+ but not Ba2+ as the charge carrier (Niemeyer et al., 2001). 
To investigate whether inclusion of ATP alters the pulse inactivation behaviour we applied a 1 s 
hyperpolarizing pulse following the voltage ramp protocol. To quantify pulse-induced inactivation we 
analyzed the residual current fraction at 930 ms (r930) relative to the peak current. Compared to the no 
ATP condition, the residual current fraction was significantly increased when 6 mM ATP was included 
in the pipette solution. However, this effect is not seen when 10 mM EGTA was substituted with 20 
mM BAPTA (Fig. 12a, b), suggesting that the effect may be due to ATP’s buffering capacity towards 
Ca2+. The higher Ca2+-buffering capacity of BAPTA and abrogation of ATP effect indicate that ATP 
can only interfere with Ca2+-dependent inactivation mechanisms that are not buffered by 10 mM 
EGTA. Nevertheless, in the voltage ramp protocol ATP was still able to significantly suppress 
rundown as well as alter the current on-set kinetics even in the presence of the faster buffer (Fig.12d, 
e). This finding indicates that the effect of ATP is not entirely mediated by interference with Ca2+-
dependent mechanisms. This conclusion is in agreement with prevention of rundown in divalent free 
condition observed by Hoenderop and coworkers (Hoenderop et al., 2001). To test potential influence 
of ATP on Ca2+-dependent mechanisms, we deleted a C-terminal domain calmodulin-binding domain 
(CAM) (Niemeyer et al., 2001). The CAM mutants were still influenced by ATP and showed slower 
current development and significantly less rundown than the wildtype (Fig.12c), indicating that ATP 
and calmodulin do not have overlapping interaction sites.  
 
Generated by Foxit PDF Creator © Foxit Software
http://www.foxitsoftware.com   For evaluation only.
                                                                                                                                                          Results 
63 
 
 
Figure 12: a. TRPV6b current traces in the presence (grey) and absence (black) of 6 mM ATP in response to a 1 
s voltage step to -100 mV. b. Quantification of residual current fractions at 930 ms (r930) relative to the peak 
current with either 10 mM EGTA or 20 mM BAPTA. c. Quantification of rundown for transiently expressed 
wildtype TRPV6b and TRPV6CAM mutants in the presence and absence of ATP. d. TRPV6b whole-cell 
current densities (CD) measured at –80 mV ramp potential normalized to CDmax with 20 mM BAPTA in presence 
(red) or absence (blue) of 6 mM ATP. e. Quantification of rundown with 20 mM BAPTA with and without ATP. 
8.1.1.4 ATP depletion inhibits TRPV6-mediated Ca2+ influx 
To investigate the ATP effects in a more physiological milieu we measured the Ca2+ influx in intact 
control TRPV6 cells and in cells kept in ATP-depleting buffer containing a metabolically non 
utilizable form of glucose and sodium azide (Schwoebel et al., 2002). Fura2 loaded control TRPV6 
cells showed a transient increase in intracellular calcium concentration ([Ca2+]i) upon shifting the 
external calcium concentration ([Ca2+]e) from 1 to 10 mM. This transient could again be evoked after ~ 
50 min when cells were kept at physiological conditions (Fig. 13 upper panel). Depriving the cells of 
ATP hampered the subsequent Ca2+ influx (Fig. 13 lower panel) indicating that an adequate 
concentration of ATP or of a metabolite is a prerequisite for a TRPV6 response to an increased [Ca2+]e. 
In our protocol, [Ca2+]e was brought back to a lower level (1 mM) during incubation time. 
Interestingly, the ATPases were still functional as indicated by retrieval of the resting [Ca2+]i. A set of 
control experiments using HEK cells kept at the same conditions was done in parallel. HEK cells 
showed a lower resting calcium [Ca2+]i and were lacking the rapid transient increase in [Ca
2+]i upon 
exposure to 10 mM [Ca2+]e  
 
Figure 13: Upper panel: Fura-2/AM loaded HEK-TRPV6b cells showing a transient increase in [Ca2+] when 
extracellular [Ca2+] is increased to 10 mM. Influx can again be evoked after 50 min. Middle panel: Same 
protocol as above but bath solution after the first transient includes 20 mM deoxyglucose instead of glucose and 
Generated by Foxit PDF Creator © Foxit Software
http://www.foxitsoftware.com   For evaluation only.
                                                                                                                                                          Results 
64 
 
 
10 mM sodium azide. Lower panel: HEK-wt cells before and after depletion. Traces are averages of > 100 cells 
for HEK-TRPV6 and 75 cells for HEK-wt. 
8.1.1.5 ATP effect is PIP2-independent and does not require hydrolysis 
ATP is essential for maintenance of intracellular PIP2 levels. End of 2008, Thyagarajan et al. showed 
that Ca2+ influx induces depletion of PIP2 and thereby mediating Ca
2+-induced inactivation of TRPV6 
channels (Thyagarajan et al., 2008). To examine the probable involvement of PIP2 in the ATP effect, 
we replaced ATP with 50 µM diC8PIP2, maintaining high intracellular [PIP2] in absence of ATP. This 
water soluble PIP2 derivative was unable to prevent rundown when solely included (Fig 14a,b). 
Furthermore, we mutated a highly conserved arginine residue, R606, equivalent to R599 in rTRPV5. 
The latter residue was shown to be essential for PIP2-mediated regulation of TRPV5 (Rohacs et al., 
2005). Site directed mutagenesis was done in TRPV6/pCDNA3 and the mutation containing 
EcoRV/MfeI-digested fragment replaced that of the wildtype in pCAGGS-IRES-EGFP (Fig 24b). The 
PIP2-binding defective mutants (R606Q) still showed significantly reduced rundown when ATP was 
included in the pipette solution (Fig. 14c, d). Many regulatory effects of ATP were shown to require 
hydrolysis of ATP therefore we tested whether a non-hydrolyzable ATP analogue, AMP-PCP 
(Ashcroft and Kakei, 1989), is still able to prevent rundown. This analogue retained the ability to 
prevent rundown and slowed current development (Fig. 14a, b). When put together, this evidence 
indicates that ATP regulates TRPV6 in a PIP2-independent manner and that this regulation does not 
require ATP hydrolysis. 
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Figure 14: a. Normalized current densities over time in the absence of ATP (grey), in the presence of 50 µM 
diC8PIP2 (brown) or in the presence of 6 mM AMP-PCP (blue) in TRPV6 stable cell line, error bars represent 
mean + SEM. b. Bar graph of the % REM for traces seen in (a). c. Normalized current densities over time for 
transiently expressed TRPV6b-R606Q mutants with (black) and without (grey) ATP in the recording pipette 
showing that R606Q mutants retain the ATP effect. d. % REM after 10 min recording time, see also Fig.11b, c 
for transiently expressed wildtype. 
8.1.1.6 The nucleotide specificity of the ATP effect 
To test nucleotide specificity of the ATP effect we substituted ATP with an equal concentration of 
variable nucleotides having either fewer phosphate substitutions or a different nucleobase. For 
nucleotides known to chelate magnesium, the total added Mg2+ was adjusted to keep the free [Mg2+] at 
11 µM. Similar to recordings with ATP, we applied the voltage ramp protocol and analyzed the 
%REM. Figure 15 shows that having another nucleobase (UTP, IMP and GTP) reduces the 
nucleotide’s ability to prevent rundown regardless of the number of phosphates. Similarly, adenine-
based nucleotides with fewer phosphate substitutions were less effective than ATP in prevention of 
rundown with adenosine being ineffective. The second messenger cAMP was also unable to prevent 
rundown. 
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Figure 15: a. Sample traces of normalized current densities over time in the presence of different intracellular 
nucleotides at 6 mM concentration each, error bars represent mean + SEM. b. Quantification of the remaining 
current (%REM) for all nucleotides tested. Asterisks indicate significant differences of the %REM against the no 
added nucleotide (no NT) control. Numbers on bars represent number of cells. Recordings were obtained in 
stable TRPV6b cells.  
These results indicate that: firstly, the effect of ATP is not due to an increased Ca2+-buffer capacity 
because UTP and ATP have similar Ca2+-buffering capacities but affect current kinetics quite 
differently. Secondly, the effect shows nucleobase specificity. Thirdly, at least one phosphate is 
necessary because AMP but not adenosine slows the current and prevents some of the rundown.  
8.1.1.7 ATP effect is concentration-dependent 
To find out whether and how concentration-dependent the ATP effect is, we analyzed the %REM for 
recordings from cells supplemented with different concentrations of ATP then plotted the dose 
response (Fig 16b). Our regular internal solution for the +ATP recordings contained 6 mM Na2ATP, 1 
mM MgCl2 and 10 mM EGTA resulting in a free [ATP] of 3.7 mM which is higher than the estimated 
cellular free [ATP]. To obtain the dose response relationship we included free [ATP] of 609, 304, 124, 
60 and 6µM always keeping free [Mg2+] at similar levels and fitted the data points with a sigmoidal 
dose-response function of variable slope, where % REMMAX is the maximal remaining current obtained 
after addition of 3.7 mM free ATP, EC50 is the half-maximal concentration of free ATP,
 and n is the 
Hill slope. The following equation was used to fit ATP concentration-response curve: 
rate
X
X
base
baseY
)1(
)(max
2/1


  
As shown in Figure 16 the mean EC50 obtained from the graph was 378 µM free ATP and the Hill 
slope was 4.8. The EC50 value obtained is one order of magnitude
 greater than that normally required 
for a kinase-mediated phosphorylation reaction (Hilgemann, 1997) but conforms well with estimated 
free [ATP]i within cells (~ 0.5 mM) (Gajewski et al., 2003) 
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Figure 16: a. Normalized current densities over time for selected concentrations of intracellular free ATP, error 
bars represent + SEM. b. Mean relationship between free [ATP] and the degree of run-down after 20 min 
(%REM). Data points (number of cells above) were best fitted to equation (1), see text. EC50 = ATP concentration 
at which prevention of rundown is half-maximal. nH = Hill slope. 
8.1.1.8 ATP binds TRPV6 at atypical domains 
ATP is shown to regulate the activity of several channels by means of direct binding. In an initial trial 
to test if this is also the case for TRPV6 we performed ATP pull down experiments using the in vitro 
translated full length TRPV6 protein and ATP-agarose. TRPV6 was retained by ATP-agarose and that 
retention was competed for by ATP in the binding buffer (Fig. 17). With this initial result at hand, we 
set out to further define ATP binding sites within TRPV6. 
 
Figure 17 In vitro translated full length TRPV6 is retained on ATP-agarose. Using reticulocytes lysates, TRPV6 
protein was in vitro translated, purified and bound to ATP-agarose in presence or absence of ATP in binding 
buffer. a. Autoradiographic image of SDS-PAGE analyzed in put (IP) and bound fractions. b. Quantification of 
signal of bound/unbound fractions in absence (green) and presence (blue) of ATP. 
To map the potential ATP binding site(s), we made use of two mTRV6 histidine tagged fusion 
proteins, provided by Marcel Meissner (FP1 and CT1) and we cloned several additional N-terminally 
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10 histidine tagged proteins to cover the intracellular protein domains. At the N-terminus, the fusion 
protein FP1 started at the very beginning of TRPV6 and extended to the second ANK repeat (Fig. 18b), 
followed by a fusion protein covering the 6 ANK repeats (ARD) (Fig. 18c). The fusion protein (NP) 
covered the sequence downstream of the ANK repeats to the first transmembrane domain (NP) (Fig. 
18d). Two fusion proteins covered the C-terminus with the first starting after the sixth transmembrane 
domain and including the TRP box (CT1) (Fig. 18e) while the second extended downstream to the very 
C-terminal end of TRPV6 protein (CT2) (Fig. 18f). We cloned the N- and C-termini fusion proteins 
into the BamHI and XhoI sites, respectively, of the pET19b vector. The fusion proteins were expressed 
in BL21 cells and purified from cell lysates by binding to Ni-beads. Retention of the eluted purified 
proteins by ATP-agarose was tested. Specificity of the binding was tested for by inclusion of free ATP 
or UTP. 
 
Figure 18: a. Schematic diagram of the TRPV6 protein domains. b-f. Schematic diagrams of the individual 
fusion proteins, numbers indicate amino acids next to Coomassie-stained PAGE gels of ATP-agarose pull down 
experiments. “input” 2% of total protein used for binding, “b-ATP” is the total fraction of protein retained by 
ATP-agarose in the absence of free ATP and “b+ATP” is the total fraction of protein retained in the presence of 6 
mM free ATP in the binding buffer. g. Schematic diagram and ATP-agarose pull-down of rTRPV1 ARD fusion 
protein (aa 101-364).  
Investigating binding at the N-terminus showed that P1 could not be retained on ATP-agarose (Fig. 
18b) pointing to the fact that the His tag by itself does not confer unspecific binding to the agarose. On 
the other hand, ARD was weakly retained, an observation that remained consistent upon repetition of 
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the experiment also with different batches of purified protein. The NP was initially more strongly 
retained by ATP-agarose than ATP but this binding was variable when we repeated the experiment. 
(Fig. 18c,d). The proximal region of the C-terminal domain was efficiently but unspecifically retained 
on ATP-agarose as indicated by inability of free ATP to compete this binding (Fig. 18e). The distal 
part of the C-terminus was equally retained and the binding was, in contrast, specifically competed for 
by free ATP (Fig. 18f). Because the ARD region of rat TRPV1 had already been shown to bind ATP 
(Lishko et al., 2007), we also created a His tagged rTRPV1 ARD to serve as reference bound protein. 
This latter protein was retained by ATP-agarose in our experimental conditions (Fig. 18g). though with 
lower efficiency than the previously reported binding. Because no binding of TRPV6-ARD was 
detected in another independent study of the same group, (Phelps et al., 2008) which is in contrast to 
our results, we considered the differences in our experimental conditions. Among these differences is 
that we purified our proteins in presence of a denaturing agent (6M Urea). Based on results illustrated 
in the next chapter (regulation by protein kinase), that were obtained in parallel, we proposed that ARD 
and CT2 fusion proteins contain the functionally relevant ATP binding sites hence we wanted to 
confirm that both proteins still bind ATP when purified under native conditions.  
Our trials to purify the N-terminal 10His tagged proteins resulted in weakly soluble proteins that we 
could not keep in solution in absence of urea. Based on the cloning strategy described by Jin and 
coworkers (Jin et al., 2006), we constructed a new bacterial expression vector (Fig. 20) where we 
created a cloning site upstream of a 6 His tag to be C-terminally linked to the protein via a 3 alanine 
linker. Figure 19 shows that proteins purified under native conditions were still specifically retained by 
ATP-agarose to a comparable extent to that of the N-terminally tagged proteins  
 
Figure 19: a. Coomassie stained PAGE gels showing expression of ARD and CT2 fusion proteins with C-
terminal 6 His tag purified under native conditions. Middle panel is a schematic diagram of the two 
fusionproteins. b. Coomassie stained gels of ATP-agarose pull down experiments, TCA: 8% of trichloroacetic 
acid-precipitated total protein used for binding, “input”: 2% of total protein used for binding, “b-ATP” is the total 
fraction of protein retained by ATP-agarose in the absence of free ATP and “b+ATP” is the total fraction of 
protein retained in the presence of 6 mM free ATP in the binding buffer.  
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Figure 20: Modification of pET21a vector for cloning 6 His C-terminally tagged fusion proteins. Original 
pET21a (a) and a double stranded oligonucleotide containing a NotI recognition site (c) ligated into the 
NotI/SalI-digested fragment (b) reconstituting the SalI site and destroying the original NotI site (d). cDNA of the 
desired fusion protein was PCR amplified and cloned into the NdeI/NotI of the modified vector (f). 
The results presented so far shed some light on how TRPV6 activity is linked to the metabolic status of 
the cell. Moreover, the results indicate that ATP modulates TRPV6 channel activity by direct binding 
at several binding sites. Because it is imaginable that not all the binding sites are functionally relevant, 
we performed further functional analyses presented in the following chapter to narrow down the 
relevant sites. 
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8.1.2 Regulation of TRPV6 activity by PKC modulation 
8.1.2.1 Effect of stimulation of PKC 
Because the human alleles TRPV6a/b differ in a potential phosphorylation site for PKC, we 
investigated whether we could uncover a functional difference under conditions of stimulated PKC. 
Accordingly, we incubated the stable cells with 500 nM of the phorbol ester PMA that, among other 
effects, is a potent activator of PKC. Surprisingly, preincubation with PMA resulted in reversion of the 
ATP effect where currents developed fast and attained the maximal values within the first 2 min 
despite the presence of ATP (Fig. 21a,c). Interestingly, the extents to which both alleles were affected 
by PMA stimulation were different. Whereas PMA annulled the effect of ATP on the ancestral allele 
(Fig. 21b) it could only partially revert it for the derived allele (Fig. 21d). With the polymorphic 
exchange (R158C) deleting a potential PKC consensus site (S/TxR) in the derived allele, this data 
reveals a unique though modest difference between the alleles that could have further functional 
relevance.  
 
Figure 21: a. Normalized current densities over time for TRPV6a expressing control cells (black) and cells that 
were pretreated for 1hr with 500 nM PMA, also PMA present in bath solution (blue), for both 6 mM ATP 
included in patch pipette error bars represent +SEM. b. Quantification of run-down (%REM) after 20 min, in 
presence of ATP (black), absence of ATP (grey), and in presence of ATP with preincubation with PMA (blue). c. 
and d. Same as in (a) and (b) for TRPV6b stable cell line. 
To test whether PMA has an effect in the absence of ATP, we recorded from cells preincubated with 
PMA without adding ATP to the internal solution. For both alleles currents developed fast. While the 
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ancestral allele showed similar rundown to that of the control recordings (258%), the derived allele 
showed more extensive rundown (173%) which could mean that at the ground state TRPV6a is more 
phosphorylated than TRPV6b. 
 
Figure 21: a. Normalized current densities over time for TRPV6a (black) or TRPV6b (red) expressing cells 
pretreated for 1hr with 500 nM PMA, also included in bath solution pipette solution not containing ATP, error 
bars represent + SEM. b. Quantification of run-down (%REM) after 20 min from recording done in (a) compared 
to corresponding recording from cells not pretreated with PMA in grey (see Fig. 10). 
8.1.2.2 PMA effect is isozyme specific 
Considering the multiple effects of PMA, it was important to ascertain that the observed PMA effects 
were specific to PKC. Currents recorded from cells preincubated with 4PDD (an inactive analogue 
that still binds C1 domains of proteins but is unable to stimulate PKC) were slow with no evident 
rundown indicating that PMA effect is PKC-mediated (Fig. 22a, b). In an attempt to block the effect of 
PMA, we pretreated TRPV6b cells for 1h with the inhibitor mix (Bisindolylmaleimide I and Gö 6983, 
Calbiochem), before stimulating with PMA. This pretreatment failed to prevent PMA-induced 
rundown (Fig. 22a, b). Screening the available literature about PKC inhibitors we noted that Bis/Gö 
have well characterized IC50 [6 – 60 nM, (Gschwendt et al., 1996; Toullec et al., 1991)] for most 
classical PKCs but not for the isozyme PKCßII. Ro-31-8220 (Calbiochem), however, has a defined IC50 
of 14 nM for PKCßII (Wilkinson et al., 1993). Pretreatment with 500 nM Ro-31-8220 abolished the 
PMA effect suggesting that the effect is mediated by PKCßII stimulation.  
In line with the specificity of PMA effect to the isoform PKCßII are the findings obtained from the next 
set of experiments. Investigating the time required for the PMA effect we recorded from cells after 
descending incubation time periods: 30, 10 and 0 min, in the latter PMA was only acutely added to the 
bath solution and cells were recorded within 10 min. The PMA effect was either partial or gone with 
reduced incubation. To investigate why it takes an entire hour to see the PMA effect while, PKC 
activation and translocation to the plasma membrane occurs within min. A possible explanation is that 
HEK cells express very low levels of PKCßII (Feng et al., 1998) and the fraction of enzyme 
translocating to the plasma membrane might need longer to accumulate to a sufficient amount to exert 
a measurable effect. If this is the case, PKCßII overexpression should speed up the effect of PMA. We 
therefore overexpressed PKCßII as well as PKC in TRPV6 stable cells and as shown in Figure 22c,d, 
only overexpressing of PKC ßII but not PKC obliterated the need to PMA preincubation though both of 
them translocated to the plasma membrane when PMA stimulated (Fig. 22e and data not shown). To 
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test whether PKC ßII and TRPV6 share expression pattern, we examined its expression in the human 
placental DNA, from which TRPV6 was originally cloned (Wissenbach et al., 2001). We were able to 
amplify PKC ßII using isoform-specific PCR primers (Fig. 22f). PCR products were of the expected size 
and the intensity correlated with the amount of template used. Taken together, this indicates that PMA 
specifically regulates TRPV6 activity via a PKCßII -specific pathway.  
 
Figure 22: a. Normalized current densities over time for TRPV6b expressing cells that were pretreated either for 
1 hr with PMA or 4--PDD or for 30 min with 500 nM each of inhibitors Gö6983/BIS or Ro-31-8220 then 500 
nM PMA for 1 hr, recordings with ATP included in pipette solution and PKC modulators included in bath 
solution, error bars represent +SEM b. Percent REM for recordings with PKC modulators obtained in (a). c. 
Normalized current densities recorded from TRPV6b stable cells with transient expression of GFP-PKCßII or 
GFP-PKCwith acute PMA treatment (≤10 min in bath, no pretreatment), 6 mM ATP included in pipette 
solution. d. Bar graph of percent REM with acute PMA treatment for TRPV6b cells alone or TRPV6b cells 
transfected either with GFP-PKCßII or GFP-PKC, as in (c). e. Fluorescent images from TRPV6b cells expressing 
GFP-PKCßII before and after induction of translocation with 500 nM PMA perfusion. f. Amplification products of 
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the 162 C terminal nucleotides distinctive of PKCßII from PKCßI out of human placental cDNA or from 
recombinant PKCßII vector, using the shown amount of templates in ng. 
We next investigated whether PKCßII directly phosphorylates the channel by incubating microsomal 
membrane fractions of TRPV6b expressing cells with recombinant PKCßII or, alternatively, lysates of 
cells transfected with GFP-PKCßII, and [-
32P] labelled ATP. Proteins were blotted onto nitrocellulose 
membrane then phosphorylated proteins were detected by exposure to phosphoimager plates or x-ray 
film. Figure 23 shows that a band of a similar molecular mass as complex glycosylated TRPV6 is 
phosphorylated which could mean that PKCßII specifically phosphorylates complex glycosylated 
TRPV6. The identity of the phosphorylated band was confirmed by incubating the same blot with 
antibodies against TRPV6. 
 
 
Figure 23: In vitro phosphorylation experiment. Proteins were labelled with [-32P]-ATP by incubation of 
TRPV6 containing microsomes (mi) with lysates of HEK293 cells expressing GFP-PKCßII Protein extracts were 
separated by SDS-PAGE and blotted to nitrocellulose film that was first incubated with an X-ray film (left panel) 
then the identity of phosphorylated bands was confirmed by incubation withTRPV6-antibody (right panel). 
8.1.2.3 Mutational analysis of the putative phosphorylation sites mutants. 
In an endeavor to reveal the functional relevance of effects of PMA, we mutated the putative 
phosphorylation sites identified by either the Prosite [http://www.expasy.ch/prosite, (Hulo et al., 2008)] 
or NetPhosk algorithms [http://www.cbs.dtu.dk/services/NetPhosK/, (Blom et al., 2004)]. We recorded 
from cells with and without preincubation with PMA. Control recordings without ATP were also done 
in parallel. Site directed mutagenesis was used to mutate the identified potential phosphorylation sites. 
Those sites were mutated by replacing the serine or threonine codons with alanine codons. The mutated 
fragments were confirmed by double stranded sequencing. Unless otherwise noted, mutations were 
done in the hTRPV6b background. To clone mutations within the N-terminal end of the protein 
(S144A, T150A, T298A/T299A, S318A, R153Q/R154P), mutagenic PCRs were initially done in 
TRPV6/pCDNA3, the mutated DNA was digested with BamHI and EcoRV (at 37°C) then BsmBI (at 
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55°C) and the BsmBI /EcoRV fragment hosting the mutations was swapped with the wildtype BsmBI 
/EcoRV fragment of TRPV6/pCAGGS (Fig. 24a). Resulting constructs were then used for 
electrophysiological recordings. Similarly, the mutation in the C-terminus (T688A) was first done in 
pCDNA3 and exchanged with the wildtype fragment in pCAGGS by MfeI/EcoRV-double digestion 
(Fig. 24b).  
 
Figure24: Different TRPV6 mutageneses were done in TRPV6/pCDNA3 plasmid vector. a. For the N-term 
mutations, DNA confirmed to contain the desired base exchange was digested with BamHI/BsmB1/EcoRV then 
mutant BsmB1/EcoRV fragment (NT:66-1149) was exchanged with that of the wildtype in pCAGGS. b. 
Similarly, for C-term mutant, DNA was digested with EcoRV/MfeI and the mutant fragment (NT:1149-2079) 
replaced that of the wildtype in pCAGGS. 
Recordings in absence of ATP from all mutants showed comparable rundown to the wildtype (Fig. 
25b). In presence of ATP, for all mutants rundown is significantly prevented compared to the no ATP 
condition (Fig. 25 b-h). However, transient transfection of mutant constructs generally resulted in 
slightly altered kinetics of current development (see below: transient transfection and oxidative stress, 
subchapter 7.1.4). The first putative PKC site (S144) lies within the ARD in the solvent exposed finger 
loop between ANK3 and ANK4 and.is a potential functionally relevant site since mutants of this site 
did not show the effect of PMA (Fig. 25c) while in the same protein domain mutants of the threonine 
residue (T150A) still showed PMA-induced rundown (Fig. 25d). At the proximal end of the N-term, 
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the double mutant T298/299A showed a reduced PMA effect (Fig. 25e) while mutating the next 
putative serine residue (S318A) had no effect (Fig. 25f). Likewise, in the C-terminus mutating the first 
site T688 resulted in loss of PMA effect (Fig. 25g) while recordings from a stable cell line expressing 
the distal T702A mutants showed retention of the PMA effect (Fig. 25h). This data suggest that a PKC 
regulatory effect is mediated through phosphorylation at an N- as well as a C-terminal site. 
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Figure 25: a. Schematic representation of putative PKC phosphorylation sites as found by the Prosite algorithm. 
b. Bar graph of percent REM from HEK cells transiently expressing mutants S144A, S150A, T298/299A, S318A 
and T688A or stably T702A. REM calculated after 10 min for transiently expressed mutants and 20 min for the 
stable T702A Pipette solution including no ATP (grey) or 6 mM ATP (black) in addition to pretreatment of cells 
with PMA for 1 hr and having PMA in bath solution during recording (blue), numbers on bars are numbers of 
cells. c-h. Normalized current densities over time from cells expressing the different mutants in (a) in presence of 
ATP (black) and with pretreatment with PMA (blue), error bars represent +SEM. 
8.1.2.4 A double arginine mutation within the ARD region disrupts 
regulation by ATP 
Our data show that the TRPV6 ARD region is able to bind ATP and that stimulation of PKC reverts 
the effects of ATP on current development and rundown. Because mutation of the S144 consensus site 
for PKC phosphorylation obliterated the effects of PMA on rundown, it is possible that the negatively 
charged phosphates added by PKC repel the binding of the phosphates of ATP and thereby shield an 
interactive site on the protein. If so, one would expect electrostatic attraction of ATP to positive 
residues within this domain to occur in the absence of channel phosphorylation. Two positively 
charged arginine residues (R153/R154) are present in the finger loop region between Ank3 and Ank4, 
close to the phosphorylation site S144 and also to the polymorphic phosphorylation site S155 (Fig. 
26a). We mutated these residues to glutamine and proline (RR/QP, as present in hTRPV4) and 
recorded currents in the absence and presence of 3.7 mM free ATP. Indeed, this mutation rendered 
ATP incapable of slowing current development or preventing rundown. The %REM obtained 
(4510%) is similar to that obtained in absence of ATP (5111%) (Fig. 26b,d). To confirm the 
functional importance of this region we also included a peptide encompassing the sequence from aa 
147-165 in patch pipette in presence of ATP assuming that this peptide being present in excess would 
bind ATP and make it unavailable for binding to the channel. Figure 26c,e shows that, in presence of 
the peptide, currents developed quickly and showed extensive rundown (4812%). Because the peptide 
has limited solubility, we used a lower concentration of ATP that still showed the ATP effect as 
demonstrated in the dose response findings. Furthermore, we tested the binding of 10His RR/QP-
ARD fusion protein to ATP-agarose. To clone this construct, primers used for cloning the ARD into 
the BamHI site of the pET19b vector were used to amplify the same fragment using RR/QP mutant 
cDNA as template. This fusion protein showed reduced binding to ATP compared to the wildtype (Fig. 
26f). Together, these results suggest that the ANK3-4 linker region encompassing residues R153 and 
R154 binds ATP’s negatively charged phosphate moieties and is crucial for its physiological effects. 
Phosphorylation at S144 and possibly at S155 in the case of TRPV6a may prevent binding either by 
charge screening or by inducting conformational change. 
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Figure 26: S144 is a critical PKC phosphorylation site. a. Linker region between ankyrin repeats 3 and 4 
showing the first consensus site (S144, black circle) for PKC mediated phosphorylation according to the Prosite 
algorithm. Serine 155 (red circle) is a potential phosphorylation site only in TRPV6a. Threonine 150 (light grey) 
is the site most likely to be phosphorylated according to the NetPhosK algorithm. Underlined is the peptide 
sequence used for competition. b. Normalized current densities over time for transiently expressed TRPV6-
wildtype (black) and R153Q/R154P mutants (purple) in the presence of 3.7 mM free ATP. c. Normalized current 
densities over time for transiently expressed TRPV6-wildtype recorded in the presence of 609 µM free ATP 
(black trace), 609 µM free ATP + 2 mM competing peptide (blue trace) or without added ATP (grey trace).d-e. 
Quantification of run-down of currents measured in (b) and (c), respectively. f. ATP-agarose pull-down 
experiment with wildtype and R153Q/R154P (QP) mutant fusion proteins of the ARD (aa 43-268). Input or 
bound His-tagged fusion proteins were detected by Western blot using an anti-HIS antibody. Binding was 
competed with 6 mM ATP but not with 6 mM adenosine (ade). 
8.1.3 Regulation of mouse TRPV5 and mouse TRPV6 by PKC-mediated 
phosphorylation 
Both mTRPV6 and mTRPV5 contain positive charges at position 153 and both show the ATP effect 
(Fig. 27b,c). Moreover, mTRPV5 shares the putative consensus sites of TRPV6 except the C-terminal 
T688. Therefore, we recorded from mTRPV5-expressing cells preincubated with PMA to test if 
mTRPV5 is similarly regulated by PMA despite the lack of the C-terminal site. PMA was not able to 
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revert the effects of ATP on mTRPV5 cells indicating the relevance of the C-terminal site for 
regulation by PMA (Fig. 27c). These results, in addition to the aforementioned ATP pull down and 
mutational analyses data, point towards a synergistic role of the C-terminal phosphorylation site 
together with the ARD region in mediating the effect of PMA. 
 
Figure 27: Regulation of other TRPV channels by PKC-mediated modulation: Normalized current densities over 
time for (a) transiently expressed TRPV6a, (b) mTRPV6, (c) mTRPV5-expressing control cells (black) and cells 
that were pretreated for 1hr with 500 nM PMA, also PMA present in bath solution (blue), for both 6 mM ATP 
included in patch pipette, error bars represent +SEM. c. lower panel is the alignment of mTRPV5 and hTRPV6 
showing PKC consensus site T688 in hTRPV6 and lacking in mTRPV5. d. Quantification of run-down (%REM) 
after 10 min, in presence of ATP without (black), or with (blue) pretreatment with PMA. 
8.1.4 Transient expression of TRPV6 is accompanied by increased oxidative 
stress 
When we recorded from cells transiently expressing TRPV6 we noticed that current development was 
faster (Fig. 28b) despite the presence of ATP, but the extent of rundown was similar (Fig. 28a). It is 
well established that thiol oxidizing compounds, including hydrogen peroxide (H2O2), can influence 
ion transport mechanisms (Kourie, 1998) including calcium channels (Zima and Blatter, 2006). We 
therefore investigated if the altered kinetics of currents development could be due to oxidative stress 
accompanying transient transfection. 
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Figure 28: Whole-cell inward current densities (CD) measured at –80 mV ramp potential normalized to CDmax 
and plotted over 10 min recording time. a. Traces are averages of HEK cells stably expressing (black, violet) or 
transiently transfected with (grey, red) TRPV6b. Error bars represent mean  SEM. currents recorded in absence 
or presence of 6 mM ATP as indicted on traces. b. Bar graph showing quantification of the time to half-maximal 
activation for stably and transiently expressing cells in absence and presence of ATP. 
To check if transient transfection causes oxidative stress, we employed the oxidative stress indicator 
2,7-dichlorofluorescin (DCF). The rate of DCF oxidation depends on the concentration of glutathione, 
another alternative target of reactive oxygen species (ROS). Therefore, intracellular oxidation of DCF 
can be used to measure the production of ROS and to monitor the oxidative status of a cell 
(Jakubowski and Bartosz, 2000). The fluorescent signal of DCF in transiently transfected cells was 
almost five times stronger than that of the stable cells (25344 RU vs. 573 RU) (Fig. 29c-f) indicating 
that transient transfection was accompanied by increased oxidative stress which might interfere with 
the interaction between ATP and the channel alter kinetics of current development. 
 
Figure 29: Measurement of H2O2 levels in stably and transiently-expressing TRPV6 cells preincubated with 1 
µM CM-H2DCFDA (DCF). The measurements were performed in 96-well plates at 485 nm excitation and 535 
nm emission. a. Transillumination image of TRPV6b stable cell line b. Fluorescent image of HEK cells 
transfected with TRPV6b using GFP filter. c-d. DCF image of TRPV6 stable and transient cells, respectively. f. 
Quantification of DCF signal, numbers represent count of cells measured.  
To confirm that increased oxidative stress is the reason for the faster kinetics of current development 
observed we recorded TRPV6 currents in stable cell lines in presence of H2O2. While in absence of 
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ATP we could not detect major oxidation-induced differences in current development or rundown (Fig. 
30a, d), the slow-down of current development in the presence of ATP, but not the effect of ATP on 
rundown was much reduced (Fig. 30b-d). These results show that the faster kinetics accompanying 
transient expression in the presence of ATP are to a large extent due to increased oxidative stress, and 
also explain the variability of this parameter. 
 
Figure 30: H2O2 speeds up current development in presence of ATP: Normalized current densities over time for 
TRPV6b stably expressing cells a. Pipette solution contains no ATP, recordings from control cells (black) or 
cells in bath solution containing 1mM H2O2. b. Cells treated as in (a) with 6 mM ATP included in pipette 
solution. c. Recordings from cells in bath solution containing 1mM H2O2 with (red) or without (black) ATP in the 
pipette solution. d. Quantification of run-down (%REM) after 20 min, in absence or presence of ATP in pipette 
solution and without (black), or with (green) inclusion of 1mM H2O2 in the bath solution.  
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8.2 Regulation of ORAI1 channel activity by ROS 
8.2.1 ROS blocks ORAI1 mediated currents 
Ivan Bogeski, Carsten Kummerow and Markus Hoth in our laboratory generated a set of data in which 
they investigated differential redox regulation of ORAI channels as a mechanism to tune T-cell 
responses (submitted manuscript). They show that H2O2 extensively reduced the viability of naïve T-
helper (Th) cells with an IC50 of ~40 µM while effector Th cells were more tolerant with IC50 of ~200 
µM. For the importance of Ca2+ influx in T cell proliferation, they investigated the Ca2+ signal in both 
naïve and effector cells. H2O2 induced a stronger Ca
2+ influx in naïve cells with EC50 ~130 µM vs. 739 
µM for the effector cells. Emptying the stores with thapsigargin (Tg) resulted in a store-activated Ca2+ 
influx that was dose-dependently inhibited by H2O2. Again the naïve cells were more sensitive to the 
effect of H2O2 with IC50 of ~ 10 µM (naïve) vs. 47 µM (effector). Because H2O2 could activate TRPM 
thereby hyperpolarizing the cell membrane and reducing the deriving force for Ca2+ entry, effects of 
H2O2 were also analyzed by comparing cells with similar intracellular Ca
2+ concentration before Tg 
induced influx, the so called “iso-cells”. The iso-cell analyses confirmed that naïve cells are more 
sensitive than effector cells to H2O2-evoked reduction of store activated Ca
2+ influx. These results 
suggest that H2O2 inhibits CRAC channel activity. To investigate this, directly, they obtained whole-
cell patch clamp recordings. Inclusion of 10 mM EGTA in the patch pipette led to passive depletion of 
stores and development of typically inwardly rectifying ICRAC in Jurkat T or human effector T cells. 
The average current density was 2.2 pA/pF within 5 min recoding time. In presence of H2O2, current 
density was reduced to 16% in Jurkat T cells vs 40% for effector T cells, in agreement with the 
imaging data.  
Because T-cell CRAC channel function is mainly encoded for by the Orai1 gene, the next aim was to 
identify the molecular target of oxidation in ORAI1. Here, our collaboration started. We made use of a 
HEK293 cell line stably expressing STIM1 (HEKS1) and co-expressed different Orai1 constructs that 
were necessary to investigate how ROS regulate ICRAC. 
To test how the heterologous expression system correlates with the native one, we transfected the 
HEKS1 stable cell line with Orai1-pCAGGS-IRES-GFP vector (HEKS1O1 cells) and repeated both 
Ca2+ imaging and whole cell recordings. Fura2-preloaded HEKS1O1 cells showed large sustained Tg-
induced increases in [Ca2+]i in absence of H2O2 (Fig. 31a black trace) which is ~ 5 fold larger than in 
HEKS1 cells (Fig. 31b, grey bar). Different concentrations of H2O2 inhibited up to 90% (Fig. 31b) of 
the increase in [Ca2+]i subsequent to Tg addition with an IC50 of 40 µM (Fig. 31c).  
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Figure 31: a. Calcium concentration in Fura 2/AM-loaded HEK-Stim1 (HEKS1) cells transiently transfected 
with Orai1 (HEKS1) before and after addition of different concentrations of H2O2, black trace: 0 µM (n=81), 
green: 10 µM (n=94), blue: 100 µM (n=71), red: 1 mM H2O2, (n=61). b. Quantification of the average change in 
[Ca2+]i between 1200 s and 2000 s with 0 or 1 mM H2O2 in HEKS1O1 (black, red) and HEKS1 cells (grey, pink). 
(grey: n=244, pink, n=220). c. Dose dependence of Tg-induced rise in [Ca2+]i on [H2O2].  
Similarly, patch-clamp analyses of HEKS1O1 cells revealed large IP3-induced currents with an average 
current density of ~-30 pA/pF after 300 s (Fig. 32a black trace). Preincubation for  10 min with 1 mM 
H2O2 reduced current density to ~10 pA/pF (Fig.32a red trace). When tested against a range of 
different H2O2 concentrations and fitted to a sigmoidal dose-response function, the IC50 for H2O2 
induced block of ICRAC was 34 µM. In addition, H2O2 slowed current development. 
 
 
 
Figure 32: a. Whole cell currents were extracted at -80 mV ramp potential, normalized to cell capacitance and 
plotted versus time, from HEK-Stim1 (HEKS1) cells transiently transfected with Orai1 in absence (black, n=15) 
or presence of 100 µM (blue, n=14), or 1 mM H2O2, (red, n=14). For clarity, error bars represent SEM at every 
third data point. b. Average current densities analyzed 300 s after break-in in the absence or presence of 1 mM 
H2O2. c. Dose dependency of H2O2-induced current inhibition. 
Interestingly, H2O2 only causes inhibition of calcium influx when cells are preincubated. Addition of 
H2O2 after CRAC channels activation blocks neither the Tg evoked increase in [Ca
2+]i (Fig. 33a), nor 
ICRAC (Fig. 33b). This suggests that oxidation may either reduce activation or clustering of channels 
directly or of proteins involved in activation (e.g. STIM1). 
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Figure 33: a. Fluorescence (Fura 2/AM) based measurements of [Ca2+]i in Orai1 expressing HEKS1 cells, n=72 
500 µM H2O2 added after development of full Ca
2+ influx induced by 1 µM Tg. b. ICRAC in Jurkat T-cells was 
induced by passive store depletion and analyzed at -80 mV. 500 µM H2O2 added after 3 min recording were 
current was at stable value (representative experiment by Ivan Bogeski). 
8.2.2 ORAI3 channels are insensitive towards oxidation 
As an approach to test whether H2O2 influences channel proteins mediating ICRAC directly or affects 
other proteins involved in activation (e.g STIM) we investigated if and how H2O2 affects other 
homologues of ORAI1. HEKS1 cells transfected with Orai2 (HEKS1O2) showed similar Ca2+ signals 
and inhibition by H2O2 (data not shown). Conversely, the Ca
2+ signal from Fura2 preloaded 
HEKS1cells expressing ORAI3 (HEKS1O3) showed a Tg-induced increase in [Ca2+]i which is smaller 
than that of ORAI1. However, the increase in [Ca2+]i persisted in the presence of 1 mM H2O2 (Fig. 33 
a, b). While HEKS1 cells without overexpression of ORAI show a ~ 50% block of Tg induced increase 
in [Ca2+]i. (Fig. 31b), HEKS1O3 cells show no block, indicating that ORAI3 may have a dominant-
negative effect on endogenous store-operated influx pathways. Whole-cell recordings from HEKS1O3 
cells showed IP3-induced currents with much smaller average current densities compared to ORAI1 (-
4.9±0.4 vs -33±6 pA/pF), but significantly higher than in HEKS1 cells (-0.5 pA/pF). Similar to the 
results obtained with Ca2+-imaging, currents were not blocked by preincubation with 1 mM H2O2 (Fig. 
34 c, d). 
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Figure 34: a. Ca2+ concentration before and after Tg-induced store depletion in Fura 2/AM-loaded HEK-Stim1 
Orai3-transientlytransfected (HEKS1O3) control cells (black, n= 53) or cells treated with 1 mM H2O2 (red, n=54) 
at the shown arrow. b. Quantification of the average change in [Ca2+]i between 1200 s and 2000 s for untreated 
(black) and cells treated with 1 mM H2O2 (red). c. Current densities of ORAI3 currents normalized to cell 
capacitance and plotted versus time of HEKS1O3 control (black) or 1 mM H2O2 pretreated cells (red). d. 
Quantification of current densities at 0 (black) and 1 mM (red) H2O2 from ORAI3-expressing cells. 
8.2.3 Identification of ORAI1´s redox sensor 
When a protein is subjected to a redox reaction, cysteines are usually the targets of the redox agent due 
to their nucleophilic oxidizable thiol group. Comparing the cysteine content of Orai1 and 3 we noticed 
that Orai1 contains 3 cysteines (C126, C143, C195) with C195 being the most extracellularly located 
site. On the other hand, Orai3 contains two additional closely spaced cysteines (likely to form disulfide 
bonds) within the extracellular loop between S3 and S4, but lacks the homolog of Orai1’s C195. 
 
Figure 35: Schematic diagram of ORAI1 and 
ORAI3 showing location of the cysteine residues 
(red circles). ORAI1 has an extracellular C195 
residue lacking in ORAI3 that on the other hand 
contains two closely spaced cysteines likely to form 
disulfide bonds 
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To investigate whether this difference in cysteine content underlies the difference in redox sensitivities 
of the two proteins, we first performed site-directed mutagenesis on Orai1. We mutated the divergent 
cysteine to serine (C195S) and tested regulation by H2O2. Because the bicistronic expression vector 
pCAGGS and Orai1 in pMAX vector were not amenable to site-directed mutagenesis, we subcloned a 
SmaI digested fragment of Orai1 (NT: 119-692) into pBlue. Site-directed mutagenesis was performed 
and mutated fragments were cloned into a SmaI digested EGFP-tagged Orai1 in pMAX vector. An 
additional pMAX vector SmaI site had been previously deleted. Finally, full length Orai1 sequence 
was amplified and cloned back into pCAGGS (Fig. 36). 
 
 
Figure 36: Strategy for cloning different Orai1-mutants. Site directed mutagenesis was done in the Orai1-SmaI 
digested fragment cloned in pBlue script. Fragments containing mutation exchanged with WT fragment of Orai1 
in mEGFP-pMax from which multiple cloning site the SmaI site was previously removed. To obtain the untagged 
ORAI1, full length sequence was amplified out of mEGFP-pMax and cloned into ERV site of pCAGGS 
Measurements of Ca2+ signals from C195S mutants showed that block of Tg-evoked increase in [Ca2+]i 
by 1 mM H2O2 was much reduced compared to wildtype (Fig. 37b, h). Likewise, whole-cell patch 
clamp recordings from the C195S in presence of H2O2 showed an impaired blockade compared to 
wildtype (67 vs 37%) (Fig. 37c,i).  
If C195 is the major reactive cysteine conferring redox sensitivity, then the introduction of cysteine 
residue at the equivalent locus in Orai3 may render Orai3 redox sensitive. We created a potential gain-
of-function mutation by exchanging the glycine, at the cysteine 195 homologous position of Orai3, to 
cysteine (G170C). Both imaging data (Fig. 37e, h) and patch-clamp recordings (Fig. 37f, i) confirmed 
our hypothesis: ORAI3 turned sensitive to H2O2 blockade of both Tg-induced Ca
2+ influx and IP3-
induced ICRAC when a cysteine residue is introduced at the exterior side of the third transmembrane 
domain. 
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Figure 37: Identification of Cysteine 195 as the major redox sensor of ORAI1 a. Schematic topology of Orai1, 
its cysteines (red) and cysteine to serine mutations (blue). b. Calcium imaging experiments of HEKS1 cells 
expressing C195S mutant channels. The black trace (n=45) represents the average of calcium signal in the 
absence of H2O2, the red trace (n=58) the average after addition of 1 mM H2O2, grey and pink correspond to the 
signals without and with 1 mM H2O2 of ORAI1 wildtype. c. Current densities were plotted versus time, colour 
code like in (b). d. Same as in a-c for ORAI3_G170C mutant (n=48 for black and 53 for red), grey and pink are 
ORAI3 wild-type signals. g. Alignment of the C-terminal end of the third transmembrane helix of hORAI1 and 
hORAI3. h. Quantification of the change in [Ca2+]i in HEKS1 cells transfected with ORAI1, ORAI1_C195S and 
ORAI3_G170C, treated or not treated with H2O2. i. Average current densities of ORAI1 (grey, untreated), 
ORAI1_C195S and ORAI3_G170C.  
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8.2.4 Cysteine195 is ORAI1’s major reactive cysteine 
To test whether C195 is the residue mainly involved in sensing redox status, we made use of a 
modified form of biotin (MTSEA-Biotin, Biotrend) that reacts specifically with reactive cysteine 
residues located at the extracellular sites of membrane proteins when applied to nonpermeabilized 
cells. Surface labeling of HEKS1O1 cells showed a weak signal corresponding to the presence of 
reactive sulfhydryl group at the plasma membrane. This signal was much reduced when cells were 
transfected with C195S or Orai3, respectively, indicating that C195 can serve as a sensor for changes 
in extracellular levels of oxidants. 
 
 
Figure 38: Biotinylation of reactive cysteine. HEKS1 cells transfected with C-terminally EGFP tagged ORAI1-
WT, ORAI1_C195S or ORAI3-WT in pMAX were labelled with MTSEA-Biotin, lysed and incubated with 
avidin beads. Protein fraction were separated by SDS-PAGE and blotted to nitrocellulose membrane and detected 
by an anti-GFP antibody. IP is 5% of total input (50 µg), M-Bio is total fraction bound to avidin beads 
8.2.5 Characterization of other cysteine mutants in ORAI1  
We also mutated the other two cysteine residues in Orai1 to test if C195 is the sole sensor or other 
residues also contribute to redox sensitivity. The C143S mutants showed much smaller currents (-
8.01.4 pA/pF) that were significantly reduced by pretreatment with 1 mM H2O2 to -2.70.7 pA/pF 
(Fig. 39c). Similarly, Ca2+ imaging showed reduced signal in HEKS1 transfected with C143S mutants 
(Fig. 39d). Mutating C126 resulted in currents smaller than wildtype (-18.63.4 pA/pF) that were, in 
contrast to wildtype, enhanced by treatment with 1 mM H2O2 likely due to alteration of ion selectivity. 
From whole cell recordings C126 does not contribute to H2O2 induced block of current development, 
although Ca2+ imaging still revealed inhibition (Fig. 39e,d). The triple mutant (TM: C195S, C143S, 
C126S) completely lost inhibition by H2O2 on both Tg-induced Ca
2+ influx and IP3-induced ICRAC with 
average current density (20.43.9 pA/pF) in between the larger wildtype value and the smaller value of 
the C143S mutants (Fig. 39a,b). 
Generated by Foxit PDF Creator © Foxit Software
http://www.foxitsoftware.com   For evaluation only.
                                                                                                                                                          Results 
89 
 
 
 
 
Figure 39: Effect of H2O2 on other cysteine residues in Orai1. a., c., e.. Ca
2+ imaging experiments of HEKS1 
cells expressing the triple mutant C126/143/195/S; C143S or C126S, respectively. The black traces represent the 
average of Ca2+ signal in the absence of H2O2, the red traces represent the average after addition of 1 mM H2O2 
b.,d.,f. Current densities were plotted versus time of mutants as in (a, c, e) with same colour code for non- and 
pretreated cells. g-h. Quantification of the change in [Ca2+]i or current densities of mutants as in (a-f). Black bars 
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are non treated cells and red bars represent average of 1mM-treated cells. The right panel shows the schematic 
diagram of the corresponding measured mutant with WT cysteine residue(s) in red and mutated residue(s) in 
blue. 
8.2.6 Expression of Orai1 and Orai3 in naïve and effector Th-cells. 
As mentioned above, differentiation of naïve into effector Th cells was accompanied by an increased 
tolerance towards H2O2. In addition, differentiation was accompanied by an increase in Orai3/Orai1 
ratio, as found from the qRT-PCR analysis (Fig. 39a,b) performed in our group (Eva Schwarz) as well 
as by another independent group (Lioudyno et al., 2008).The following primer pairs were used for 
amplification of a 193 bp fragment of Orai1 and a 159 bp fragment of Orai3. 
Orai1 for 5-GTACCGGGAGTTCGTGCA-3 
Orai1 rev 5-GGTACTCGTGGTCACTCT-3 
Orai3 for 5-GTGGGTAGTCGTGGTCAG-3 
Orai3 rev 5-GTGGGTAGTCGTGGTCAG-3 
 
To test whether the altered relative expression of the H2O2-sensitive ORAI1 to the H2O2-insensitive 
ORAI3 upon differentiation is the reason for increased Th effector cells tolerance, we transfected 
HEKS1 cells with both Orai1 and Orai3 at a ratio of 5/1. HEKS1O1/O3 cells showed significantly less 
inhibition of ICRAC by H2O2 indicating that even a single subunit of ORAI3 in a heterotetrameric 
complex might be sufficient to alter H2O2 sensitivity (Fig. 39c). 
 
Figure 40: a-b.. Quantitative RT-PCR analyses of Orai1 and Orai3 expression in naïve and 72-96h effector Th-
cells b. Averaged results from 5 independent blood donors with Orai expression normalized to RNA polymerase. 
c. Percent inhibition (CD 1 mM H2O2 /average unblocked CD) for HEKS1 cells expressing Orai1 (light blue), Orai3 
(black) or Orai1 together with Orai3 at a ratio of 5/1(dark blue). Total amount of DNA transfected was 1 µg for 
each condition 
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9 Discussion 
Cell signalling involves communication between different intracellular components to mediate 
perception of stimuli from surrounding milieu while also securing cellular survival and efficiency. Fast 
cellular signalling works by means of second messengers: a complex system of diffusible components 
that convey the necessary molecular information within diverse signal transduction cascades. Calcium 
ions were recognized as second messengers more than 125 years ago (Ringer, 1883) and since then 
have been shown to be involved in synthesis and secretion of growth factors, hormones and 
neurotransmitters. Furthermore, Ca2+ is involved in direct and indirect modulation of processes such as 
proliferation, fertilization, muscle contraction, immune response and apoptosis. Not only is Ca2+ 
important for physiological processes but also an imbalanced [Ca2+]i can lead to development of 
several diseases. Mutations in Ca2+ sensor or binding proteins or in Ca2+ channels lead to molecular 
dysfunction which ranges from altered gene expression to post-translational protein modification 
leading eventually to pathogenesis. For example, an EF-hand malfunction in the Ca2+ binding protein 
calpain-10 has been shown to mediate an increased susceptibility to diabetes (Baier et al., 2000). In 
addition, many neurological and retinal disorders involve neuronal sensor (NCS) proteins. One 
example is autosomal-dominant cone dystrophy which is caused by a mutation in the guanylate 
cyclase-activating protein-1 (Sokal et al., 1998). Moreover, several human diseases including 
autosomal-dominanat hypokalemic periodic paralysis, malignant hyperthermia, Huntignton’s disease 
and several autoimmune diseases are linked to mutations in Ca2+ channels [reviewed in (Carafoli, 
2004)]. A very tight control of Ca2+ homeostasis is therefore vital. Within the blood and the interstitial 
fluids, [Ca2+] is kept between 1-2 mM (Carafoli, 1987; Clapham, 2007) and is regulated via absorption 
from the intestine and mobilization from bones on one side and its excretion via the kidneys or 
deposition in bones on the other side. Intracellularly, [Ca2+] is kept at ~100 nM by the interplay of Ca2+ 
sources, namely Ca2+ channels at the plasma or endo- and sarcoplasmic reticula membranes, and a 
number of ubiquitous Ca2+ pumps and buffers, either soluble or intrinsic to membranes, that reversibly 
complex Ca2+ with variable affinities [Ca2+ signalling reviewed in (Bootman et al., 2001; Carafoli, 
1988; Perez et al., 2008)]. 
The current work aimed at studying mechanisms regulating two Ca2+-selective ion channels belonging 
to two different ion channel families. The results obtained present biochemical and 
electrophysiological evidence that the activity of the Ca2+ selective TRPV6 channel is linked to 
intracellular ATP levels where ATP directly binds to the channel protein and modulates its 
susceptibility to Ca2+-dependent and independent regulatory mechanisms. In addition, the data shows 
that phosphorylation of TRPV6 at two distinct sites opposes the effects of ATP. 
This work also shows that the concentration of extracellular oxidants is able to directly alter the 
activity of ORAI1, but not other closely related members of the same family of channels. The data also 
suggests that modulation by redox is the basis of how T cells become less sensitive when developing 
from the naїve to effector status. Importantly, the results identify a specific residue involved in 
interaction with oxidizing agents. 
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9.1 Sufficient intracellular ATP levels are able to sustain activity of TRPV6 
While processes such as paracellular Ca2+ transfer in intestinal or renal epithelial cells, follow the 
concentration gradient and are energetically “favoured”, cells have to invest a significant fraction of 
their energy to keep the free [Ca2+]i in the nM range against a gradient that it ~10,000 fold higher. 
Therefore, one can anticipate that the activity of a Ca2+-specific channel is regulated by ATP levels to 
allow for Ca2+-influx only when sufficient energy equivalents are available for rapid extrusion. Among 
other channels shown to be regulated by ATP, regulation of KATP channels has been most thoroughly 
investigated. In our work we investigated if and how ATP regulates TRPV6 activity. Whole cell 
recordings show that inclusion of ATP slows down the “on” kinetics of TRPV6-mediated currents and 
protects channels against mechanisms causing inactivation or run-down. Though a related observation 
of the stabilizing effect of ATP on TRPV6 was previously reported, it was not further investigated 
(Hoenderop et al., 2001). 
A well documented feature of TRPV6 currents is the two-component Ca2+-dependent inactivation 
during application of hyperpolarizing pulses to negative potentials, an inactivation that is not observed 
when Ba2+ is the charge carrier (Hoenderop et al., 2001). Part of the ATP effect can be explained by 
interference with Ca2+-dependent inactivation or possibly by a rapid, though low affinity, Ca2+ 
buffering effect of ATP since ATP prevents pulse inactivation with 10 mM internal EGTA but not with 
20 mM BAPTA (Fig. 12). Nevertheless, the sole interference of ATP with Ca2+-dependent mechanisms 
could be excluded by the ATP-induced prevention of rundown during repetitive voltage ramp 
stimulation of wildtype TRPV6 in presence of 20 mM BAPTA and of a mutant lacking the calmodulin 
binding site (CAM). In addition, Hoenderop et al. demonstrated that ATP was able to prevent 
rundown in divalent free bath. 
Thyagarajan and colleagues (Thyagarajan et al., 2008) have recently shown that PIP2 
(phosphatidylinositol-4,5-biphosphate) is, unlike other phospholipid metabolites tested, able to activate 
TRPV6 and prevent Ca2+-induced inactivation. They also showed that Ca2+- but not Ba2+-influx via 
TRPV6 reduces intracellular level of PIP2. In our hands, replenishment of PIP2 via the patch pipette 
solution is not able to prevent rundown. Additionally, a mutant likely unable to bind PIP2 (Rohacs et 
al., 2005) still shows ATP-induced prevention of rundown. Together this data shows that the ATP 
effect is not entirely dependent on PIP2 production nor does it require hydrolysis. In line with a PIP2-
independent effect is the finding that the nonhydrolyzable analogue AMP-PCP is also able to slow 
current development and prevent rundown. Similarly, AMP which cannot be further hydrolyzed slows 
current development and prevents rundown though not as efficient as ATP. The fact that adenosine, 
mono- or diphospho-nucleotides and nucleotides having different nucleobase are either unable to or 
less efficient in preventing rundown than ATP indicates that the ATP effect requires at least one 
phosphate and is nucleotide-specific.  
An additional argument for the link between functional TRPV6 and sufficient ATP is that ATP 
depletion was deleterious to the TRPV6-mediated Ca2+ influx triggered upon shifting to a higher 
[Ca2+]-containing bath. We estimated the intracellular level of ATP that is needed to prevent TRPV6 
Generated by Foxit PDF Creator © Foxit Software
http://www.foxitsoftware.com   For evaluation only.
                                                                                                                                                     Discussion 
93 
 
 
rundown by measuring the % REM to different concentrations of free ATP. The obtained EC50 was 
~378 µM. The cytosole contains 5-10 mM total ATP (Katz and Lorell, 2000), and 14-20 mM total 
Mg2+ (Grubbs and Maguire, 1987). However, Mg-ATP is the most abundant form in the cell leading to 
free [Mg2+]i of 0.5-0.7 mM (Grubbs and Maguire, 1987; Romani and Scarpa, 1992) and free [ATP] i of 
less than 0.5 mM (Gajewski et al., 2003). Thus, the obtained EC50 is in agreement with the 
physiological levels of ATP. 
9.2 Phosphorylation counteracts ATP regulatory effects on TRPV6 
For many ion channels the crosstalk between ATP levels and protein kinases is shown to influence 
channel activities For example, in TRPV1-expressing cells ATP has been shown to increase currents 
evoked by capsaicin or protons through activation of P2Y metabotropic receptors in a PKC-dependent 
manner (Tominaga et al., 2001). Considering the fact that TRPV6 has several putative sites for PKC-
mediated phosphorylation it was conceivable that a mutual influence between the two regulatory 
ligands exists for TRPV6 as well. If higher levels of intracellular ATP were to increase preactivated 
PKC activity and thereby prevent rundown, the prediction would be that inhibiting PKC would lead to 
rundown even when ATP is continuously supplied via the patch pipette. To our surprise, it was not 
inhibition (data not shown) but activation of PKC that led to significant rundown for both alleles (Fig. 
21). Interestingly, TRPV6a showed more extensive rundown with a remaining current that completely 
reverted to the no ATP level. This means that stimulating PKC has distinct effects that are able to 
counteract the effects of ATP. 
In order to analyze the effects of PMA on PKC-mediated phosphorylation we aimed to first prove 
those effects PKC-specific then link them to one or more of the putative phosphorylation sites. 
Specificity was demonstrated by the inability of the PMA analogue, 4-PDD, which is able to bind to 
C1 domains but does not activate PKC, to simulate the effect of PMA. Site directed mutagenesis was 
used to disrupt PKC consensus sites. This enabled us to pinpoint two physiologically relevant PKC 
consensus sites, S144 and T688, which, when mutated to alanine, led to loss of the PMA effect. This 
finding indicates PMA effects involve PKC-mediated direct phosphorylation of the channel. 
Unexpectedly, we were not able to simulate the effects of PMA by mutating the serine or threonine to 
the phosphomimetic aspartic acid residues (data not shown). Though this finding questions whether the 
channel is directly phosphorylated, the in vitro phosphorylation experiment using recombinant PKCßII 
argues that it indeed is. The fact that mutation to aspartatic acid does not revert the ATP effect is 
maybe due to the smaller size of the substituting amino acid or smaller charge to mass ratio compared 
to that added by phosphorylation, hence being unable to sterically hinder the binding of ATP to an 
adjaced site, as discussed below.  
A puzzling observation was that the classical PKC inhibitors (Bis and Gö6983) were not able to block 
the effects of PMA. A thorough screen of available literature revealed that this pair of inhibitors had 
well defined IC50 for PKC isoforms except PKCßII. If phosphorylation were to be mediated by this 
particular isoform of PKC then a specific inhibitor would be needed to block the effect of PMA. This 
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was the case when Ro-31-8220 was applied and suggested that the PMA effect was mediated by 
PKCßII. 
Another puzzeling observation was that the effects of PMA could only be observed with a 
preincubation time that is much longer than needed for translocation of PKC to the membrane. We 
exploited this observation to further confirm that PMA is exquisitely mediated by PKCßII. The 
expression level of this isoform is rather low in HEK293 cells (Feng et al., 1998) requiring prolonged 
preincubation for a sufficient number of enzyme molecules to find their targets at the plasma 
membrane. Overexpression of this isoform actually precluded the need for preincubation and the 
effects of PMA were immediate. 
Besides direct phosphorylation of TRPV6 and steric hindrance of ATP interaction, it is possible that 
PMA has other indirect effects. PMA increases production of ROS within the cell (Chen, 2002) which 
can result in the observed faster current development (see below). In addition, it has been shown that 
stimulation of PKC is accompanied by membrane blebbing, as early as 20 min after stimulation with 
PMA (Goerke et al., 2002). Membrane blebbing is an early hallmark of apoptosis that we also 
observed when we investigated translocation of stimulated PKCßII (data not shown). Accordingly, it is 
possible that PMA-induced current rundown is part of the apoptotic process that the cell undergoes 
when stimulated with PMA. 
9.3 Identification of ATP binding sites in TRPV6 
The in-vitro translated full length TRPV6 protein is retained by ATP-agarose despite the fact that 
TRPV6 lacks typical ATP binding motifs such as Walker motifs A, B, C (Azzaria et al., 1989; 
Gottesman et al., 1996; Loo and Clarke, 1995). We used fusion proteins to “dissect” the protein and 
narrow down a potential ATP-binding site. Pull down experiments using the distal part of the N-
terminus (NP) show variable and inconclusive binding. Whole cell recordings from mutants of the two 
phosphorylation sites within this domain (T298/299A) indicate that phosphorylation is still able to 
revert the effect of ATP although to a less extent than the wildtype. The proximal part of C terminus 
was consistently retained by ATP-agarose. Nevertheless, owing to the poor specificity we anticipate 
that this domain is not physiologically relevant. Conversely, the ARD and CT2 fusion proteins were 
consistently and specifically retained by ATP-agarose and the effect of phosphorylation was 
completely abolished in mutants of phosphorylation sites within both of these domains. These latter 
findings strongly indicate that a binding site at both domains is likely to regulate channel activity.  
In a previous report investigating structural and ligand-binding properties of ARDs of TRPV5 and 
TRPV6, mTRPV6-ARD was not retained by ATP-agarose (Phelps et al., 2008). The discrepancy 
between previous and current findings could be explained by species difference (mouse vs. human), the 
use of different type of agarose which could alter accessibility of ATP to binding due to different linker 
lengths and differences in elution buffers. In contrast to Phelps et al, the elution buffer used in current 
work did not include 2 mM EDTA or 1 mM DTT. Inclusion of the latter components led to reduced 
binding (data not shown). However, taking into account that the binding we observed with rTRPV1 
was weaker than that already demonstrated by the same group in an earlier study (Lishko et al., 2007), 
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we considered the differences in our experimental conditions. Proteins purified under native conditions 
showed similar binding and specificity to those purified in presence of urea. 
Considering possible mechanisms explaining the effect of ATP on channel activity other than direct 
binding, an effect on single channel conductance is unlikely because both identified binding sites are 
distant from the selectivity filter identified in the pore region (Voets and Nilius, 2003). However, it is 
still interesting to perform single channel recordings and investigate whether ATP alters opening time 
duration or open channel probability that has been shown to be reduced by ATP for TRPC6 and 
TRPC7 (Shi et al., 2004) but increased for inositol (1,4,5)-triphosphate receptor (InsP3RI) 
(Betzenhauser et al., 2009). An effect on expression level or exocytosis of TRPV6-containing vesicles 
is argued against by the unchanged maximum current density without vs. with ATP. 
9.4 The Ank3-Ank4 linker region contains essential amino acids for regulation by 
phosphorylation and ATP  
The nature of interaction between ATP and channel protein is unclear. Yet, the opposition of two 
similarly charged moieties, ATP and phosphates added by phosphorylation, suggests an electrostatic 
nature of this interaction. With this assumption in mind we screened residues in the vicinity of 
physiologically relevant phosphorylation sites identified by our data that would mediate this 
interaction. Mutational analysis of the positively charged residues (R153, R154) within Ank3-Ank4 
linker region argues for electrostatic interaction of ATP with TRPV6 at this region. In agreement is the 
competition for ATP by a peptide including sequence of this linker region. 
  
Figure 41: Structure of TRPV6-ARD. The left panel is alignment of ARDs of mammalian TRPV channels 
separated into individual repeats (ANK1-6). Residues that conform to the ankyrin repeat consensus (indicated 
above each repeat) in all species are colored dark green, and ankyrin repeat residues conserved in just mammalian 
TRPVs are colored light green. Residues that are conserved in TRPV ARDs and either are not part of or deviate 
from the ankyrin repeat consensus are colored dark blue for residues conserved in all species and light blue for 
residues conserved in mammalian TRPV ARDs only. For ARDs where a structure is yet to be determined 
(TRPV3, TRPV4 and TRPV5) the human sequences are used. The sequence of crystallized species is used for 
ratTRPV1, ratTRPV2 and mouseTRPV6. The secondary structure of TRPV1-ARD (dark grey) is indicated above 
each repeat, and the secondary structure of TRPV6-ARD (light grey) is shown below. Insertions in TRPV1-4 
compmared to TRPV5 and TRPV6 are shown in red. Left panel: Sequence similarities mapped onto the overall 
structure of TRPV6-ARD. The relative backbone is colored according to sequence similarity in the alighnment 
shown in the right panel (Phelps et al., 2008). 
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The crystal structure of TRPV6 ARD revealed six ankyrin repeats each having characteristic 
antiparallel inner and outer -helices and finger loops connecting the helical layers (Fig. 41) (Phelps et 
al., 2008). Variable residues, most likely specify binding partners, are found on the exposed faces of 
the repeat helices and at the tip of the finger loops while the conserved ankyrin-repeat consensus 
residues consist the hydrophobic core. Hence, the location of the arginine residues at the solvent 
exposed tip of finger loop 3 makes it probable that ligands bind to this region. In addition to the 
arginine residues, the finger loop between ANK3 and ANK4 contains the phosphorylation site shown 
to be physiologically important for the PMA effect (S144) (Fig.25c). This region also contains the 
T150 phosphorylation site, mutants of which still showed the PMA effect, and the polymorphic 
phosphorylation site present only in the ancestral allele (Fig. 42). The variable relevance of different 
residues within this domain points to the importance of conformation of the channel that governs 
exposure of these residues and determines accessibility of the channel to different regulatory ligands. 
 
Figure 42: The ANK3-ANK4 linker region. Right panel is enlarged view of the ankyrin repeats 3 and 4 encircled 
in the schematic presentation of TRPV6 in the left panel. The finger loop3 between ANK3 and ANK4 contains 
three putative PKC phosphorylation sites (red: S144, T150 and S155) in TRPV6a, the S155 is lacking in 
TRPV6b. In addition, the finger 3 contains the arginine residues (white: R153, R154) shown to be essential for 
interaction with ATP. 
9.5 TRPV6 acts as a signal integrator 
Evidence gathered in this work indicates that TRPV6 is able to integrate signals reflecting cellular ATP 
levels on one side and activation of PKCßII on the other side. With sufficient intracellular ATP, influx 
of Ca2+ is permitted through TRPV6 raising [Ca2+]i to a threshold initiating a chain of Ca
2+ dependent 
and independent inactivation mechanisms. Ca2+-ATPases sense the rise of [Ca2+]i above the resting 
levels and start pumping Ca2+ in an ATP-consuming process. A drop in [ATP]i may then constitute a 
feedback signal that down regulates the activity of TRPV6 manifested experimentally as a rundown 
phenomenon. Conversely, at free [ATP]i>400 µM ATP binds at both C- and N-termini of the protein, 
maintaining the channel in an open conformation. The influx of Ca2+ can activate a plethora of 
regulatory mechanisms among which is phosphorylation. A fully functional PKC requires a rise in 
[Ca2+], binding of either diacylglycerol (DAG) or phorbol ester (Burns et al., 1990; Hannun et al., 
1985; Kaibuchi et al., 1981) and anionic lipids, in particular L-phosphatidylserine (PS) (Burns et al., 
1990; Lee and Bell, 1989). It is possible that a rise in [Ca2+]i initiates an upstream signal via a G-
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protein coupled receptor (GPCR) that in turn activates PKCßII (Shirai and Saito, 2002) leading to 
channel phosphorylation. If the channel is phosphorylated, the added negatively charged phosphate 
moieties shield the positive charges at the N-terminus and a yet not well defined putative binding site 
at the C-terminus preventing ATP binding and leaving both termini accessible to inactivation 
mechanisms. The C-terminal domain shown to bind ATP (CT2) contains 11 positively charged amino 
acids upstream to the calmodulin binding domain (Niemeyer et al., 2001) which we show not likely to 
overlap with ATP binding domain (Fig. 12e). Biochemical and mutational analyses can provide an 
insight to residues of most physiological relevance to ATP binding at the C-terminal end of the protein.  
The low binding affinity of ATP to TRPV6 as assessed by an EC50 of ~380 µM allows the channel to 
respond to small drops in [ATP]i due to ATP consumption or due to an increase in [Mg
2+]i. (Romani 
and Scarpa, 2000). The consequent downregulation of TRPV6-mediated Ca2+ current is important to 
occur while [ATP]i is still sufficient for functional plasma membrane Ca
2+-pumps [EC50 for ATP 0.1-1 
µM (Guerini, 1998)] to prevent Ca2+overload.  
The finding that phosphorylation of either the N- or the C-terminal site, while the other is mutated, is 
not sufficient to prevent the effect of ATP implies the need for concerted phosphorylation at both sites 
and provides additional evidence that ATP binds to multiple sites on the channel. Furthermore, PMA-
induced reversion of ATP is observed for mTRPV6 but not mTRPV5, both containing positive charges 
at position 153 but only the latter lacks the C-terminal phosphorylation site, strongly indicating that 
regulation at C-terminal region is an ultimate requirement for tuning channel activity. 
It is possible that ATP binds C- and N- termini on one subunit or on different subunits thus altering the 
channel’s accessibility to inactivation mechanisms or favouring an open conformation. Antcliff and 
associates suggested a model of ATP binding to different subunits of the KATP channel Kir6.2 In this 
model, ATP binds at the interface between two subunits where the phosphate tail of ATP interacts with 
R201 and K185 in the C-terminus of one subunit, and with R50 in the N-terminus of another; the N6 
atom of the adenine ring interacts with E179 and R301 in the same subunit. In this model, contrary to 
our suggested model, ATP-dependent gating favours closure of the Kir6.2 channel (Antcliff et al., 
2005). Our data support a model in which TRPV6 has to decipher multiple signals regarding [ATP]i 
and phosphorylation status that determine the channel activity. A model of how TRPV6 might 
integrate these signals is depicted below (Fig. 43). 
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Figure 43: Model of regulatory mechanisms on TRPV6 by ATP and phosphorylation. To simplify graph, only 
one pore-forming subunit is represented. In the absence of ATP the channel is prone to both Ca2+-dependent 
(calmodulin) and Ca2+-independent regulation and run-down. Sufficient ATP stabilizes N-and C-termini and 
prevents channel run-down. Phosphorylation hinders ATP binding thus reduces its stabilizing effect.  
9.6 Regulation by phosphorylation unravels a minor difference between the two 
human TRPV6 alleles 
The disclosure of the unique geographical distribution of the two alleles of human TRPV6 prompted 
several groups to find functional differences that could have conferred a basis for selection. So far, the 
published studies could detect no difference in electrophysiological experiments (Hughes et al., 2008) 
or a minor clinical difference in occurrence rate of renal stones (Suzuki et al., 2008b) and, using 45Ca2+ 
uptake assay, a higher Ca2+ transport activity of the ancestral allele (Suzuki et al., 2008b). In our hands 
no significant difference could be detected in whole cell recordings obtained from both alleles in 
absence or presence of ATP regarding current densities or kinetics of current development. The three 
non-synonymous substitutions in the derived compared to the ancestral alleles are C157R, M378T, 
M681V. The first substitution (C157R), deletes a putative PKC consencus site (R/SxT). Interestingly, 
minor but still significant differences were detected regarding regulation of both alleles by PKC 
phosphorylation. First: while the %REM of the ancestral allele (TRPV6a) was completely reverted by 
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PMA to the rundown seen in absence of ATP, the reversion was only partial for the new world allele 
(TRPV6b). Second: in absence of ATP, PMA induced no additional rundown for TRPV6a currents 
while TRPV6b %REM was smaller than without PMA preincubation. A possible interpretation of this 
difference is that TRPV6a is already phosphorylated at the ground state. That, in addition to the 
stronger susceptibility of TRPV6a to effects of phosphorylation might be due to the additional PKC 
phosphorylation site (S155) that the new world allele lost with the first polymorphic substitution. 
9.7 Outlook: ROS regulation of TRPV6  
The faster kinetics of current development despite the presence of ATP in HEK cells transiently 
expressing TRPV6 compared to the stably expressing cells support a hypothesis that increased 
oxidative stress alters kinetics of current development. Direct measurement of H2O2 levels and whole 
cell recordings in presence and absence of H2O2 verified the hypothesis (Fig. 29, 30).  
Taking the difference in their cysteine content into consideration, it is interesting to find out whether 
the ancestral and derived alleles react differently to H2O2. Using MTSEA biotin-labeling of reactive 
cysteines can give an insight into susceptibility of the channel protein to regulation by H2O2. Therefore, 
further investigation of ROS regulation of TRPV6 and whether a difference between the alleles 
imposed a selective advantage will be an exciting field for future research.  
9.8 Redox regulation of ORAI channels is a mechanism to tune T-cell responses. 
An efficient but well tuned immune response requires exquisite balance between immune activator and 
suppressor mechanisms. Growing evidence indicates that ROS influence the outcome of an immune 
response. Both enhanced and deficient ROS production have equally been shown to be involved in 
initiation or progression of different diseases (Abramov and Duchen, 2005; Droge, 2005; Imai et al., 
2008; Voss and Siems, 2006). ROS have also been shown to modulate multiple ion channels (Feissner 
et al., 2009). However, it was unknown whether ROS regulates ORAI channels. Our interest in 
regulation of ORAI stems from the fact that ORAI is the main component of CRAC currents in 
immune cells and thus contributes essentially to the Ca2+ signal mediating immune cells’ propagation 
and differentiation in an immune response. 
Current work shows that monocytes produce concentrations of H2O2 that are permissive for survival of 
effector but not of naïve Th cells in their vicinity. Selecting for the effector Th cells, production of ROS 
enhances the clonal proliferation of cells more useful in the immune response. In H2O2-tolerant Th cells 
CRAC currents are likely mediated by heterotetrameric ORAI channels where the levels of ORAI3 are 
higher compared to their expression in naïve cells [Fig. 40 and (Lioudyno et al., 2008)]. ORAI3 
upregulation attenuates the overall inhibitory effect of H2O2 on CRAC currents and permits persistence 
of Ca2+ influx necessary for the immune response. As identified by mutational analyses, C195 is the 
ORAI1's H2O2-sensitive residue. Introduction of cysteine residue at the homologous location rendered 
ORAI3 susceptible to H2O2. 
Altogether, the data suggests that ROS production plays multiple roles during an immune response. At 
the periphery of the ROS gradients surrounding the producing APC, concentration of H2O2 is very low 
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(nM to low µM) and is able to actually enhance proliferation of nearby cells (Droge et al., 1987) likely 
due to an increase in Ca2+-influx. In regions of slightly higher ROS concentrations, Th -cells will 
already undergo partial CRAC channel inhibition that will not yet affect viability of effector –cells 
(Schwarz et al., 2007; Zitt et al., 2004). Within the center of inflammation, ROS concentrations within 
T-cells reach much higher levels through both increased macrophage activity and massive activation of 
the TCR mediated signaling (Reth, 2002) that may then activate TRPM channels (Hara et al., 2002), 
release Ca2+ from intracellular stores, affect phosphorylation, cause irreversible cysteine oxidation and 
ultimately apoptosis (Hildeman et al., 2003). Defects in the cellular H2O2 producing machinery (e.g. 
NADPH oxidases) can lead to autoimmune diseases in humans (Erickson et al., 1992) and mice 
(Hultqvist et al., 2004). This may be caused by inefficient migration of Th-cells to sites of inflammation 
(Niethammer et al., 2009) or compromised Th activation as well as the inability to derive activated Th-
cells into apoptosis. Our results suggest that redox regulation of Ca2+-signaling can be a mechanism to 
control the T-cell mediated immune response. 
 
Figure 44: Model of extracellular ROS production and its effects on Th-cell Ca2+ signaling in inflamed tissues.In 
inflamed tissues, activated macrophages generate H2O2 which affects several Ca
2+ signaling pathways in 
neighboring effector Th-cells. H2O2-induced inhibition of ORAI1 but not ORAI3 tunes Th-cell function, while 
H2O2-induced activation of TRPM channels leads to apoptosis. 
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